Identification of a putative <em>Litomosoides sigmodontis</em> phosphate permease, <em>Ls-ppe-1</em>, and its role in the interaction between filarial nematodes and their Wolbachia endosymbionts & Establishment of RNA interference in the rodent filaria <em>Litomosoides sigmodontis</em>, a model of human filariasis by Klemm, Claudia Ulrike
Identification of a putative Litomosoides sigmodontis
phosphate permease, Ls-ppe-1, and its role in the
interaction between filarial nematodes and their
Wolbachia endosymbionts
&
Establishment of RNA interference in the rodent filaria
Litomosoides sigmodontis, a model of human filariasis
Dissertation
Submitted in fulfillment of the requirements for the doctoral degree (Dr. rer. nat.) at the
Rheinische Friedrich-Wilhelms-University of Bonn
Faculty of Mathematics and Natural Sciences
by
CLAUDIA ULRIKE KLEMM
from Görlitz
Bonn, 2009
Angefertigt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der
Rheinischen Friedrich-Wilhelms-Universität Bonn.
1. Referent: Prof. Dr. Achim Hörauf
2. Referent: Prof. Dr. Hans-Georg Sahl
Tag der Promotion: 12. November 2009
Erscheinungsjahr: 2009
Diese Dissertation ist auf dem Hochschulschriftenserver der ULB Bonn unter
http://hss.ulb.uni-bonn.de/diss_online elektronisch publiziert.
In advance publication of the dissertation
Parts of the results of this study have been published in advance by the permission of
Prof. Dr. Achim Hörauf, Director of the Institute for Medical Microbiology,
Immunology and Parasitology, University Clinic Bonn, Germany.
Publications
Heider, U., Blaxter, M., Hoerauf, A., Pfarr, K.M., (2006) Differential display of genes
expressed in the filarial nematode Litomosoides sigmodontis reveals a putative
phosphate permease up-regulated after depletion of Wolbachia endobacteria.
Int J Med Microbiol 296: 287.
Heider, U. and Pfarr, K.M., Hoerauf, A., (2006) RNAi mediated silencing of actin
expression in adult Litomosoides sigmodontis is specific, persistent and results
in a phenotype.
Int J Parasitol 36: 661.
Pfarr, K.M., Heider, U., Schmetz, C., Büttner, D.W., Hoerauf, A., (2008) The
mitochondrial heat shock protein 60 (HSP60) is up-regulated in Onchocerca
volvulus after the depletion of Wolbachia.
Parasitology 135: 529.
List of abbreviations
APOC African Program for Onchocerciasis Control
APS ammonium persulfate
aRNA amplified antisense ribonucleic acid
BME beta-mercaptoethanol
Bm-WSP Wolbachia surface protein of Brugia malayi
bp base pair
BSA bovine serum albumin
cDNA complementary desoxyribonucleic acid
CI cytoplasmatic incompatibility
CoA coenzyme A
ct cycle threshold
DD PCR differential display polymerase chain reaction
DEC diethylcarbamazin
DEPC diethyl propyl carbonate
Dicer dsRNA-specific ribonuclease / RNase III-like enzyme
dNTP desoxy nucleotide triphosphate
dsRNA double-stranded ribonucleic acid
EDTA ethylenediamin-tetraacetic acid
EM electron microscopy
EtBr ethidium bromide
FAD flavin adenin dinucleotide
FCS fetal calf serum
FITC fluorescein isothiocyanate
GPELF Global Program to Eliminate Lymphatic Filariasis
IL interleukin
i.p. intraperitoneal
IVM ivermectin
kb kilobase
L.s. Litomosoides sigmodontis
LF lymphatic filariasis
LPS lipopolysaccharide
Ls-ppe-1 phosphate permease of L. sigmodontis
MF microfilaria (= the first stage larvae L1)
MOPS 3-(N-morpholino) propane sulphonic acid
mRNA messenger ribonucleic acid
NaAc sodium acetate
NAD nicotineamid adenine dinucleotide
OCP Onchocerciasis Control Program
OD optical density
OEPA Onchocerciasis Elimination Program for the Americas
PBS phosphate buffered saline
p.i. post infection
PTGS post transcriptional gene silencing
RdRP RNA dependent RNA Polymerase
RISC RNA induced Silencing Complex
RLM-RACE RNA Ligase Mediated-Rapid Amplification of cDNA Ends
RNAi RNA interference
RT Reverse Transcription
RT-qPCR Reverse Transcription-quantitative PCR
SDS sodium dodecyl sulfate
siRNA short interfering ribonucleic acid
SPF specific pathogen free
SSC saline-sodium citrate buffer
TEMED tetramethyl ethylene diamin
wBm Wolbachia of Brugia malayi
wMel Wolbachia of Drosophila melanogaster
wPip Wolbachia of Culex pipiens
w/v weight per volume
Table of contents
Table of contents
1 Introduction .............................................................................................................. 1
1.1 Nematodes.........................................................................................................................1
1.1.1 Nematode morphology............................................................................................................... 1
1.1.2 Filarial nematodes ...................................................................................................................... 2
1.1.3 Transmission of filarial infections ............................................................................................. 2
1.1.4 Geographic distribution.............................................................................................................. 4
1.1.5 Pathology of lymphatic filariasis ............................................................................................... 5
1.1.6 Pathology of onchocerciasis ...................................................................................................... 6
1.1.7 The WHO control programs ...................................................................................................... 7
1.2 Wolbachia endosymbionts...............................................................................................8
1.2.1 Phylogeny of Wolbachia ............................................................................................................ 9
1.2.2 Localization of Wolbachia ....................................................................................................... 10
1.2.3 The lifestyle of Wolbachia in filarial nematodes .................................................................... 11
1.2.4 The role of Wolbachia phenotypes.......................................................................................... 12
1.2.4.1 In arthropods................................................................................................................... 12
1.2.4.2 In filariae......................................................................................................................... 13
1.2.5 Anti-Wolbachia treatment in humans...................................................................................... 14
1.2.6 Host adaptation in the endosymbiont genome ........................................................................ 14
1.3 An animal model for helminth infections ...................................................................16
1.3.1 The parasite life cycle of Litomosoides sigmodontis .............................................................. 17
1.4 RNA interference: a robust reverse genetics tool for the future .............................19
1.4.1 The biological function of RNAi............................................................................................. 19
1.4.2 The RNAi pathway................................................................................................................... 19
1.4.3 The characteristics of RNAi..................................................................................................... 21
1.4.4 Delivery methods of dsRNA.................................................................................................... 22
1.4.5 RNAi in filarial nematodes ...................................................................................................... 22
1.5 Objectives........................................................................................................................23
2 Material and Methods ........................................................................................ 24
2.1 Animals ...........................................................................................................................24
2.1.1 Animal maintenance................................................................................................................. 24
2.1.2 Infection cycle .......................................................................................................................... 24
2.1.2.1 Anesthetic ....................................................................................................................... 25
2.1.3 Animal model ........................................................................................................................... 26
2.1.4 Antibiotic treatment and worm recovery................................................................................. 26
2.1.5 Exposure of L. sigmodontis to heat and oxidative stress ........................................................ 27
2.2 RNA extraction ..............................................................................................................28
2.2.1 Worms from human patients.................................................................................................... 28
2.2.2 Worms from animals................................................................................................................ 29
2.2.3 Determination of the RNA concentration ............................................................................... 30
2.2.4 Reverse Transcription .............................................................................................................. 30
2.3 Differential Display........................................................................................................31
2.3.1 cDNA synthesis for Differential Display ................................................................................ 32
2.3.2 Differential Display PCR......................................................................................................... 32
2.3.3 Preparation of denaturing polyacrylamide gels....................................................................... 33
2.3.4 Differential Display gel electrophoresis.................................................................................. 34
2.3.5 Visualization of DD PCR amplicons....................................................................................... 34
2.3.6 DNA gel elution and re-amplification..................................................................................... 34
Table of contents
2.4 Antisense RNA (aRNA) amplification ........................................................................35
2.4.1 Synthesis of fluorescein labeled cDNA probes....................................................................... 36
2.4.2 Synthesis of 32P labeled cDNA probes .................................................................................... 37
2.5 Validation of Differential Display results ...................................................................38
2.5.1 Reverse Northern...................................................................................................................... 38
2.5.2 Northern blot analysis .............................................................................................................. 39
2.5.2.1 RNA gel preparation and running conditions ............................................................... 39
2.5.2.2 Northern blot technique ................................................................................................. 40
2.5.3 Real time-quantitative PCR ..................................................................................................... 40
2.5.3.1 Cycling conditions.......................................................................................................... 41
2.6 Optimization of the RT-qPCR .....................................................................................43
2.6.1 Cloning of PCR products ......................................................................................................... 43
2.6.2 Indicator plates for blue/white selection.................................................................................. 44
2.6.3 Liquid medium for overnight cultures..................................................................................... 44
2.6.4 Long-term bacterial storage ..................................................................................................... 44
2.6.5 Plasmid preparation and sequencing ....................................................................................... 45
2.6.6 Standard gel electrophoresis .................................................................................................... 45
2.6.7 Generation of plasmid standards for RT-qPCR ...................................................................... 46
2.6.7.1 Estimation of copy numbers for a plasmid standard..................................................... 46
2.6.7.2 Standard curves for absolute quantification .................................................................. 46
2.7 RLM-RACE PCR ..........................................................................................................48
2.8 Establishment of RNAi in L. sigmodontis ...................................................................49
2.8.1 Plasmid preparation for RNAi ................................................................................................. 49
2.8.2 In vitro transcription to generate double-stranded RNA ........................................................ 51
2.8.3 Soaking L. sigmodontis in dsRNA........................................................................................... 52
2.8.4 Phenotype assessment .............................................................................................................. 54
2.8.4.1 Video documentation of the worm movements ............................................................ 54
2.8.4.2 Evaluation of the microfilarial release .......................................................................... 54
2.9 Statistical test used.........................................................................................................54
3 Results................................................................................................................ 55
3.1 Altered gene expression after anti-Wolbachia treatment .........................................55
3.1.1 Wolbachia and mitochondria localize in different zones of the hypodermis and are
morphologically different ........................................................................................................ 56
3.1.2 Anti-Y-HSP60 labeling is increased in O. volvulus upon doxycycline treatment ................. 59
3.1.3 Evidence for Wolbachia depletion by staining with Bm-WSP antiserum ............................. 61
3.1.4 No alteration in HSP60 expression in the Wolbachia-free nematode Acanthocheilonemea
viteae ......................................................................................................................................... 62
3.1.5 Quantification of hsp60 transcription following Wolbachia depletion .................................. 62
3.1.6 Spearman Rank Correlation..................................................................................................... 66
3.2 Screening for L. sigmodontis genes affected by tetracycline treatment ..................67
3.2.1 Differential display................................................................................................................... 67
3.2.2 Confirmation assays ................................................................................................................. 68
3.2.2.1 Reverse dot blot with fluorescein labeled probes ......................................................... 69
3.2.2.2 Reverse dot blot with radioactive labeled probes ......................................................... 70
3.2.2.3 Reverse dot blot with radioactive labeled DD PCR products ...................................... 71
3.3 Identification of Litomosoides sigmodontis phosphate permease (Ls-ppe-1) as a
tetracycline up-regulated gene .....................................................................................72
3.3.1 Full-length cloning of Ls-ppe-1 and identification of transcript variants .............................. 72
3.3.2 Phylogenetic analysis of nematode homologues of Ls-ppe-1 ................................................ 76
3.3.3 Quantification of Ls-ppe-1 expression after tetracycline treatment ....................................... 78
3.3.3.1 Northern blot analysis .................................................................................................... 78
3.3.3.2 Real time-quantitative PCR ........................................................................................... 78
Table of contents
3.3.4 Up-regulation of Ls-ppe-1 is specific to Wolbachia depletion............................................... 80
3.3.4.1 Ls-ppe-1 remains elevated after the end of the tetracycline treatment......................... 80
3.3.4.2 Gentamicin treatment of L. sigmodontis has no effect on Ls-ppe-1............................. 80
3.3.4.3 Tetracycline treatment of A. viteae has no effect on Ls-ppe-1 ..................................... 81
3.3.4.4 Ls-ppe-1 is not induced upon oxidative stress and heat shock ..................................... 82
3.4 Quantification of other candidate genes .....................................................................83
3.5 Establishment of RNAi for Ls-act in adult L. sigmodontis .......................................84
3.5.1 RNAi is dependent on the dsRNA concentration ................................................................... 84
3.5.2 RNAi of Ls-act is gene specific............................................................................................... 86
3.5.2.1 Quantification of non-targeted genes: Ls-hsp60 and Ls-gst2 ....................................... 86
3.5.2.2 Testing a non-filarial gene from C. elegans as negative control .................................. 87
3.5.3 Persistence of the RNAi effect in the absence of dsRNA....................................................... 88
3.5.4 Silencing Ls-act produced visible phenotypes in L. sigmodontis........................................... 89
3.5.4.1 Reduced motility after RNAi treatment ........................................................................ 89
3.5.4.2 Reduced release of microfilariae after RNAi treatment ............................................... 91
4 Discussion .......................................................................................................... 92
4.1 Filarial HSP60 is up-regulated in O. volvulus after Wolbachia depletion but not
directly involved in the symbiosis ................................................................................93
4.2 Wolbachia, targets for a new chemotherapy against filarial infections ..................95
4.3 Screening for genes involved in the symbiosis between Wolbachia and its filarial
host...................................................................................................................................96
4.4 Identification of a L. sigmodontis phosphate permease ............................................97
4.5 Characterization and potential function of Ls-ppe-1 ................................................98
4.5.1 Identification of three Ls-ppe-1 sequence variants ................................................................. 98
4.5.2 Phylogenetic studies of nematode homologues of Ls-ppe-1 .................................................. 99
4.5.3 Ls-ppe-1 does not respond to stress stimuli .......................................................................... 100
4.5.4 The hypothetical function of Ls-ppe-1 in the symbiosis....................................................... 100
4.5.5 Prospects................................................................................................................................. 102
4.6 Implementation of RNAi in the model organism L. sigmodontis...........................103
4.6.1 The characteristics of silencing Ls-act .................................................................................. 103
4.6.2 Additional control for off-target effects ................................................................................ 104
4.6.3 The differences between different model organisms ............................................................ 105
4.6.4 Prospects................................................................................................................................. 107
5 Summary .......................................................................................................... 108
6 References........................................................................................................ 110
Appendix A .............................................................................................................. 123
Appendix B .............................................................................................................. 126
Acknowledgment...................................................................................................... 128
Declaration .............................................................................................................. 129
Introduction
1
1 Introduction
1.1 Nematodes
The phylum nematoda includes roundworms that are free-living in water and soil, in
addition to an impressive number of species that are parasitic to plants and animals. Out
of the approximately 20.000 species that have been described thus far, only 138 species
have been found to infect humans (Orihel, Ash, 1995). Thus, parasitic nematodes have a
substantial impact on the infected individuals and the community through corporal
damage and diseases of both humans and domestic animals. These negative effects
include the health of the individual, the psychological and social stigmatization of the
infected individuals, an immense economic impact due to the loss of productivity, and
increased mortality rate (Evans, 1993; Pion, 2002; Little, 2004).
Eight main species of filarial nematodes infect humans. Three of these are responsible
for most of the morbidity due to filariasis: Wuchereria bancrofti and Brugia malayi
cause lymphatic filariasis, and Onchocerca volvulus causes onchocerciasis (river
blindness). The other five species are Loa loa, Mansonella perstans, M. streptocerca,
M. ozzardi and Brugia timori, the last also causes lymphatic filariasis.
1.1.1 Nematode morphology
The filarial nematodes are unsegmented, cylindrical, thread-like worms that are round in
transverse sections. They have four main longitudinal chords, a tri-radiate esophagus
and an esophageal nerve ring. Nematodes have neither a circulatory nor a respiratory
system. The nematodes are sexually dimorphic, and in general the males are much
smaller than females. The worms have one or two gonads that open at the vulva in the
female and in the rectum of the male. Their exoskeleton is composed of a multilayer
collagenous cuticle, which is covered by a lipidic epicuticle, as well as a negatively
charged glycocalyx (Page, 1992).
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1.1.2 Filarial nematodes
Filarioidea is a superfamily of nematoda. The members of this superfamily parasitize
tissues of a great variety of animals, ranging from amphibians to mammals. Insect
vectors are required for development of the immature larvae into the infective third
stage larvae (L3), and for transmission to the mammalian hosts.
Lymphatic filariasis (LF), also known as elephantiasis, is transmitted by several genera
of mosquitoes (Aedes, Anopheles, Culex, and Mansonia). Onchocerciasis is an eye and
skin disease that is transmitted by blackflies of the genus Simulium.
The adult nematodes are long, slender and delicate worms that reside in the lymphatic
vessels (Wuchereria bancrofti, Brugia malayi), subcutaneous nodules (Onchocerca
volvulus, Loa loa), or connective tissues (Mansonella ozzardi, M. perstans) (WHO,
1992; Ottesen, 1994). Because of their habitat selection in tissues, the adults of most
species are rarely seen without tissue section analysis. An infection is typically
diagnosed by the presence of microfilariae, the first stage larvae (either microscopically,
or by finger-prick tests to measure the circulating antigen), which are produced by adult
females and are found in the blood or in the epidermis of the host.
1.1.3 Transmission of filarial infections
The insect vectors take up the microfilariae during blood meals on infected individuals.
Within the insect, the larvae migrate through the gut wall of the arthropod to the thorax
muscles, and develop into infective third stage larvae (L3) in a process that usually
takes 7 to 21 days. Then, these L3 larvae migrate to the mouthparts and are deposited
with the saliva on the skin of the host during subsequent blood meals. Following, the
larvae enter through the lesion made by the insect and develop into adult worms in the
definitive host, thus completing the cycle (Figure 1). The development from infective
L3 larvae to sexually mature adult worms (separate sexes) requires a few to several
months (Orihel, Ash, 1995). The adult nematodes, depending on the species, can
survive up to 15 years in the human host.
Introduction
3
Figure 1. The Life Cycle of O. volvulus
During a blood meal, an infected blackfly (genus Simulium) introduces third-stage filarial larvae onto the
skin of the human host, where they penetrate into the bite wound (1). In subcutaneous tissues the larvae
(2) develop into adult filariae, which commonly reside in nodules in subcutaneous connective tissues (3).
Adults can live in the nodules as many as 15 years. Some nodules may contain numerous male and
female worms. Females measure 33 to 50 cm in length and 270 to 400 µm in diameter, while males
measure 19 to 42 mm by 130 to 210 µm. In the subcutaneous nodules, the female worms are capable of
producing microfilariae for approximately 9 years. The microfilariae, measuring 220 to 360 µm by 5 to
9!µm and unsheathed, have a life span that may reach 2 years. They are occasionally found in peripheral
blood, urine, and sputum, but are typically found in the skin and in the lymphatics of connective tissues
(4). A blackfly ingests the microfilariae during a blood meal (5). After ingestion, the microfilariae migrate
from the blackfly's midgut through the hemocoel to the thoracic muscles (6). There the microfilariae
develop into first-stage larvae (7) and subsequently into third-stage infective larvae (8). The third-stage
infective larvae migrate to the blackfly's proboscis (9) and can infect another human when the fly takes a
blood meal (1). (Centers of Disease Control and Prevention, http://www.dpd.cdc.gov/dpdx)
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1.1.4 Geographic distribution
The geographic distribution of human filariasis is closely linked to the availability of the
specific insect vectors (Figure 2). Filarial infections are endemic in more than 80
countries of the tropics. In these countries 200 million individuals are already infected
and more than 1.33 billion people are at risk of infection (WHO, 2000b, 2008). The
major forms of the human filarial infections are lymphatic filariasis, caused by
W.!bancrofti (90%) and Brugia spp. (10%), and onchocerciasis (river blindness), caused
by O. volvulus.
Lymphatic filariasis is a major health problem in the tropics and sub-tropics of Asia,
Africa, the Western Pacific and part of the Americas. Although the disease is global in
its distribution, around one third of infected people live in India. Another third resides
in the countries of Africa, and most of the remaining in the countries of South-East Asia
and the Pacific Islands. Onchocerciasis is the major cause of blindness in 28 countries in
tropical Africa, but is also prevalent in isolated foci in Latin America (six countries) and
Yemen. It is estimated that there are about half a million blind people due to river
blindness. L. loa, the African eye worm, is distributed in the rain forests of West and
Central Africa (Nutman, 1986). Additionally, Mansonella species can be found in the
tropical regions of Africa and the Amazon region of South America (WHO, 1995;
Fischer, 1997).
Figure 2. Global distribution of lymphatic filariasis.
The areas indicated in red show the countries and territories endemic for lymphatic filariasis.
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1.1.5 Pathology of lymphatic filariasis
In lymphatic filariasis, the adult nematodes reside in the in the afferent lymphatic
vessels. Some patients develop a severe dysfunction of the lymphatic system caused, in
part, by high plasma levels of lymphangiogenic factors (i.e. vascular endothelial growth
factor-C [VEGF-C] and soluble vascular endothelial growth factor receptor-3
[(s)VEGFR-3]) (Debrah, 2006), that finally results in lymph vessel dilation,
lymphoedema and elephantiasis (a painful disfiguring swelling of the limbs) (Figure 3).
Damage and swelling of the scrotum in males, hydroceles, or enlarged breasts in
females often occur. Filariae are responsible for a variety of clinical manifestations. The
majority of infected people are asymptomatic but all of them have hidden damage to the
lymphatic vessels and as many as 40% have damaged kidneys (proteinuria, haematuria).
In the acute and chronic stages of the disease, recurrent debilitating fever attacks occur
by secondary bacterial infections, as well as lymphangitis and elephantiasis (WHO,
2000a).
Figure 3. A typical example of chronic lymphatic filariasis.
Lymphatic filariasis can progress to elephantiasis, a painful, disfiguring disease that has a devastating
effect on the victims and their families and carries a huge social stigma.
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1.1.6 Pathology of onchocerciasis
In contrast to lymphatic filariasis, host inflammatory reactions to dead O. volvulus
larvae (microfilariae) in the skin can cause dermatitis with intensely itching rashes,
wrinkling and depigmentation of the skin (also known as Sowda form, or leopard/lizard
skin), and onchocercomata (subcutaneous nodules) (Figure 4A and B). Nevertheless, the
most serious manifestation consists of ocular lesions that can progress from visual
impairment to blindness (river blindness) (Figure 4C). Onchocerciasis can also lead to
lymphadenitis, resulting in elephantiasis of the genitals and to general debilitation
(WHO, 1995).
Figure 4. The clinical symptoms of onchocerciasis.
The skin is the principle site of infection. A) Intense irritation and itching of the skin occurs in response to
O. volvulus antigens and can lead to cutaneous lesions (Sowda form). B) Subcutaneous nodules are a
significant indicator of infection with O. volvulus and appear in 30% of all cases. Nodules vary in size
and number. C) Ocular lesions appear during chronic onchocerciasis because of the migration and death
of microfilariae in the eye. Conjuctivitis is the first reaction to the microfilariae. Dead microfilariae also
cause corneal infections that can result in sclerosing keratitis and vascularization. Sclerosing keratitis is
the main cause of irreversible blindness due to onchocerciasis.
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1.1.7 The WHO control programs
Endemic countries have established control programs with the aid of the World Health
Organization (WHO) to fight against filarial infections. The Onchocerciasis Control
Program (OCP) has successfully targeted transmission of the blackfly vector, eventually
included ivermectin treatment at the end, but this program ended in 2002.
Currently, there are two programs to control onchocerciasis, the African Program for
Onchocerciasis Control (APOC; http://www.who.int/ocp/apoc), administered in areas of
participating countries hyperendemic for onchocerciasis, and the Onchocerciasis
Elimination Program for the Americas (OEPA; http://www.cartercenter.org) (Richards,
2001; Benton, 2002). Efforts to control lymphatic filariasis are managed by the Global
Program for the Elimination of Lymphatic Filariasis (GPELF) (Molyneux, Zagaria,
2002; Ottesen, 2002; Molyneux, 2003). The ambitious goal of all programs is to reduce
the infection rate, prevent new infections, and eliminate the disease as a major public
health problem. Thus, these control programs use microfilaricidal drugs once or twice a
year in mass administered chemotherapy to interrupt transmission. Administering a
single dose of two drugs concurrently, optimally albendazol (ALB) with either diethyl-
carbamazin (DEC) or ivermectin (IVM) is effective only for one year after treatment.
There are indications that IVM and DEC treatment alone are not sufficient to
completely interrupt transmission since it does not sustainably suppress micro-
filaraemia. The remaining microfilaria level is still high enough to re-establish the
infection within a few years (Borsboom, 2003).
APOC and OEPA administer IVM in regions where onchocerciasis alone is endemic.
The GPELF administers DEC and ALB where lymphatic filariasis is mono-endemic,
and IVM and ALB in areas where lymphatic filariasis is co-endemic with oncho-
cerciasis (most of Africa). There, DEC cannot be used because severe side reactions can
occur when other infections, such as onchocerciasis are also present. The appearance of
severe side effects upon IVM treatment, when given to patients that are co-infected with
L. loa (fast killing of microfilariae leads to encephalitis), inhibits the current mass drug
administration in places where L. loa is co-endemic with onchocerciasis.
The current drugs administered are not sufficient to eliminate filariasis but other
anthelminthic drugs tested are either less effective or they are too toxic (Awadzi, 2004c;
Hoerauf, 2006; Pfarr, Hoerauf, 2006). Drug resistance, especially for DEC (Esterre,
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2001) and ivermectin (Awadzi, 2004a; Awadzi, 2004b), is also becoming more of a
concern to the control programs. Research, which has lead to a new antifilarial therapy,
focuses on the intracellular, endosymbiotic Wolbachia bacteria in filarial nematodes
(see also section 1.2.5).
APOC’s strategy to eliminate the disease is the community-directed treatment with
IVM, which relies on active community participation to distribute IVM treatment to the
individuals who need it. These circumstances lead to an inadequate coverage, and
therefore this program might not succeed. In contrast, the OEPA is rather successful.
Already in 2003, all endemic countries have reached the necessary treatment coverage
of at least 85%. Since then, these countries maintained at least 85% treatment coverage,
which must be sustained to halt the transmission by the end of the decade. Additionally,
there has been no new case of blindness from river blindness, and six of the 13 endemic
areas have likely interrupted transmission.
Mathematical simulation models can help to understand the complex transmission
dynamics of parasitic diseases and are useful tools for studying the prospects of
lymphatic filariasis elimination (Stolk, 2006). The predictions conclude that it is
possible to eliminate lymphatic filariasis by yearly mass treatment, but that the number
of treatment rounds depends on coverage, pre-control MF prevalence and the
macrofilaricidal effects of drugs.
1.2 Wolbachia endosymbionts
Intracellular bacteria were first detected 1924 by Hertig and Wolbach in the
reproductive organs of the mosquito Culex pipiens; a similarity to Rickettsiae was
already noted. In the following years, up until the 1990s, intracellular bacteria with a
similar morphology were detected in most of the insects and many other arthropods like
mites, crustaceans, and spiders. Almost 30 years ago, McLaren and Kozek (McLaren,
1975; Kozek, Marroquin, 1977) first described Rickettsia-like structures in filarial
nematodes using electron microscopy. In the last decade, interest in the endosymbiotic
bacteria in filarial nematodes has rekindled, and the bacteria were positively assigned to
the alpha proteobacteria of the genus Wolbachia (Genchi, 1998; Hoerauf, 1999).
Wolbachia are obligate intracellular bacteria that belong to the order Rickettsiales
(Anderson, Karr, 2001). Further, Wolbachia are present in nearly all species of filarial
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nematodes, including the human infective nematodes W. bancrofti, O. volvulus, and
B.!malayi. A few exceptions for nematodes that lack Wolbachia (sporadic losses during
evolution) are the human pathogenic species L. loa and M. perstans, the rodent filariae
Acanthocheilonemea viteae, and the red deer filariae O. flexuosa (Hoerauf, 1999;
Taylor, Hoerauf, 1999).
1.2.1 Phylogeny of Wolbachia
Wolbachia are classified by their place in molecular phylogenies and can be divided
into eight supergroups (denoted clades A!H). These supergroups were defined by
analyses of the 16S rRNA, wsp (Wolbachia surface protein) and ftsZ genes (O'Neill,
1992; Lo, 2002; Casiraghi, 2004; Baldo, Werren, 2007). An overview is shown in
Figure 5.
The majority of arthropod Wolbachia belongs to clades A and B, and a restricted set of
crustaceans, chelicerates, hexapods and filarial nematodes belong to clades E and F. The
analysis of intracellular bacteria of filarial nematodes revealed two additional clades (C
and D). In detail, clade C contains Wolbachia from the nematodes O. volvulus and
Dirofilaria immitis, and clade D contains Wolbachia from B. malayi, W. bancrofti and
L. sigmodontis (Bandi, 2001b; Lo, 2002; Lo, 2007). Wolbachia of Australian spiders
belong in clade G (Rowley, 2004), while Wolbachia from termites belong in clade H
(Bordenstein, Rosengaus, 2005).
Very recently, Ros et al. discovered a new Wolbachia supergroup (K) in the spider mite
Bryobia  species V and have shown that other Bryobia species (B. praetiosa,
B.!sarothamni, Bryobia species I, and Tetranychus urticae) harbor B-group Wolbachia
(Ros, 2009). The occurrence of two supergroups (B and K) within a single host genus is
very unusual and has previously noted only for arthropod species where they are known
to recombine.
Complete sequences have been determined for three Wolbachia genomes: wMel of
Drosophila melanogaster in clade A (Wu, 2004), wBm of Brugia malayi in clade D
(Foster, 2005), and wPip from Culex pipiens in clade B (Klasson, 2008).
Work is underway to sequence eight additional genomes of other Wolbachia strains of
clades A, B, and D, where only partial sequence information is available.
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Figure 5. Phylogenetic diagram of Wolbachia based on various studies of the genes ftsZ, groEL, gltA
and dnaA.
Letters represent supergroups that have been confirmed on the basis of ftsZ, groEL, gltA and dnaA. The
position of supergroup G is tentative since it was estimated using the wsp and 16S rRNA genes. Host
species are indicated next to each clade or lineage. (Lo, 2007)
1.2.2 Localization of Wolbachia
Wolbachia are found throughout all stages of the life cycle of the filarial nematodes, and
occur clustered within host-derived (presumed) vacuoles. In adult nematodes of both
sexes, Wolbachia are predominantly found in the hypodermal cells of the lateral chords.
In females, Wolbachia are also present in the ovaries, oocytes, and all embryonic and
larval stages within the uteri (Hoerauf, 2003a), whereas they have not been
demonstrated in the muscles, the epithelia of the digestive and genital tracts, nor in the
male reproductive system (Taylor, Hoerauf, 1999; Sacchi, 2002; Büttner, 2003; Kozek,
2005).
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1.2.3 The lifestyle of Wolbachia in filarial nematodes
In filarial nematodes, the Wolbachia endobacteria are transmitted strictly vertically
(transovarially) to the next generation. No evolutionary recent horizontal transmission
to distantly related species, as is seen with insect Wolbachia, has been described. The
treatment of infected nematodes with antibacterial agents not only harms the
Wolbachia, but also adversely affects the biology of the nematode host. These facts
suggest a mutualistic symbiotic co-evolution between Wolbachia and their filarial hosts
(Bandi, 2001a; Taylor, Hoerauf, 2001; Fenn, Blaxter, 2004). Consistent with this, the
phylogenies of the Wolbachia strains from various nematodes closely parallel that of the
worm host (see also Figure 6) (Bandi, 1998; Lo, 2002; Taylor, 2005a). There are also no
indications for multiple infection of a single host, or for the presence of different types
of Wolbachia in a given species.
The Wolbachia of filarial nematodes appear not to be under any genetic selection
pressure, probably due to their mutualistic lifestyle, nor has there been any evidence of
recombination found. These facts are contrary to the positive genetic selection and
recombination documented in arthropod Wolbachia (Jiggins, 2002a; Jiggins, 2002b). As
nematode Wolbachia lack both of these factors the rapid development of resistance to
any drug found to have anti-wolbachial activity would be hindered.
Figure 6. Comparison of Wolbachia and filarial nematode trees.
Symbiont tree (left) is based on results of ftsZ and 16S rDNA phylogenetic analyses. Host tree (right) was
derived from the phylogeny inferred by Xie et al. (1994), after assuming the monophylogeny of the
genera Dirofilaria and Onchocerca and introducing D. repens and O. gibsoni (not included in Xie et al.’s
study). A –D indicate the four main lineages of Wolbachia (Bandi, 1998).
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1.2.4 The role of Wolbachia phenotypes
1.2.4.1 In arthropods
The interactions between Wolbachia and their hosts are very complex and range from
parasitism to mutualism. The Wolbachia bacteria are mainly vertically transmitted from
infected females to progeny through the egg cytoplasm (Werren, 1997). Insect
Wolbachia live mostly parasitic and alter host reproduction in a number of ways to
enhance their own transmission. These alterations include induction of parthenogenesis
(Stouthamer, 1993), feminization of genetic males (Bouchon, 1998), cytoplasmic
incompatibility (CI) (Hurst, 1999), and even killing of male embryos, leading to sex
ratio distortion (Stouthamer, 1999). All these effects are advantageous to Wolbachia and
allow them to persist in the host populations.
Horizontal transmission from one species to another is generally assumed to be rare. In
nature, horizontal transfer can occur when a donor and a recipient host are in close
contact because Wolbachia is assumed to be incapable of surviving outside the host’s
tissues. High rates of natural horizontal transfers were first shown in the parasitoid
wasp, Trichogramma kayakai (Huigens, 2000; Huigens, 2004). Further, insect
Wolbachia are rarely found to be beneficial to their hosts. Although Wolbachia engage
in a wide range of interactions with their hosts, they have never been demonstrated to be
obligate symbionts, but rather facultative (secondary symbionts) to their hosts, because
cured (aposymbiotic) individuals are unaltered physiologically. Then, Dedeine et al.
(Dedeine, 2001) showed that the removal of Wolbachia by antibiotic treatment had a
totally unexpected effect on the parasitic wasp Asobara tabida, aposymbiotic female
wasps were completely incapable of producing mature oocytes and therefore could not
reproduce. In contrast, oogenesis was not affected in the closely related species Asobara
citri that is devoid of Wolbachia. Male reproduction or other physiological functions in
females were unaffected, indicating that the effect on oogenesis is highly specific.
These findings demonstrated the first obligate association between Wolbachia and their
arthropod hosts.
Introduction
13
1.2.4.2 In filariae
In filarial infections of animals and humans it has been demonstrated that Wolbachia are
essential for embryogenesis, larval development and worm survival. Depletion of
Wolbachia by the use of tetracycline antibiotics or its derivates lead to larval moulting
and growth defects, sterility of females, a block in embryogenesis (Genchi, 1998;
Langworthy, 2000; Hoerauf, 2001; Gilbert, 2005; Hoerauf, 2006), and to death of adult
worms (Hoerauf, 2003c; Taylor, 2005a; Hoerauf, 2008). The block of the
embryogenesis after antibacterial treatment is a direct effect to the loss of the Wolbachia
as there are no alterations on embryogenesis or worm vitality seen in treatment of the
Wolbachia-free nematode A. viteae (Hoerauf, 1999).
Several reports have demonstrated that the release of Wolbachia after killing the
microfilariae correlate with pro-inflammatory responses of the infected individuals with
a high microfilaria load by increased serum levels of interleukin (IL)-6, IL-10 and
tumor necrosis factor. These patients show severe reactions directly after treatment with
antifilarial drugs, including periodic fever attacks, headache, and enlargement of the
lymph nodes. Following death of microfilariae, increased levels of Wolbachia antigen,
detectable in the blood, are responsible for these adverse reactions (Allen, 2008; Masud,
2009). Therefore, to lower the potential of these undesired side effects, doxycycline
antibiotics effective against Wolbachia, were applied prior to DEC or IVM treatment.
After doxycycline treatment, the patients had milder reactions to the antifilarial drug,
and their level of inflammatory cytokines was significantly decreased, which in turn
could also be associated to lower microfilaria- and Wolbachia loads (Keiser, 2002;
Masud, 2009).
Turner et al. (Turner, 2006) reported the results of a placebo-controlled trial of
doxycycline for the treatment of W. bancrofti infection. Patients were treated for 3
weeks with doxycycline and were then administered ivermectin plus albendazole 4
months later. The results showed that doxycycline treatment for 3 weeks is sufficient to
significantly reduce the microfilaremia level. Further, the patients of the doxycycline
group experienced moderate adverse events after receipt of treatment with ivermectin
and albendazole, compared to the placebo group.
A similar setup was used to treat patients infected with B. malayi (Supali, 2008). In a
placebo-controlled trial, doxycycline was administered for 6 weeks, and then 4 months
later, the participants received DEC plus albendazole. The prevalence of microfilaremia
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was significantly reduced after doxycycline treatment alone and in combination with
DEC!albendazole. This effect sustained for at least 12 months. The adverse reactions
were lowest in the group receiving doxycycline plus DEC!albendazole and highest in
the placebo group plus DEC!albendazole. These results lead to the conclusion that the
“slow death” of nematodes should be considered to avoid the pathologic symptoms.
1.2.5 Anti-Wolbachia treatment in humans
Doxycycline, used in initial trials against O. volvulus, is an antibiotic that targets the
intracellular, endosymbiotic Wolbachia bacteria, which are found in many filarial
nematodes. The loss of Wolbachia leads to a complete block of the embryogenesis that
remains for at least 24 months after the start of the therapy, and is possibly irreversible
(Hoerauf, 2003b; Hoerauf, 2003c; Hoerauf, 2008). Macrofilaricidal effects were seen in
W. bancrofti when doxycycline was administered for either eight weeks (200 mg/day)
(Taylor, 2005b) or even as few as four weeks (Debrah, 2007). Similarly, a 70%
macrofilaricidal rate was observed when patients infected with O. volvulus were treated
for 6 weeks (100 mg/day). Killing of adult nematodes was detected 27 months post
doxycycline treatment in B. malayi and O. volvulus (Hoerauf, 2008).
Nonetheless, doxycycline regimens are not suitable for mass drug treatment. The
therapy duration of 4 weeks is still too long, and pregnant and/or breast-feeding women
as well as children under eight years of age are excluded from the therapy concept
because of the high risk of sustainable damage caused by the antibiotic.
1.2.6 Host adaptation in the endosymbiont genome
The ubiquity of Wolbachia and their capacity to drastically alter host biology, including
disruption of host reproduction, lead to research strategies that aimed at controlling
vector-borne diseases. Wolbachia were suggested as potential chemotherapeutic targets.
Despite extensive interest in Wolbachia for many years, relatively little is known about
the molecular mechanisms that mediate its varied interactions with different hosts. A
project has been initiated to complete sequencing and annotation of Wolbachia genomes
from different species.
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The first Wolbachia genome from Drosophila melanogaster (wMel) was published in
late 2004 (Wu, 2004). Some incomplete but informative sequences of two more
Drosophila strains, as well as the first complete Wolbachia genome of a filarial
nematode, B. malayi (wBm), revealed a lot of new information in understanding the
host–symbiont interactions (Foster, 2005; Brownlie, 2007). Very recently, the third
complete genome sequence of another Wolbachia strain from the Culex pipiens group
of mosquitoes (wPip) has been published (Klasson, 2008). Comparative analyses of
wBm, wMel and wPip (Foster, 2005; Fenn, Blaxter, 2006; Brownlie, 2007; Klasson,
2008) with other related endosymbionts such as Rickettsia spp., Anaplasma marginale,
and Ehrlichia ruminantium offer new means for empirical study of the symbiosis, thus
finding potential metabolites that might be supplied from Wolbachia to their hosts
(Dale, Moran, 2006).
A characteristic of intracellular endosymbionts is the loss of genetic information
following adaptation to the host. This is verified by the reduced genome size of wBm
(1.1 Mb), which is smaller than wMel (1.3 Mb) and wPip (1.5 Mb), that are strictly
parasitic, and Rickettsia prowazekii, but larger than Mycobacterium, thus reflecting a
long-term endosymbiotic relationship (Sun, 2001).
Wolbachia encode only a limited number of metabolic pathways, and they are able to
make only one amino acid de novo. Wolbachia have lost genes needed to infect new
cells and genes needed to invade the host system. The wBm lack some genes necessary
for DNA repair and genes required for RNA modifications. Wolbachia are not able to
synthesize lipopolysaccharide (LPS), a component of the cell membrane of most gram-
negative bacteria. They also lack genes necessary to cross-link and degrade the
carbohydrate backbone of peptidoglycan that is needed to form a cell wall. Incomplete
pathways for the biosynthesis of vitamins and co-factors like CoA, NAD, biotin, folate
and pyridoxal phosphate makes wBm dependent upon supply of these precursors from
the host.
However, for a better understanding of the symbiosis it is not only important what
Wolbachia has lost, but also what has been kept in the wBm genome. In contrast to
other endobacteria, Wolbachia are able to synthesize the full range of purine and
pyrimidine nucleotide triphosphates. Further, Wolbachia has retained all genes for
cofactors riboflavine, FAD, and heme. To date, there is no evidence of genes for
riboflavine and heme synthesis in the genome of B. malayi (Ghedin, 2004; Ghedin,
2007). Thus, heme might play an important role in filarial reproduction and
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development, as there is evidence that moulting and microfilarial release in D. immitis
and B. pahangi are affected by ecdysteroid-like hormons (Warbrick, 1993), whose
synthesis requires heme. In contrast to most endosymbionts, wBm has preserved the
genes to make all nucleotides. Therefore, Wolbachia could be an essential source of
nucleotides for the host during embryogenesis, when more DNA is required (i.e.
embryogenesis). Additionally, Wolbachia has the genes for a type IV secretion system
(vir genes) that is normally used by intracellular bacteria to secrete various molecules to
the host cells (Masui, 2000; Christie, 2005; Rances, 2008), suggesting that the above
described metabolites could be provided from Wolbachia to the nematode. The
postulated dependencies indicate an exchange of metabolites between wBm and
B.!malayi,  but the traffic across the host derived vacuolar and the bacterial cell
membranes remains unknown. These transport mechanisms should be further
investigated because they might be excellent drug targets.
1.3 An animal model for helminth infections
The Litomosoides sigmodontis mouse model (Chandler, 1932) is the only fully
permissive mouse model for filariasis. To overcome the non-permissivity of inbred
mice to filarial parasites and the inaccessibility of fully permissive rodents to analyses
of all developmental stages, the L. sigmodontis mouse model, originally established by
Petit (Petit, 1992), was used in these studies. This model accommodates the full cycle
from the infective third stage larvae (L3) to the release of microfilariae (MF) in BALB/c
mice, and therefore allows the study and the modulation of distinct states of infection.
L. sigmodontis belongs to the family Onchocercideae. Phylogenetic analyses of the 5S
ribosomal DNA spacers carried out by Xie et al. (Xie, 1994) show high similarity
(97%) to the other members of this family. While in BALB/c mice the full parasite
development was observed, in C57BL/6 mice the worm development cannot proceed
beyond the L4 stage (Le Goff, 2002). Immunological modulation, such as depletion of
CD4+ T cells, results in a higher L. sigmodontis worm burden and an increased and
prolonged microfilaraemia (Al-Qaoud, 1997). IL-5 appears to control adult worm
development and microfilaremia in primary infections (Al-Qaoud, 2000; Martin, 2000;
Volkmann, 2003a). In contrast to wild type mice, IL-5 deficient mice have an up to 200-
fold higher parasite load and prolonged patency (Volkmann, 2001; Volkmann, 2003a),
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which permits prolonged therapeutic regimens (>2 weeks), which is impossible in wild
type BALB/c mice. Another benefit in using IL-5 deficient BALB/c mice rather than
wild type mice is the reduction in inflammatory nodule formation around the adult
nematodes (i.e. less accumulation of neutrophils and eosinophils in the pleural cavity),
facilitating parasite recovery for further analyses.
1.3.1 The parasite life cycle of Litomosoides sigmodontis
This rodent parasite lives naturally in the cotton rat (Sigmodon hispidus), which can
survive very high blood microfilariae levels (up to 10.000 MF/µl blood). During the
blood meal from an infected rat, the arthropod intermediate host (Ornithonyssus bacoti
mite) ingests the microfilariae, which then migrate through the gut wall into the thoracic
muscles where they molt twice to develop into infective L3 larvae within 10-12 days
(see also Figure 7). The L3 larvae migrate to the head and are frequently localized in the
blood-sucking mouthparts. L3 larvae are then transmitted at the next blood meal with
the saliva, and make their way through the skin via the lymphatic vessels to the heart,
the blood circulation and finally to the lungs, from which they penetrate into the
thoracic cavity (Marechal, 1996). Ten days post infection, up to 90% of L4 larvae are
detected in the thoracic and peritoneal cavities, and about 99% reach the thoracic cavity
28 days post infection (Marechal, 1996). The female and male adult worms mature
within 25-33 days when they become sexually mature. The viviparous females release
microfilariae into the thoracic cavity. These microfilariae penetrate the heart and
eventually reach the blood circulation. Microfilariae are detectable in the blood between
days 50-130 post infection. The infection of BALB/c mice ends with the encapsulation
of adult worms by host inflammatory cells and the eventual absorption of dead parasites
by the host.
Mice deficient for IL-5 were used in the following studies. The parasite life cycle is
maintained in cotton rats, due to longer worm survival in the natural host.
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Figure 7. The life cycle of Litomosoides sigmodontis in its natural host, the cotton rat (Sigmodon
hispidus), and the experimental IL-5 deficient BALB/c mouse.
During a blood meal on L. sigmodontis infected rats, the mites (O. bacoti) ingest the microfilariae (MF).
The microfilariae then molt twice into infective third stage larvae (L3). These L3 are transmitted in a
subsequent blood meal to either infect new rats (to close the life cycle) or to Balb/c mice deficient for
IL-5, which were used in subsequent experiments.
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1.4 RNA interference: a robust reverse genetics tool for the future
1.4.1 The biological function of RNAi
During the last decade, RNA interference (RNAi), the sequence specific degradation of
mRNA mediated by homologous double-stranded RNA (dsRNA), has become a
valuable tool for determining the biological role of genes, especially in organisms for
which knockouts cannot be made (i.e. parasitic nematodes). A fundamental difference
between the traditional antisense approaches of the past (the ribozyme technologies) and
the siRNA-based technologies for gene silencing is the use of a very ancient and natural
mechanism found in most cells.
The natural function of RNAi is thought to be a defense mechanism against repetitive
and mobile genetic elements, such as transposons and viruses that are found in all
eukaryotic genomes, from yeast to humans (Scherer, Rossi, 2003; Meister, Tuschl,
2004). Some of these elements replicate through DNA intermediates while others (i.e.
retroelements) replicate through RNA intermediates, but all have the potential to harm if
the host could not fight back by silencing expression. RNAi denotes the ability of
double-stranded RNA (dsRNA) to inhibit homologous gene expression at the RNA or
DNA level. RNAi is an evolutionarily conserved gene-regulatory mechanism with many
species-specific variations, for example in the origin of the dsRNAs and in the number
of homologous RNA silencing proteins expressed.
1.4.2 The RNAi pathway
RNAi refers to a group of related gene-silencing mechanisms, which is triggered by
dsRNAs that vary in length and origin. One mechanism uses relatively long dsRNA
(Figure 8). On entry into the cell cytoplasm, these dsRNAs are recognized by a protein
complex containing a dsRNA binding protein (Rde-4), the dsRNA-specific ribonuclease
(dicer), which rapidly cleaves the dsRNA into short interfering RNA duplexes (siRNA),
a DexH box helicase (drh-1) and a Rde-1 protein which is thought to transport the
siRNAs to the RNA induced silencing complex (RISC) (Geldhof, 2007). The siRNAs
are typically 21-28 base pairs in length and have 5’ phosphates and 2-nucleotide 3’
overhangs. Assisted by an RNA helicase (drh-1), the siRNA-duplexes are unwound
prior to assembly into RISC to help interactions with the target mRNA (Martinez,
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2002). The functional RISC contains only single-stranded siRNA, i.e. the strand
complementary to the targeted mRNA (antisense) is incorporated into RISC. Then the
single-stranded siRNAs in RISC guide the complex to the appropriate sequences in
cellular RNA or DNA. RISC contains an endonuclease that cleaves the targeted mRNA
within the hybridized region. As mentioned, siRNAs are also able to target DNA
(Dernburg, 2000). Complementary sequences in DNA are most likely targeted by
pairing of RISC with nascent RNA transcripts, leading to a histon methylation, which in
turn recruits histone deacetylase to silence the chromatin. Alternatively, siRNAs can
also serve as a primer for a RNA-dependent RNA polymerase, creating many more
siRNAs, thus amplifying or maintaining the RNAi signal. This could explain the
catalytic mechanism of RNAi, because only a few dsRNA molecules are required to
degrade a much larger mRNA population (Fire, 1998).
Figure 8. Schematic overview of RISC formation and dsRNA-mediated mRNA degradation.
On entry into cells, dsRNA is cleaved by Dicer into 21- to 23-nucleotide siRNAs. These siRNAs bind
several proteins to form a large multiprotein complex, RISC, which is thought to unwind the siRNA to
help target the appropriate mRNA. The siRNA/mRNA hybrid is cleaved, releasing the siRNA, and the
mRNA is degraded by endo- and exonucleases. In worms and plants, the siRNA can also serve as a
primer for an RNA-dependent RNA Polymerase, creating more siRNAs (Dillin, 2003).
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1.4.3 The characteristics of RNAi
Sequence-specific gene silencing can be found in almost every organism (Maine, 2000),
but was first described in Caenorhabditis elegans (Fire, 1998), and later demonstrated
in a wide range of other organisms, including parasitic nematodes (Hussein, 2002;
Urwin, 2002; Aboobaker, Blaxter, 2003; Lustigman, 2004; Ford, 2005; Issa, 2005).
Fire et al. (1998) showed in C. elegans that the RNAi effect spreads systemically by the
activity of the SID and RSD proteins throughout the whole organism. Systemic RNAi,
the RNAi signal travels from cell to cell over long distances, is apparently restricted to
worms and plants, where it is called posttranscriptional gene silencing or PTGS
(Weiner, 2003). Feinberg and Hunter (Feinberg, Hunter, 2003) discovered a single
transmembrane protein (SID-1) in C. elegans that allowed passive uptake of dsRNA in
Drosophila cells that naturally lack systemic RNAi. SID-1 preferentially transports
large dsRNA with the result that 500 bp dsRNA silenced up to 1000-fold better than
100 bp dsRNA, and 100 bp dsRNA silenced about 105-fold better than 21 bp siRNAs.
Other research groups have shown that the RNAi effect is heritable to several
consecutive generations without alteration of the genome by microinjection of dsRNA
(Montgomery, Fire, 1998; Chuang, Meyerowitz, 2000; Grishok, 2000; Shi, 2000;
Mello, Conte, 2004). Methods developed for RNAi in C. elegans have also been used in
parasitic helminths of animals and plants with variable success (Lendner, 2008). It is
unclear why some of the genes tested are more susceptible to RNAi than others.
Differences in location, stability and/or levels of target transcript in the parasite could
be important.
However, several research groups were unable to identify genes, which are thought to
be essential for a functional systemic RNAi pathway, including rde-4 (RNA binding in
dicer complex), rde-2 (siRNA accumulation), sid-2 and rsd-2 (both: systemic RNAi) in
H. contortus and B. malayi and the corresponding available species EST data sets
(Zawadzki, 2006; Knox, 2007). In recent studies, there was also no functionally
conserved SID-1 orthologue in filarial worms identifiable (Ghedin, 2007; Hong, 2008;
Kang, Hong, 2008; Viney, Thompson, 2008).
The possible absence of the mentioned genes in some parasitic nematodes could infer
the lack of an effective uptake and spreading pathway. It is also possible that there are
fundamental differences between the RNAi pathways of these nematodes such that
alternative pathways might exist.
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1.4.4 Delivery methods of dsRNA
Several delivery methods including soaking, hairpin transgenes, microinjection and
feeding of bacteria expressing the dsRNA are known to effectively knockdown
transcript levels of targeted genes in C. elegans (Mello, 1991; Tabara, 1998; Timmons,
Fire, 1998; Tavernarakis, 2000; Timmons, 2001; Britton, Murray, 2002; Johnson,
2005). All these methods have been successfully used in large-scale screens of gene
function in C. elegans (Maeda, 2001; Simmer, 2003; Sonnichsen, 2005).
In parasitic nematodes, Issa et al. (Issa, 2005) showed effective RNAi in the sheep
gastro-intestinal parasite Trichostrongylus colubriformis by electroporation using
dsRNA and small synthetic siRNA molecules. Another group introduced dsRNA via
electroporation in Schistosoma mansoni and obtained specific and long-lasting
suppression for >30 days (Correnti, 2005).
1.4.5 RNAi in filarial nematodes
RNAi in filarial nematodes was first described in B. malayi (Aboobaker, Blaxter, 2003).
This group experimentally demonstrated the uptake of dsRNA by adult B. malayi by
soaking the worms in FITC-labeled dsRNA. Soaking of these nematodes with dsRNA
to "-tubulin, microfilarial sheath protein and RNA polymerase II large subunit led to a
reduction in gene expression and a visible phenotype when using microfilarial sheath
protein dsRNA. Another group established RNAi in Onchocerca volvulus L3 larvae and
observed a significant molting defect phenotype when targeting two cysteine proteases,
Ov-cpz and Ov-cpl (Lustigman, 2004), and the serine protease inhibitors Ov-sp-1 and
Ov-sp-2 (Ford, 2005). The success of this technique in adult B. malayi and then later in
O. volvulus larvae was exciting to the field of filariasis as previously there were no
genetic tools for filarial nematodes. However, the technique as described for B. malayi
had its limitation. The dsRNA concentration used was extremely high, circa 15 µM. The
financial cost to perform experiments with such high concentrations of dsRNA would
hinder effective RNAi studies in filariae. Additionally, the authors themselves conceded
that there was apparent off-target gene inhibition in B. malayi. Off-target effects in other
systems have been shown to be the result of toxicity due to high dsRNA concentration
(Yang, 2000; Huppi, 2005).
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1.5 Objectives
Wolbachia, the obligate intracellular endosymbionts of most filarial nematodes, are
essential for embryogenesis and larval development into adult worms, and thus
represent a new target for antifilarial drug development. Despite many years of interest,
very little is known about the molecular basis of the interaction in the symbiosis
between Wolbachia and its filarial host. Thus, the aim of this study was to address
questions concerning the biological function of Wolbachia in the mutualistic symbiosis
with its nematode host.
• Why do filarial nematodes carry Wolbachia?
• Why are Wolbachia so important to their filarial hosts?
• What kind of metabolites and/or pathways may be provided from Wolbachia to
the nematode?
Differential display PCR, a molecular technique to enrich differentially expressed
genes, was used to screen for alterations in gene expression, as the microarray technique
was not yet available for filariae at the beginning of this work. The goal of this study
was to find nematode genes that were up-regulated after depletion of Wolbachia
endobacteria upon tetracycline treatment, and to define the potential function of these
genes in the mutualistic relationship. Further analyses and characterization of these
genes would contribute to a better understanding of the symbiosis.
The second part of this thesis describes the establishment of RNA interference in our
model organism, the rodent filaria L. sigmodontis. Therefore, specific silencing of the
Ls-actin gene was performed. The former success of RNAi in filarial nematodes (adult
B. malayi and O. volvulus L3) was exciting to the field of filariasis since, in the past for
filarial nematodes, no other genetic tools were existent. Thus, the following questions
arose:
• Is RNAi in L. sigmodontis a viable method to assess the biological function of
filarial genes?
• If yes, is it advantageous to use L. sigmodontis for RNAi studies to identify and
validate potential new drug targets?
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2 Material and Methods
The specific instruments used in these studies will be mentioned in the corresponding
section of the materials and methods. All of the chemicals whose supplier is not
specified in this section are either from Sigma-Aldrich (Taufkirchen, Germany), Fluka
(Neu-Ulm, Germany) or Merck (Darmstadt, Germany); the culture medium and its
additives are from PAA Lab. (Coelbe, Germany).
2.1 Animals
2.1.1 Animal maintenance
IL-5 deficient mice on BALB/c background (Kopf, 1996), kindly provided by Dr. Klaus
Matthaei (Division of Biochemistry and Molecular Biology, John Curtin School of
Medical research, Australian National University Canberra, Australia), were housed
under specific-pathogen-free (SPF) conditions in micro-isolator cages. The mice, jirds
(Meriones unguiculatus) and cotton rats (Sigmodon hispidus) were bred at the animal
facilities of the Bernhard Nocht Institute of Tropical Medicine, Hamburg, and after the
year 2004 at the animal facilities of the Institute for Medical Immunology,
Microbiology and Parasitology, University Clinic Bonn.
Clearance for animal studies had been given to the laboratory by the appropriate
authorities (Behörde für Arbeit, Gesundheit und Soziales der Hansestadt Hamburg,
Genehmigungsnummer 34/99, and Bezirksregierung Köln Nummer50.203.2-BN15,
40/04 respectively).
2.1.2 Infection cycle
The parasite L. sigmodontis was maintained by passage through cotton rats (S. hispidus)
and an arthropod intermediate host, the Ornithonyssus bacoti mite, as previously
described (Zahner, Wegerhof, 1986).
The natural infection of mice with L. sigmodontis was carried out as follows. Ten days
prior to infection of mice, the mites, which had been kept in glass containers filled with
10 cm of bedding material and a removable cover, were allowed to have a blood meal
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on an infected rat (>1000 MF/µl blood). Therefore, the infected rat was kept in a small
wire cage and then placed for 4-6 hours onto the hungry mites in a mouse cage.
Afterwards, the rat cage was hung overnight on the inside of the cover to allow the
remaining mites to fall back into the bedding material after the blood meal. Upwards
crawling mites were trapped by cotton pieces placed on the upper side of the removable
cover and were returned back to the glass container. To avoid contamination of the
rooms with mites, the rat cage was placed in a large tray containing water with a
detergent for another 12 hours to guarantee the death of any mites that fell off during
the night. After 10 days, during a subsequent blood meal, the mites transmitted the L3
larvae to the cotton rats to close the cycle, or in case of mice infection, the L3 larvae
containing mites were allowed to take blood from naïve mice and thereby transmit the
L3 larvae. Prior to the blood meal, the mice received 50 µl Rompun/Ketanest
intramuscular as long-term anesthetic. All mentioned processes were at 80-90% air
humidity and a room temperature of 26-28°C.
In the rodent host the L3 larvae migrate to the thoracic cavity and reach sexual maturity
within 25-33 days. After copulation, the viviparous female worms start producing
microfilariae (MF), which are detectable in the blood after 50 days.
2.1.2.1 Anesthetic
Rompun (20 mg/ml, Bayer, Leverkusen, Germany)
Ketanest (10 mg/ml, Parke-Davis, Berlin, Germany)
Rompun is diluted 1:5 (v/v) in Ketanest, (1:1 (v/v) in PBS)
Mix: 200 µl Rompun
400 µl Ketanest
400 µl PBS
50 µl – 100 µl of the solution were injected intramuscular depending on the size (body
weight) of the mice.
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2.1.3 Animal model
The fully permissive IL-5 deficient BALB/c mice (usually 6 to 8 weeks old with an
average weight of 20 g) were chosen to infect with L. sigmodontis. IL-5 deficient mice
have a parasite load up to 200-fold higher than wild type mice and a prolonged patency
(Volkmann, 2001; Volkmann, 2003a). This allows a prolonged therapeutic regime of
more than 2 weeks that would be difficult to perform in wild type BALB/c mice. In wild
type mice, most of adult nematodes are already eliminated by their immune system on
day 80 post infection. The recruitment of neutrophils and eosinophils into the pleural
cavity promote encapsulation and killing of adult worms.
Another benefit in using IL-5 deficient BALB/c mice rather than wild type mice is the
reduction in inflammatory nodule formation around the adult nematodes, facilitating
parasite recovery for further analyses.
2.1.4 Antibiotic treatment and worm recovery
The treatment of IL-5 deficient mice infected with L. sigmodontis was started at day 58
post infection (the time of patency, when released MF are detected in the blood) with
intraperitoneal injections of 50 mg tetracycline per kg body weight per day (Hoerauf,
1999). A single cycle of infection and treatment takes three to four months. Therefore,
multiple infections and treatments were accomplished.
In separate infections, gentamicin, an antibiotic known to be ineffective in eliminating
Rickettsiales, was applied at 15 mg per kg body weight per day (Hoerauf, 1999). The
animals were treated daily for 36 days. Nematode worms were collected on days 3, 6,
15, 30 and 36 of the treatment trial by flushing the thoracic cavity with PBS. The
nematodes were separated by sex, snap frozen in liquid nitrogen and stored at -80°C for
RNA isolation. In additional experiments, the nematode worms were also collected on
days 50 and 70 to analyze the expression pattern of Ls-ppe-1, two weeks and one month
after the treatment has been stopped.
Ornithodoros moubata ticks infected with A. viteae (a filaria devoid of Wolbachia) were
a kind gift from Prof. Dr. Richard Lucius (Humboldt University, Berlin, Germany). The
L3 larvae were isolated and naïve Meriones unguiculatus were infected with 80 L3
larvae as described (Lucius, Textor, 1995). Infected animals carrying adult nematodes
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were treated orally for 6 weeks with tetracycline in drinking water at a concentration of
0.5% (w/v). The water was changed daily. Treated animals were sacrificed at days 3, 6,
15, and 36 post infection and the nematode worms isolated. Nematodes were then snap
frozen in liquid nitrogen and stored at –80ºC for later RNA isolation.
Tetracycline:
50 µg tetracycline dissolved in 10 ml PBS
treatment: intraperitoneal injection of 0.2 ml/mouse daily (for 36 days)
     or
     jirds: 0.5% (w/v) in drinking water (36 days)
Gentamicin:
original stock solution = 50 mg/ml
dilute to 3 mg/ml (900 µl in 15 ml PBS)
treatment: intraperitoneal injection of 0.1 ml/mouse daily (for 36 days)
PBS (phosphate-buffered saline solution)
10#PBS: 80 g NaCl
11.6 g Na2HPO4
2 g KH2PO4
2 g KCl
ad 1000 ml nanopure water
adjust to pH 7.4 when preparing 1#PBS
2.1.5 Exposure of L. sigmodontis to heat and oxidative stress
Oxidative stress was applied to adult L. sigmodontis nematodes (recovered from the
pleural cavity of jirds) with three reagents: 2 mM xanthine-xanthine oxidase; 100 µM
plumbagin; and 200 mM paraquat.
Following a previously described protocol (Liebau, 2000), three replicates of five
female nematodes were used for a single experiment. Nematodes were incubated for 2
hours at 37°C under different oxidative stress conditions. Each experiment was
conducted twice. In parallel, L. sigmodontis were incubated for 2 hours at 42°C to heat
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stress the nematodes (Thompson, 2001). RNA from these worms was extracted and the
transcription levels of Ls-ppe-1 quantified by RT-qPCR (see section 2.5.3).
Additionally, steady state mRNA levels of the L. sigmodontis heat shock protein 60
gene (Ls-hsp-60) was measured to compare Ls-ppe-1 expression to a known stress
response gene. For further details see also Table 2 and Table 3 in section 2.5.3.
Xanthine (Sigma-Aldrich)
Stock solution: 10 mM dissolved in 0.1 N NaOH
Working solution: 0.5 mM, 1 mM, 2 mM in RPMI
Xanthine oxidase (Sigma-Aldrich)
Stock solution: 5 U/200 µl
Working solutions: 0.5 mU, 1 mU, 2 mU in RPMI
Plumbagin (Sigma-Aldrich)
Stock solution: 1 mM dissolved in 50% EtOH
Working solutions: 25 µM, 50 µM, 100 µM in RPMI
Paraquat (Sigma-Aldrich)
Stock solution: 1 M dissolved in nanopure water
Working solutions: 50 µM, 100 µM, 200 µM in RPMI
For the medium control approaches, the same amount of the appropriate solvent was
added to the RPMI culture medium to exclude an effect on the gene expression coming
from culturing conditions.
2.2 RNA extraction
2.2.1 Worms from human patients
Onchocercomata from 16 untreated controls and 23 doxycycline treated patients in
Ghana were extirpated prior to ivermectin treatment, 5 months after the commencement
of doxycycline treatment. Total RNA was isolated from these nodules using the RNeasy
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Maxi kit (Qiagen, Hilden, Germany). The collagenase protocol for heart and muscle
tissue was followed. DNase treatment of the RNA was performed on the column.
2.2.2 Worms from animals
Ten adult female nematodes in 350 µl RLT buffer (containing 10mM BME) were finely
minced with scissors. To homogenize the solution, the lysate was applied onto a
QIAshredder column (Qiagen) and centrifuged for 3 min at maximum speed in a
tabletop centrifuge (Eppendorf). Total RNA was then isolated using the RNeasy kit
(Qiagen) according to the manufacturer’s protocol. The RNA was eluted in 50 µl water.
To eliminate genomic DNA contamination, a DNA digest with RNase free DNase I
(Ambion, Austin, TX, USA) was performed for 30 minutes at 37°C. Next, the RNA was
extracted with phenol chloroform and then precipitated with lithium chloride at a final
concentration of 2.5 M (Ambion) and 10 µg/ml linear acrylamide (Ambion) as co-
precipitant.
For better isolation of small quantities of RNA and to reduce genomic DNA
contamination, a modified Trizol extraction recommended for small volumes was used.
In detail, ten female nematodes in 800 µl Trizol reagent (Invitrogen GmbH, Karlsruhe,
Germany) were finely minced with scissors and then homogenized with a glass-glass
homogenizer at 1200 rpm (Sartorius BBI Systems, Melsungen, Germany). Instead of
chloroform, 80 µl 1-bromo-3-chloro-propane (BCP*) (Sigma-Aldrich, Steinheim,
Germany) was added to separate the homogenate into RNA-containing aqueous and
DNA- and protein-containing organic phases. DNase treatment was performed as
described above and then removed following the RNeasy clean up protocol (Qiagen).
For the RNAi experiments, DNase removal and RNA concentration was achieved using
the RNeasy MiniElute Kit (Qiagen), for which the elution volume could be reduced to
10 µl per sample.
*Note: BCP is less toxic than chloroform and its use reduces the possibility of contaminating RNA with
DNA (Chomczynski, Mackey, 1995).
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2.2.3 Determination of the RNA concentration
RNA concentration was determined at 260 nm using an Eppendorf BioPhotometer
(Eppendorf Inc., Wesseling, Germany). The quality of extracted RNA was assured by
spectrophotometric determination of the OD260/280 ratio. A ratio of 1.7—2.0 was
considered to be free of contaminations such as phenol and proteins.
2.2.4 Reverse Transcription
In general, 1 µg of total RNA was reverse transcribed with the Omniscript RT Kit
(Qiagen) according to the manufacturer’s instructions with oligo-dT primer (Roche),
which bind to the poly-A tail of the mRNAs and thus lead to a selective transcription.
Briefly, the reagents listed in Table 1 were combined and vigorously mixed. Template
RNA was added and the solution mixed again, followed incubation at 37°C for one hour
to reverse transcribe the template RNA into cDNA. The cDNA was then stored at
–20°C for further analysis.
Table 1. Reaction mixture for Reverse Transcription
Components Volume Final concentration
10# buffer RT 2.0 µl 1#
dNTP mix 2.0 µl 0.5 mM (of each dNTP)
oligo-dT primer (10 µM) 2.0 µl 1 µM
RNase inhibitor (10 units/µl) 1.0 µl 10 U
Omniscript Reverse Transcriptase 1.0 µl 4 U
RNase-free water variable
RNA template variable 1 µg
Final volume 20 µl
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2.3 Differential Display
Differential display PCR, first reported in 1992 (Liang, Pardee, 1992; Liang, 1994), is
the method of choice, which allows the identification of differentially expressed genes
in a less labor-intensive way than subtractive library screening and differential
hybridization. Compared to the other techniques mentioned, DD-PCR has some
important advantages: (i) no need to construct and screen libraries, (ii) only small
quantities of RNA are required, (iii) recognition of subtle changes, (iv) study of more
than two variables simultaneously. The procedure consists of two major steps: (i)
reverse transcription of RNA isolated from different cell populations with anchored
oligo-dT primers to generate cDNA pools, and (ii) PCR amplification of random
sequences from the cDNA pools with the original anchored dT primer and an upstream
arbitrary primer (Figure 9).
Figure 9. The principle of Differential Display.
RNA is reverse transcribed with one-base anchored oligo-dT primer (HT11A, HT11C, and HT11G,
GenHunter); 3 cDNA pools result. DD PCR is performed using a series of arbitrary primers (H-AP-1 to
H-AP-14, GenHunter) and the original anchored oligo-dT primer. PCR products run on a sequencing gel,
and following exposed to X-ray film to identify differentially expressed genes. Subsequently, the selected
fragments are re-amplified and cloned for further confirmation analyses.
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2.3.1 cDNA synthesis for Differential Display
To facilitate the resolution of specific differential display PCR (DD PCR) products in
denaturing polyacrylamide gels, three sub-populations of cDNA were generated for the
DD PCR (Figure 9). For this, 200 ng total RNA were reverse transcribed in separate
reactions with three one-base anchored oligo-dT primer: HT11A, HT11C, and HT11G
(GenHunter, Nashville, TN, USA) using the Omniscript Reverse Transcriptase kit
(Qiagen) (see Table 1). Finally, 2 µl of the generated cDNAs were used as template in
the DD PCR.
2.3.2 Differential Display PCR
In the DD PCR amplification, 2 µl (= 20 ng) of the resulting cDNA subpopulation were
used in a 20 µl reaction mixture consisting of 1# PCR Buffer (Qiagen), 20 µM dNTPs
(without dATP), 0.2 µM arbitrary primer (H-AP-1 to H-AP-14, GenHunter), 5 µCi 33P-
dATP (Amersham Biosciences, Freiburg, Germany), 1.25 U Taq DNA polymerase
(Qiagen) and 0.2 µM of the one-base anchored oligo-dT primer originally used for the
cDNA synthesis. The reaction mixture was then covered with oil to avoid evaporation.
After an initial denaturation at 95°C for 5 min, amplification was performed for 25
cycles of 94°C - 30 s; 40°C - 2 min; 72°C - 30 s, and a final extension step at 72°C -
10!min, followed by a 4°C hold.
During the optimization process, the dNTP concentration was lowered from 200 µM to
20!µM, the annealing temperature was finally changed from 45°C to 40°C, and the PCR
cycle numbers were also reduced from 40 to 25 cycles to avoid the amplified products
reaching the plateau phase, where changes in the expression pattern could not be
analyzed.
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2.3.3 Preparation of denaturing polyacrylamide gels
Prior to pouring the gel, the two siliconized glass plates were cleaned in three steps: first
with 0.1 M NaOH, then rinsed with 10% SDS, followed again by rinsing with 0.1 M
NaOH, and subsequently rinsed off with hot water followed by a rinse with deionized
water. Finally, 80% ethanol was used to clean the glass plates and to make them fat-
free. This procedure is not necessary every time. For regular use, the glass plates were
cleaned in soap water, rinsed with deionized water, and finally rinsed with 80% ethanol
to dry the plates.
The polyacrylamide solution was then carefully poured between the two glass plates
(without air bubbles) while the upper glass plate was slowly moved forwards. After
including the comb, the gel was allowed to completely polymerize overnight (wrapped
in wet paper towels to avoid drying out).
Denaturing gel (6% polyacrylamide/ 8M urea)
for 100 ml: 42 g urea
10 ml 10x TBE
20 ml 40% acrylamide (19:1)
340 µl 10% APS
140 µl TEMED
Loading dye for denaturing gels
for 1 ml: 98%    formamide (980 µl)
10 mM   EDTA (20 µl)
0.025%   xylene cyanol
0.025%   bromophenol blue
store at –20ºC.
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2.3.4 Differential Display gel electrophoresis
It is recommended to pre-electrophorese the gel prior to loading the samples on the gel.
This step helps to remove reactive charged compounds (persulfate anions) and low
molecular weight impurities from the gel that may cause artifacts. Additionally, it heats
the gel (no temperature gradient) to facilitate the separation of the PCR products.
Therefore, the empty gel was started for at least 30 min at 1500 V in TBE buffer.
Meanwhile, 3 µl loading dye and 3 µl of the radioactive DD PCR product were mixed,
heated for 2 min at 95ºC, and then the tubes placed directly on ice. The samples were
loaded onto the gel (controls and tetracycline treated samples of each time point side-
by-side for a better comparison) and run for ~3 hours at 1500 V. For a better separation
of the bands on top of the gel, 100 ml 3 M sodium acetate (NaAc) were added to the
lower buffer chamber and the run continued for another 30 to 60 min until the lower dye
front (bromophenol blue) reached the bottom of the gel.
2.3.5 Visualization of DD PCR amplicons
After carefully removing the gel from the glass plates, it was placed onto Whatman
paper, covered with Saran Wrap and dried for 2 hours at 80ºC in a gel-dryer under
vacuum. After an overnight exposure to a Kodak Biomax MR, the film was developed
and the visualized bands were examined for differential gene expression by comparing
control and tetracycline treated samples. The bands of interest were then excised from
dried gels.
2.3.6 DNA gel elution and re-amplification
To isolate the gene fragments, the dried gel was carefully realigned with the
autoradiograph, and a sterile scapel was used to excise the cDNA fragments. A second
exposure to X-ray film was then performed to confirm that the correct fragments had
been excised. To elute the DNA fragments from polyacrylamide gel, the bands were
placed in 100 µl H2ODEPC, incubated for 5 min at room temperature and then heated for
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15 min at 95ºC. After ethanol precipitation with 3 M NaAc the DNA was dissolved in
10 µl H2ODEPC.
4 µl of the gel-eluted fragments were used to re-amplify the differentially expressed
bands by PCR using the matching set of primers and the same conditions as in the initial
DD PCR reaction, omitting radioactivity. The PCR products were then cloned with the
TOPO-TA cloning kit (Invitrogen, Karlsruhe, Germany) following the manufacturer’s
protocol.
Ethanol precipitation of DNA
1/10 Vol. 3 M NaAc
3 Vol. absolute Ethanol
The mixture was precipitated for at least 1 hour at -20ºC, then centrifuged at 4ºC, at
14.000 rpm (Hettich Universal 32R, Tuttlingen, Germany) for 20 to 30 min. The
supernatant was then removed, and the pellet dissolved in 10 µl H2ODEPC.
2.4 Antisense RNA (aRNA) amplification
To produce hundreds to thousands of antisense RNA copies of each mRNA in a sample,
the MessageAmp aRNA kit (Ambion) was used following the manufacturer’s protocol
(Baugh, 2001). Briefly, for first strand cDNA synthesis 2 µg total RNA from
tetracycline-treated or untreated control nematodes have been reverse transcribed with
an oligo-dT primer bearing a T7 promoter. Second strand synthesis was achieved using
the Second Strand Synthesis Buffer, dNTP mixture, RNase H, and DNA polymerase I
of the kit (Ambion). T7 RNA polymerase was then used in the in vitro transcription to
generate antisense RNA, whose primary application is the preparation of labeled cDNA
probes for hybridization (Figure 10).
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Figure 10. Schematic MessageAmp aRNA procedure.
2.4.1 Synthesis of fluorescein labeled cDNA probes
In general, 2 µg of aRNA were reverse transcribed with the Omniscript RT Kit (Qiagen)
according to the manufacturer’s instructions with 10µM oligo-dA primer (Roche).
Briefly, the reagents listed in Table 1 were combined and vigorously mixed. The aRNA
was added and the solution mixed again, followed by one hour incubation at 37°C to
reverse transcribe the aRNA into single-stranded cDNA. The cDNA was then stored at
–20°C for future use. The generated cDNAs were labeled with Amersham ECL
Direct™ Nucleic Acid Labeling and Detection System (Amersham Biosciences).
Therefore, 1 µl of the cDNA (= 100 ng) were mixed with 19 µl H2O and boiled for 5
minutes. Afterwards, the following kit components were added:
10 µl dNTP mix
  5 µl primer
14 µl H2O
  1 µl    Klenow enzyme
50 µl    final volume
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The mixture was incubated for 1 hour at 37ºC, and the reaction stopped with 2 µl 0.5 M
EDTA. The labeled probes were then kept in the dark at -20ºC.
25 µl (= 50 ng) of the ECL-labeled probes were denatured for 5 min at 99ºC, and
subsequently used for dot blot hybridization (see section 2.5.1).
Note: The ECL kit is based on the direct labeling of DNA or RNA probes with horseradish peroxidase
(HRP) in a simple chemical reaction. The resulting probe can be used without purification. Detection is
achieved by generation of light via the HRP-catalyzed breakdown of luminol.
2.4.2 Synthesis of 32P labeled cDNA probes
Radioactive labeled cDNA probes were made from aRNA using the SuperScript II
RNaseH-RT Kit (Invitrogen), following the method from Poirier and Erlander (1998).
2 µg aRNA and 750 ng random hexamers were mixed together and incubated for
10!min at 70°C, the tubes were placed on ice and the following components added:
   5 µl 5# first strand buffer
2.5 µl 25 mM MgCl2
2.5 µl 0.1 M DTT
   1 µl 20 mM d(GAT)TPs
   1 µl 120 µM dCTP
   5 µl   conc. 32P-dCTP (3000 Ci/mmol = 100 µCi)
 24 µl   final volume
Following an initial incubation at 42°C for 5 min, 1 µl SuperScript RNaseH-Reverse
Transcriptase was added and incubated at 42°C for 1 hour. Then, RNA was hydrolyzed
with 3 µl 3M NaOH (68°C, 30 min) and the reaction subsequently neutralized with:
10 µl 1 M Tris-HCl (pH 7.4)
  3 µl 2 M HCl
  9 µl    water
50 µl    final volume
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Unincorporated nucleotides were removed using a Nucleotide Removal Kit (Qiagen)
following the manufacturers protocol. The probe concentrations were normalized by
comparing the incorporation of 32P-dCTP as assessed by liquid scintillation counting
(LKB Wallac 1205 Betaplate, Perkin Elmer, Waltham, MA, USA) before and after the
clean up step.
2.5 Validation of Differential Display results
After DD PCR and cloning of the differentially expressed fragments, three independent
methods: Reverse Northern (Reverse dot blot), Northern blot analysis (to semi-quantify)
and RT-qPCR (to quantify) were used to confirm the genes obtained by differential
display and exclude false-positive candidates from further investigations.
2.5.1 Reverse Northern
For the reverse dot blot method, plasmids containing each candidate gene were isolated
with the Qiaprep Spin Miniprep kit (Qiagen). Plasmids (6 µg each) were spotted onto
Hybond N+ nylon membranes (Amersham Biosciences, Buckinghamshire, UK) using a
96-well dot blotter (BioRad, Hercules, CA, USA) and then UV cross-linked. Separate
blots were hybridized overnight at 45°C in Perfect Hyb solution (Sigma-Aldrich) with
either ECL-labeled or $-32P dCTP-labeled cDNAs from control or the different
tetracycline treatment time points.
The radioactive cDNA probes were generated according to the procedure previously
described by Poirier and Erlander (1998) using 2 µg aRNA and 100 µCi (3000Ci/mmol)
$-32P dCTP. In another approach, radioactive PCR products (see 2.3.2) generated by a
second DD PCR (for which gel-eluted fragments of the initial DD PCR served as DNA
template) were also hybridized to the dot blot membranes. Both kinds of radiolabeled
probes, the DD PCR products from different primer combinations and the cDNA probes
generated from aRNA, were cleaned with a Nucleotide Removal Kit (Qiagen),
normalized by comparing the incorporation of $-32P dCTP by liquid scintillation
counting, and then mixed (the same counts) to probe a single blot for either controls or
tetracycline. As expected from the literature (Poirier, Erlander, 1998), an average
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incorporation of 20 to 30% could be obtained. Hybridization of the dot blots was
performed in the presence of 4.5#106 to 2#107 cpm/cDNA probe.
The hybridized blots were washed three times in 1# SSC, 0.1% SDS for 30 min at 45°C
and then exposed to X-ray film or Phosphor Imager SI screen (Amersham Biosciences).
The program Image Quant for Macintosh version 1.2 (Molecular Dynamics, Sunnyvale,
CA, USA) was used to analyze the data. Only genes that were up-regulated by at least a
factor of 1.5 (arbitrary decision) were analyzed further using Northern blot and qPCR.
20# SSC (pH 7.0)
0.3 M Na3 citrate
3    M NaCl
2.5.2 Northern blot analysis
2.5.2.1 RNA gel preparation and running conditions
For a 1.2% formaldehyde gel, 0.9 g agarose were dissolved in 50 ml H2ODEPC (RNase-
free water) by heating in a microwave and allowed to cool to ~60°C. In a fume hood,
7.5 ml of 10# Running buffer, 13.4 ml formaldehyde (18% fin. conc.) and H2ODEPC were
added to a final volume of 75 ml. The gel was then poured into a gel tray. After 30 min
the gel is completely solid and the samples can be loaded.
The RNA samples were mixed with 5 µl RNA-loading dye (Invitrogen), heated for
5!min at 65°C, and then chilled on ice. The samples were loaded onto a horizontal gel
and the RNA electrophoresed at 100 V for 2 hours (until the bromophenol blue dye had
migrated two-thirds the length of the gel).
Note: Adding ethidium bromide at a final concentration of 1 mg/ml to each sample made staining and
destaining of the gels unnecessary.
10# Running Buffer
0.2 M MOPS buffer, pH 7.0 [3-(N-morpholino) propanesulphonic acid]
50 mM NaAc
10 mM EDTA, pH 8.0
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H2ODEPC
Working solution (0.1%):
1mL DEPC [diethylpyrocarbonate] in 1L destilled water
solution stirred overnight under a fume hood and autoclaved next day
(DEPC in water dissociates in volatile CO2 and ethanol)
Note: DEPC-water is typically used to treat water and other solutions to remove RNases.
2.5.2.2 Northern blot technique
For Northern blots, RNA (2-4 µg/lane) was separated on a 1.2% agarose gel containing
18% formaldehyde (see section 2.5.2.1) and transferred overnight to Hybond N+ nylon
membrane in 10# SSC. Radioactive probes for Ls-ppe-1 (using the initial differential
display clone) and O. volvulus 5S ribosomal RNA were made from 25 ng of excised
insert fragments labeled with $-32P dCTP using the Random Primers DNA Labeling
System (Gibco BRL, Eggenstein, Germany). The blot was probed overnight at 45°C in
7 ml Perfect Hyb solution (Sigma-Aldrich) and 1 ml formamide. Blots were washed
three times in 1# SSC, 0.1% SDS for 30 min at 45°C and exposed to X-ray film. The
software ImageQuant for Macintosh version 1.2 (Molecular Dynamics) was used to
quantify the data.
2.5.3 Real time-quantitative PCR
In general, RT-qPCR was carried out on a RotorGene 3000 (Corbett Research, Sidney,
Australia) using Sybr Green I (Roche). The LightCycler (Roche) was only used to
measure the Ov-hsp60 transcript levels, at a time when the RotorGene was not yet
available in the laboratory. Both cycling machines use hot air to achieve rapid,
controlled heating and cooling of the samples. The RT-qPCR delivers reproducible
quantification of the amplification products. As tested, the results were comparable
between these two machines. Gene specific primers (listed in Table 2) were designed
using the online program Primer 3 located at the URL http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi.
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Primer requirements
• primer length: 18-23 bp
• primer melting temperature: min. 58°C, max. 62°C
• product size: 100-200 bp
• GC content: 30-70%
Table 2. Primer sequences used in RT-qPCR
gene target primer name sequence 5’% 3’
Ls-ppe-1 DD9_F1 AGGCCAAGTTTACTGGCTGTT
Ls-ppe-1 DD9_R1 CTGGATGTTCGACAACGAAGT
Ls-hsp60 LsHspLC_F2 TACGTGAGCCAATCATGACA
Ls-hsp60 LsHspLC_R2 ATCATATCCAAACGCCAACTC
Ls-gst2 UnivGst2_F1 GTGCAGTCCGGTGCTATTCT
Ls-gst2 UnivGst2_R1 ATCACGGATGCCTTCACAG
Ls-18S Ls18S_F1 GTACAAAGGGCAGGGACGTA
Ls-18S Ls18S_R1 CATTGCCGAAAGGTACTGGT
Ls-act / Ov-act OvActin_F1 GTGCTACGTTGCTTTGGACT
Ls-act / Ov-act OvActin_R1 GTAATCACTTGGCCATCAGG
Ov-hsp60 OvHsp60LC Fw CCGGTATGGGAGGAATGTACT
Ov-hsp60 OvHsp60LC Rv TAAGACTCCCTGTTCGCTCAA
Ov-ftsz Ov wFtsZ F AGGAATGGGTGGTGGTACTG
Ov-ftsz Ov wFtsZ R CTTTAACCGCAGCTCTTGCT
2.5.3.1 Cycling conditions
RT-qPCR was performed in duplicate (LightCycler) or in triplicate (RotorGene) using
the following conditions: 1# PCR buffer (Qiagen), 0.2 µM dNTPs, 0.1 µl Sybr Green
(1:1000 dilution of stock in DMSO; Roche), 0.25 U Hotstar Taq polymerase (Qiagen)
and 2 µl cDNA in a reaction volume of 10 µl. For the LightCycler: the reaction volumes
were scaled up to 20 µl final volume). The optimized reaction conditions including final
MgCl2- and primer concentrations for each gene and the corresponding cycling
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conditions used in RT-qPCR are listed in Table 3. Fluorescence was acquired at the end
of each cycle at 72°C using the Sybr Green channel. After amplification, the melting
curve from 62°C to 99°C was measured to check specific product amplification. The
number of RNA molecules (copies/µl) was determined using a gene specific standard
curve of plasmids linearized with HindIII in every run. The transcript levels were
normalized to Ls-act, or in the case of the RNAi experiments to Ls-18S, to compensate
for differences in expression due to under- or over-estimation of the RNA template in
the reverse transcription reactions.
Table 3. Optimized reaction and cycling conditions used in RT-qPCR
gene target [MgCl2] [primer] initial denaturation cycle number cycling conditions
Ls-ppe-1 4.0 mM 300 nM 94°C 15 min 35 94°C  10 s
58°C  15 s
72°C  15 s
Ls-act 3.0 mM 900 nM 94°C 15 min 35 94°C  10 s
52°C  15 s
72°C  15 s
Ls-hsp60 4.5 mM 300 nM 94°C 15 min 40 94°C  15 s
58°C  20 s
72°C  20 s
Ls-gst2 2.5 mM 200 nM 94°C 15 min 40 94°C  10 s
58°C  20 s
72°C  20 s
Ls-18S 2.0 mM 300 nM 94°C 15 min 35 95°C  10 s
54°C  10 s
72°C  15 s
Ov-hsp60 * 4.5 mM F 900 nM
R 300 nM
94°C 15 min 40 94°C  20 s
58°C  20 s
72°C  20 s
Ov-ftsz 1.5 mM F 300 nM
R 300 nM
94°C 15 min 30 94°C  15 s
58°C  30 s
75°C  30 s
* BSA at a final concentration of 2 µg/µl was included in the reaction mix using the LightCycler (Roche).
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2.6 Optimization of the RT-qPCR
Besides optimizing the assay conditions (temperature profile), the optimal primer and
MgCl2 concentrations have to be determined separately for each target gene. This is
especially important for SYBR Green detection assays, as relatively low primer
concentrations are preferable to avoid primer-dimer formation, because SYBR Green is
a generic fluorophore that detects any double-stranded DNA (dsDNA) by intercalating
into the minor groove of the DNA double helix.
For most applications, primer concentrations between 50 nM and 300 nM were tested
against MgCl2 concentrations ranging from 1.5 mM to 5 mM. Once the run is
completed, the cycle threshold (Ct) for each combination was examined. The
combination that resulted in the lowest Ct value and the highest fluorescence was
selected. It is also crucial to analyze the melting curve for each combination tested to
ensure that only a single homogenous product has been generated. All amplified
products can be visualized in the melting curve following the amplification reaction. If
several primer combinations give very similar results, the one with the lowest overall
concentration should be used.
2.6.1 Cloning of PCR products
PCR products were cloned into the TOPO-TA cloning vector (Invitrogen, Karlsruhe,
Germany) according to the manufacturer’s instructions. Therefore, 4 µl of the PCR
product, 1 µl salt solution (kit reagent) and 1 µl TOPO-TA cloning vector were
combined and gently mixed. After 15 min incubation at room temperature, 4 µl of the
reaction mixture was added to chemically competent Escherichia coli DH5$ bacteria
(supplied with the kit), and incubated for 5 min on ice. Then, 10 µl and 40 µl of the
transformed bacteria solution were spread on pre-warmed agar plates containing
ampicillin (100 µg/ml), IPTG (0.5 mM), X-gal (40 µg/ml). Plates were incubated
overnight at 37°C. The plasmid-containing positive colonies (white) as determined by
blue/white screening were picked, confirmed by colony PCR with either vector primers
or gene-specific primers, and subsequently cultured overnight in 5 ml Circlegrow
medium containing 50 µg/ml ampicillin for plasmid isolation.
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2.6.2 Indicator plates for blue/white selection
35 g LB (Luria-Bertani, Sigma) agar were dissolved in 1000 ml nanopure water and
autoclaved for 20 min at 15 psi. The solution was allowed to cool to 55ºC, and was then
supplemented with 100 µg/ml ampicillin, 0.5 mM IPTG and 40 mg/ml X-gal. The
solution was poured into culture dishes, allowed to solidify and then stored at 4ºC until
further usage.
2.6.3 Liquid medium for overnight cultures
40 g Circlegrow powder (Q-Biogene, Heidelberg, Germany) were dissolved in 1000 ml
nanopure water and autoclaved for 20 min at 15 psi and stored at 4ºC until further use.
Circlegrow is used as liquid medium for overnight cultures and contained 50 µg/ml
ampicillin.
Ampicillin (Sigma-Aldrich)
Stock solution: 100 mg/ml ampicillin dissolved in sterile nanopure water
X-gal
(5-bromo-4-chloro-3-indolyl-beta-D-galactoside; Labscientific, Livingston, NJ, USA)
Stock solution: 20 mg/ml X-gal dissolved in dimethylformamide
stored at 4ºC in the dark
IPTG
(isopropylthio-beta-D-galactoside; Labscientific, Livingston, NJ, USA)
Stock solution: 1 M dissolved in nanopure water with subsequent sterile filtration
2.6.4 Long-term bacterial storage
To prepare a frozen permanent stock solution, 850 µl of the overnight culture were
mixed with 150 µl sterile glycerol, shock frozen in liquid nitrogen and then stored at
–80°C until further use.
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2.6.5 Plasmid preparation and sequencing
Alkaline lysis was performed to isolate the plasmids from 5 ml overnight culture using
the Qiaprep Spin Miniprep kit (Qiagen) according to the manufacturer’s instructions.
About 2 µg of the yielded plasmid were sent for sequencing to verify the insertion of the
cDNA into the vector (MWG Biotech AG, Ebersberg, Germany).
2.6.6 Standard gel electrophoresis
In electrical fields, DNA molecules of different sizes can be determined by separation in
standard agarose gels. Agarose was dissolved in TBE buffer by heating in a microwave,
after cooling down to ca. 50°C, 0.2 µg/ml ethidiumbromide (EtBr) was added. The
solution was poured into a horizontal gel tray (BioRad, Munich, Germany). 5 µl of the
PCR product were mixed with 1 µl 6# loading dye (MBI-Fermentas, St. Leon-Rot,
Germany) and applied into the slots of the gel. Electrophoresis was performed at 100
Volt for 30 to 40 min in TBE buffer. DNA was then visualized by the activation of the
DNA intercalating substance ethidiumbromide by UV light and photographed
(Mitsubishi, Japan). The molecular weight was standardized with a DNA molecular
weight marker (100 bp Marker; MBI-Fermentas, St. Leon-Rot, Germany) run on the
same gel.
TBE (Tris-borate-EDTA)
10# Stock solution: 108 g Tris
  55 g boric acid
 9.3 g Na2EDTA&2H2O
ad 1000 ml nanopure H2O
Working solution: 0.5# stock solution
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2.6.7 Generation of plasmid standards for RT-qPCR
The circular plasmid DNA purified from overnight cultures of transformed E. coli
bacteria was linearized with HindIII in the appropriate buffer system (both from New
England Biolabs GmbH (NEB), Frankfurt, Germany) to avoid the formation of
secondary structures and allow a reproducible performance of the polymerase enzyme
activity in each PCR run. Serial dilutions of the gene specific standard curve, in general
1:10 dilutions ranging from 106 to 101 copies/µl, were used in every run to quantify the
steady state mRNA level (copies/µl) in each sample.
2.6.7.1 Estimation of copy numbers for a plasmid standard
   Calculation of copy numbers by means of the Ov-hsp60 plasmid standard
    (using OvHsp60LC primers):
    insert     151 bp
    vector          +3957 bp
    total               4108 bp 4108 bp # 660 Da/bp = 2.71#106 g/mol
OD260 (plasmid stock) = 0.551 µg/µl
       (0.551#10-6 g/µl) # (6#1023 copies/mol) = 1.22#1011 copies/µl
(2.71#106 g/mol)
2.6.7.2 Standard curves for absolute quantification
The most direct and precise approach to measure the exact level of template in a sample
is to use a standard curve (absolute quantification) that is prepared from a dilution series
of control template of known concentration. The data generated from a serial dilution of
a standard curve also determines the overall performance of the RT-qPCR assay in
terms of efficiency, precision, and sensitivity. To accomplish this, the reactions were
performed in triplicate, for high and low concentrations of starting template. The
standard curve plot of the log of starting template vs. PCR cycles generates a linear fit
with a slope between approximately –3.1 and –3.6, a typically acceptable range required
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for accurate quantification (90-100% reaction efficiency). An example is illustrated in
Figure 11. A standard curve of defined concentration was always included in the same
RT-qPCR run as the unknown samples. The software compared the threshold cycle (Ct)
values of the unknown samples to the standard curve to determine the starting
concentration of each unknown. The Ct value is inversely proportional to the initial
copy number.
Figure 11. An example for a gene specific standard curve.
The amplification blot (upper panel) and the resulting standard curve (lower panel) are shown. In this
example, the data of a dilution series ranging from 106 to 100 copies/µl generate a linear standard curve
with a slope of –3.36, which is well in the acceptable range, and an amplification efficiency value of 0.98
(98%) was considered acceptable.
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2.7 RLM-RACE PCR
The FirstChoice' RLM-RACE Kit (Ambion) was used to obtain full-length cDNA
clones of Ls-ppe-1 mRNA. The RNA Ligase Mediated Rapid Amplification of cDNA
Ends (RLM-RACE) permits ligation of a synthetic RNA adapter only to the 5’ end of
decapped RNA, thus selecting for full-length messenger RNA.
Total RNA was used to ligate the adapter sequences to the 5’end and the 3’end
following the manufacturer’s protocol. Using the adaptor primers and gene specific
nested primers, a nested PCR was performed. The PCR amplification for both rounds of
PCR was carried out in 50 µl reaction volumes containing 1# PCR buffer, 4 mM MgCl2,
dNTPs to a final concentration of 0.2 µM, 0.3 µM of the adapter primer and the gene-
specific primer, 1.25 U Super Taq Plus extended range DNA polymerase (Ambion) and
1 µl cDNA. After denaturing at 95°C for 5 min, there were 35 cycles of: denaturation at
94°C for 30 s, annealing at 58°C for 30 s, and extension at 68°C for 2 min. The gene
specific nested Ls-ppe-1 primers used are listed in Table 4.
The resulting PCR products were cloned into the TOPO-TA cloning vector (Invitrogen),
the plasmids isolated with Qiaprep Spin Miniprep Kit (Qiagen) and sequenced by
MWG Biotech AG (Ebersberg, Germany). Individual clones were sequenced on both
strands using vector primers. The Swiss EmbNet ClustalW server, BioEdit version 7.0.0
and GeneDoc version 2.6.002 (Nicholas, Nicholas, 1997) were used to align and edit the
L. sigmodontis sequences.
The translated protein, Ls-PPE-1, was scanned for prediction of signal peptides and sub-
cellular localization with SignalP  3.0 (Bendtsen, 2004b), TargetP 1.1 (non-plant
network) (Emanuelsson, 2000) and SecretomeP  2.0 (Bendtsen, 2004a). For each
organism class in SignalP, Eukaryote, Gram-negative and Gram-positive, two different
neural networks were used, one for predicting the actual signal peptide and one for
predicting the position of the signal peptidase I cleavage site. The hidden Markov model
(HMM) calculated the probability of whether the sequence contained a signal peptide or
not. The eukaryotic HMM model also reported the probability of a signal anchor.
Furthermore, a possible cleavage site was assigned. The TargetP server predicted the
localization (i.e. chloroplast transit peptide, mitochondrial targeting peptide or signal
peptide for secretory pathway). The Secretome server was trained to predict the
possibility of non-classical secreted proteins.
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Table 4. Primers for Ls-ppe-1 used in RLM-RACE
gene target primer name sequence 5’% 3’
Ls-ppe-1 DD9-pcDNA-R GAGGATTAACGTCAAACCCAT
Ls-ppe-1 DD9-Ls-R3 TACAGTAACACATAGATCGG
Ls-ppe-1 DD9-5Race1R AAGTTACCGCTGCACCGAAT
Ls-ppe-1 DD9-5Race2R ATACCACGCTTCCCACCAAT
Ls-ppe-1 DD9-gwR1 CAATATCCAACGAATGAACTTCAT
Ls-ppe-1 DD9-gwR2 CGGTAAAAGCTTGTATCGAACT
Ls-ppe-1 DD9-gwR3 CAATCCTTGATAGCTAGCGG
Ls-ppe-1 DD9-gwR4 ACGCGCAAGTGTAGCAATTAAT
Ls-ppe-1 DD9-gwR5 GTATTCCAGCAACACCTCGT
Ls-ppe-1 DD9-gwR7 CAAGCACAAAAGCCAAAATTACAC
Ls-ppe-1 DD9-gwR8 GACATCTTCCTTTATTTCTCAGTTA
Ls-ppe-1 DD9-gwF GAAACGAAAAAGGGTGAAGAAAA
Ls-ppe-1 DD9-gwF2 ATTAATTGCTACACTTGCGCGT
Ls-ppe-1 DD9-gwF3 GGCAATGGGTTTGACGTTAATC
Ls-ppe-1 DD9-gwF4 CATCAGTTCACTCATTCTCATC
Ls-ppe-1 DD9-pcDNA-F CCGATCTATGTGTTACTGTA
2.8 Establishment of RNAi in L. sigmodontis
2.8.1 Plasmid preparation for RNAi
A 99 bp fragment of L. sigmodontis actin (Ls-act) was cloned into the TOPO-TA
cloning vector (Invitrogen) according to the manufacturer’s instructions. The clone was
confirmed by sequencing both strands (MWG Biotech AG).
For RNA transcription, the actin sequence was sub-cloned into the Litmus28i vector
(NEB). The C. elegans yolk receptor (Ce-rme-2) in the pL4440 vector was the kind gift
of Dr. Collette Britton, Glasgow University, Veterinary School, UK (Britton, Murray,
2004). The plasmids were purified with the Qiaprep Spin Miniprep Kit (Qiagen). Both
vectors have two T7 polymerase sites flanking the cloned insert. Thus, it was necessary
to linearize the plasmids downstream of the insert prior to in vitro transcription
reactions so that only one of the two T7 promoters could make RNA. For each plasmid,
in two separate reactions of 300 µl, 10 µg of plasmid were linearized as follows. The
Ls-act plasmid was linearized with BamHI or XhoI (see Figure 12). Ce-rme-2 was
Material and Methods
50
linearized with XhoI or XbaI. All digestions were performed overnight at 37ºC using
enzymes and appropriate buffers from NEB. After the complete digestion was checked
on a standard agarose gel, the linearized plasmids were purified following the
MEGAscript T7 Kit (Ambion) protocol.
Figure 12. Linearization of Ls-act sequence cloned in Litmus28i vector.
Digestion of the Ls-act plasmid was complete after 24 hours incubation at 37ºC, confirmed on a 0.8%
standard agarose gel. Lane 1: molecular weight marker (1 kb DNA ladder; Fermentas); lane 2: Ls-act
plasmid uncut for comparison; lane 3: linearized with BamHI; lane 4: linearized with XhoI.
Plasmid purification
300 µl of the digest were incubated for 30 min at 50ºC with:
30 µl Proteinase K
15 µl 10% SDS,
followed by a phenol/chloroform extraction and ethanol precipitation with 30 µl RNase-
free 5 M NH4Ac, 100 mM EDTA solution (Ambion) and 10 µg/ml linear acrylamide
(Ambion) as carrier molecule. All centrifugation steps were for 15 min, 4ºC, at 14.000
rpm. The pellet was eluted in 30 µl nuclease-free water, and the OD260 determined.
1000 bp
2000 bp
3000 bp
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2.8.2 In vitro transcription to generate double-stranded RNA
To produce dsRNA, 1 µg of each linearized plasmid of each gene was transcribed in a
single reaction using the MEGAscript T7 Kit (Ambion). The Ambion protocol was used
with the following changes:
1.) the in vitro transcription was extended from 2 hours to over night,
2.) after DNase I digestion and phenol/chloroform extraction, the RNA was
precipitated with 1 volume of isopropanol and 10 µg/ml linear acrylamide
(Ambion) as co-precipitant,
3.) at the end of the procedure the RNA was dissolved in 100 µl nuclease-free water,
heated for 10 min at 65ºC and the RNA annealed by allowing the solution to cool
to room temperature.
The dsRNA concentration was determined at OD260 using an Eppendorf BioPhotometer.
Typically, a 1:100 or 1:200 dilution of an aliquot of the reaction mixture gave an
absorbance reading in the linear range of the spectrophotometer.
The dsRNA integrity was also checked by running an aliquot on a standard agarose gel
(Figure 13), and then shock frozen in liquid nitrogen and stored at -80ºC.
Figure 13. The dsRNA integrity was confirmed on a standard agarose gel.
Lane 1: molecular weight marker (100 bp DNA ladder; Fermentas), lane 2: Ls-act dsRNA, and lane 3:
Ce-rme-2 dsRNA.
Note: The in vitro transcribed dsRNA on a native gel runs at a higher molecular weight than dsRNA
(charge difference).
1            2             3
500 bp
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2.8.3 Soaking L. sigmodontis in dsRNA
Adult L. sigmodontis worms (depending on the experiment, 6 to 10 months old) were
recovered by flushing the thoracic cavity of naturally infected cotton rats with PBS. The
nematodes were washed in RPMI 1640, 1% penicillin/streptomycin (PAA Lab., Coelbe,
Germany) preheated to 37ºC. Only vigorously moving worms were used in the
experiments.
RNA interference was carried out with a few important modifications to the procedure
described by Aboobaker et al. (2003). Briefly, five groups of three adult female worms
for each treatment were placed in 300 µl culture medium A (no FCS), containing RPMI
1640, 1% penicillin/streptomycin, 1 mM spermidine (Sigma-Aldrich) and Ls-act
dsRNA in serial dilutions ranging from 0.035 µM to 35 µM in domed cap PCR tubes
with the domed tops removed (see also Figure 14 for the experimental setup).
Nematodes of the control groups were incubated in culture medium A with either
3.5!µM Ce-rme-2 dsRNA (negative control) or cultured in dsRNA-free medium A
(100% control). The tubes were then covered with a single layer of dialysis tubing
(molecular weight cut-off 15 kDa), closed and placed in a beaker containing 500 ml pre-
warmed culture medium B (contained FCS). The nematodes were incubated for 24
hours at 37ºC under 5% CO2. After 24 hours, the nematodes were transferred from the
PCR tubes to culture dishes with 5 ml dsRNA-free medium B and cultured for another
24 or 48 hours. Nematodes were collected after 24, 48 and 72 hours to determine
phenotypes (adult phenotype and microfilarial release) and for RNA extraction.
Culture medium A (!FCS)
(was used to soak the nematodes during the first 24 hours in the micro-volume system)
300 µl RPMI 1640/tube
1% penicillin/streptomycin
1 mM spermidine (Sigma-Aldrich)
+/- dsRNA
Culture medium B (+FCS)
(dsRNA-free; medium was used i) during the first 24 hours as medium that the PCR tubes were in and  ii)
during the following 48 hours after removal of the nematodes from the micro-volume system)
500 ml RPMI 1640
1% penicillin/streptomycin
10% FCS (fetal calf serum)
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The micro-volume dialysis system
Figure 14. The experimental setup of the RNAi experiments.
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2.8.4 Phenotype assessment
2.8.4.1 Video documentation of the worm movements
The adult phenotype was scored at each time point by videotaping the nematodes in
culture dishes for 30 to 60 seconds. A digital video camcorder SONY'-PC 120E
Handy cam (Sony Corporation, Japan) was used to document worm movements/
behavior. Subsequently, the videos were edited using Final Cut Pro 3.0 for Macintosh.
After recording worm movements, the nematodes were washed two times in PBS, snap
frozen in liquid nitrogen, and stored at –80ºC for RNA extraction.
2.8.4.2 Evaluation of the microfilarial release
The microfilariae released from 3 females/tube were collected after 24 and 48 hours.
The microfilariae were centrifuged for 5 min at 1300 rpm (250# g) at room temperature.
Then all but 20 µl of the supernatant was removed. To the remaining 20 µl, an equal
volume of Hinkelmann’s solution was added and the contents mixed (Al-Qaoud, 1997).
After 30 min incubation at room temperature, the total numbers of microfilariae (from 3
nematodes/tube, n = 5) were counted for each time point using a light microscope (Leitz
Diaplan, Wetzlar, Germany) at 10# magnification.
Hinkelmann’s solution (Korenaga, 1991)
0.5% w/v eosin Y (2.5 g)
0.5% v/v phenol (2.5 ml)
0.185% v/v formaldehyde (0.925 ml)
ad 500 ml distilled water
2.9 Statistical test used
The nonparametric Mann-Whitney U-test was performed to determine the statistical
differences between the control group and the treatment group of each experiment
(Graphpad Prism 4.0 for Mac). P values " 0.05 were considered significant.
Some of the results were log-transformed to meet the parametric assumptions.
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3 Results
3.1 Altered gene expression after anti-Wolbachia treatment
The mutualistic living Wolbachia endobacteria, found in most filarial nematodes, are
essential for embryogenesis and required for proper larval development into adults
(Hoerauf, 1999). Therefore, Wolbachia represent new targets for antifilarial drug
development. These insights led to the innovative use of tetracycline antibiotics to
deplete the Wolbachia in the animal model filaria L. sigmodontis (Hoerauf, 2000c) and
B. pahangi (Chirgwin, 2003), as well as in the human parasite B. malayi (McGarry,
2004), O. volvulus (Hoerauf, 2003c; Hoerauf, 2008) and W. bancrofti (Hoerauf, 2003b).
Still, very little is known about the molecular mechanism of the symbiotic interaction
between Wolbachia and their filarial nematode hosts. Therefore, nematode genes that
respond to anti-Wolbachia antibiotic treatment may play important roles in the
symbiosis and were investigated (see section 3.2).
In field studies, ochocerciasis patients from Ghana were treated with doxycycline for 6
weeks at 100 mg/day to eliminate the Wolbachia. The absence of the Wolbachia in
O.!volvulus  after antibiotic treatment has been previously monitored by immuno-
histochemistry using specific antisera against bacterial Y-HSP60 protein (Yersinia
enterocolitica) and Bm-WSP (Wolbachia surface protein of B. malayi) (Hoerauf, 1999).
On the other hand, an apparent up-regulation of the mitochondrial HSP60 protein after
Wolbachia depletion was also noticed (see section 3.1.2). Therefore, it was necessary to
investigate whether a differentiation between Wolbachia bacteria and mitochondria is
feasible.
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3.1.1 Wolbachia and mitochondria localize in different zones of the hypodermis
and are morphologically different
To confirm the specificity of the anti-Y-HSP60 serum for the endobacteria and
mitochondria, the antiserum was used for staining ultra-thin sections of worms in
onchocercomata, extirpated from an untreated patient.
Detailed electron micrographs were generated from untreated female O. volvulus worms
with anti-Y-HSP60 serum. The typical localization pattern of Wolbachia  and
mitochondria was detected. As demonstrated in Figure 15A, the hypodermis can be
divided into three zones.
Starting from the cuticle of the nematode, an area that contains only mitochondria, but
no Wolbachia, was found. Next is a middle zone where the mitochondria become
sparser and Wolbachia bacteria are also found. The innermost region of the hypodermis
is almost exclusively free of mitochondria, containing just Wolbachia.
The anti-Y-HSP60 serum appeared to detect Wolbachia more intensely than the
mitochondria. Apparently, the antiserum did not react with other organelles, such as
lysosomes, granular structures also located in the middle zone of the hypodermis or the
cytoplasm. The specific distribution of Wolbachia and mitochondria was even more
pronounced when oocytes were examined. Wolbachia were detected near one or both
ends of the oocyte, whereas the mitochondria were localized to the rest of the
Wolbachia-free cytoplasm surrounding the chromosomes (Pfarr, 2008).
Additionally, histological examinations at a higher magnification showed the distinct
morphology of Wolbachia and mitochondria. Wolbachia bacteria are larger and occur
within a nematode-derived membrane (Figure 15B). These vacuoles often contain
clusters of Wolbachia bacteria.
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Figure 15. Electron micrographs of a female O. volvulus worm detailing the localization of
Wolbachia and mitochondria in the hypodermis.
(A) The hypodermis was divided into three zones (dashed lines) based on the distribution of mitochondria
(lines) and Wolbachia (arrows). (B) Higher magnification shows the different morphologies of
mitochondria (lines) and Wolbachia (arrows). The Wolbachia were often seen in clusters of several
bacteria in one membranous structure. Cu=cuticle; M=mitochondria; W=Wolbachia (Pfarr, 2008).
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Immunohistochemical staining of an untreated O. volvulus female worm with specific
anti-Y-HSP60 serum shows the location of Wolbachia. The Wolbachia endobacteria
were predominantly found in the hypodermal cells of the lateral chords of both sexes, in
oocytes, developing embryos, and all larval stages (Figure 16). The muscles, the
epithelia of the digestive and genital tracts are devoid of Wolbachia, as well as the
reproductive system (sperm) of male worms.
Figure 16. Localization of Wolbachia in an untreated female O. volvulus worm.
Immunohistochemical staining of HSP60 in Wolbachia endobacteria using specific anti-Yersinia-HSP60
antibodies. The bacteria are located in the hypodermis and oocytes of the nematode (open arrows).
h, hypodermis; i, intestine; m, muscle; u, uterus.
(Photo: D. W. Büttner, Institute for Tropical Medicine, Hamburg, Germany)
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3.1.2 Anti-Y-HSP60 labeling is increased in O. volvulus upon doxycycline
treatment
The Wolbachia endobacteria were detectable in the tissues of L. sigmodontis by antisera
against Ov-Wolbachia HSP60 (Hoerauf, 1999) or Yersinia enterocolitica HSP60
(Taylor, Hoerauf, 1999; Hoerauf, 2000a). These antibodies also label Wolbachia in
O.!volvulus (Hoerauf, 2000b) and in W. bancrofti (unpublished data).
In female O. volvulus worms that were not exposed to doxycycline, a granular staining
of Wolbachia was also seen in the innermost zone of the hypodermis, in oocytes, and all
developing embryonic stages within the uteri (morulae, coiled and stretched
microfilariae) (Figure 17, A-C open arrows).
Using antisera against HSP60 of Yersinia and of humans (Clone A57-E4, Dianova,
Hamburg, Germany), mostly weak staining, representing nematode mitochondrial
HSP60, was also seen in untreated worms or worms that were exposed to ivermectin
(Figure 17A). Nevertheless, the different localization of Wolbachia and mitochondria
within the nematode made it possible to distinguish between the two organelles.
Diffuse staining, indicating mitochondrial HSP60, was found in the outer zone of the
hypodermis (Figure 17A and C, closed arrows), the epithelia of the intestine (Figure
17A), genital tracts, muscle cells of the body wall (Figure 17A), uterus and oocytes
(Figure 17B), and embryos and sperm (data not shown). The intensity varied greatly,
being strongest in portions of the filaria where no bacteria are present and often in
moribund worms, such as those with neoplastic cells in the pseudocoeloma (Figure 17C;
(Duke, 2002).
Examination of sections from onchocerciasis patients treated for 6 weeks with
doxycycline showed that the hypodermis, oocytes, and embryos are devoid of
Wolbachia (Figure 17D-F; Figure 18A and B). Interestingly, these worms showed a
noticeable increase of mitochondrial HSP60 labeling in tissues which were normally
unstained or only lightly stained in untreated worms, especially in oocytes, and embryos
(Figure 17E and F). The mitochondria appeared as small dots or diffuse staining that
were distinct from the granular, ring-like structures of Wolbachia. The diffuse staining
was probably due to the labeled outer membrane folding of the hypodermis (lamellae).
Tissues that were unstained or only slightly stained in untreated worms also showed an
increased mitochondrial HSP60 expression after doxycycline therapy (Figure 17D-F).
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Figure 17. Mitochondrial HSP60 in filarial tissues is increased after depletion of Wolbachia
endobacteria.
(A-C) Female O. volvulus after treatment with ivermectin (A, 20 months) or untreated showing granular
endobacteria in the hypodermis (open arrows; A and C) and in oocytes in the uterus (open arrows, B).
The mitochondria of the filaria are weakly labeled in the outer zone of the hypodermis, in the intestine
(filled arrows, A), and in neoplastic cells in the pseudocoeloma (filled arrows, C). Stronger labeling of the
intestinal mitochondria after ivermectin (A) is often seen.
(D-E) Female O. volvulus collected 5 months, and (F) male O. volvulus collected 19 months after
treatment with 100 mg doxycycline per day for 6 weeks showing increased labeling of filarial HSP60 in
the outer zone of the hypodermis (filled arrows; D), muscles of the body wall (filled arrows; D, F) muscle
cells of the uterus (D), the entire oocytes (E, in comparison to the granular staining seen in B), and
developing spermatozoa in the testis (F).
c, cuticle; h, hypodermis; i, intestine; m, muscles; t, testis; u, uterus.
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3.1.3 Evidence for Wolbachia depletion by staining with Bm-WSP antiserum
The HSP60 staining seen in doxycycline-treated O. volvulus was not due to the
Wolbachia. Using consecutive sections, the anti-Y-HSP60 serum specifically labeled the
muscles in worms from patients who had received doxycycline (Figure 18A). However,
serial sections from these worms were also labeled with antiserum against B.!malayi-
Wolbachia surface protein (Bm-WSP), which is specific for bacteria. It does not stain
filarial tissues. This antiserum clearly showed that the Wolbachia were depleted from
the doxycycline-treated worms (Figure 18B), indicating that the staining detected using
the anti-Y-HSP60 serum indeed represented the filarial mitochondria. The comparison
of consecutive sections labeled using the anti-Y-HSP60 but not the Bm-WSP serum
demonstrated the specificity of the antibody probes (Figure 18A, B). The increase in
mitochondrial HSP60 was not a direct effect of the antibiotic treatment of the nematode
itself but rather due to the depletion of Wolbachia as there was no change in HSP60
expression after antibiotic treatment in a filaria devoid of Wolbachia (see also section
3.1.4). Furthermore, after administration of doxycycline for only 2 weeks, a treatment
that does not deplete Wolbachia, increased staining of the mitochondria was not
detected at any time point up to 30 months after treatment.
Figure 18. The bacteria-specific Bm-WSP antiserum confirmed Wolbachia depletion in doxycycline
treated O. volvulus.
Immunohistochemical labeling of HSP60 in Wolbachia endobacteria and in filarial tissues. Primary
antibodies against Y-HSP60 (A) and Bm-Wolbachia surface protein (B) were detected using anti-rabbit
mouse monoclonal antibodies as described. (A, B) Female O. volvulus collected 19 months after
treatment with 100 mg doxycycline per day for 6 weeks showing increased labeling of filarial HSP60 in
the hypodermis and muscles of the body wall (filled arrows; A). Consecutive sections of the respective
worms stained with anti-Bm-WSP serum demonstrated that Wolbachia endobacteria were absent (B). h,
hypodermis; i, intestine; m, muscles; v, vagina.
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3.1.4 No alteration in HSP60 expression in the Wolbachia-free nematode
Acanthocheilonemea viteae
A. viteae belongs to the subfamily of Onchocercinae and is one of a few filariae that do
not harbor Wolbachia endobacteria (Hoerauf, 1999). Comparing sections from untreated
(Figure 19A) and tetracycline-treated A. viteae (Figure 19B), there was no detectable
increase in HSP60 staining in the worms. The staining in the oocytes, the muscles and
the gut was equivalent between both groups. This experiment supports the hypothesis
that an increased labeling of HSP60 in the mitochondria of O.!volvulus  is due to the
depletion of Wolbachia.
Figure 19. Comparable HSP60 expression in untreated and tetracycline-treated A.!viteae.
(A, B) No difference is seen in the labeling of filarial HSP60 in untreated (closed arrows; A) and treated
(B) females of A. viteae, a species without Wolbachia (after 70 days treatment of Mastomys coucha hosts
with 25 mg/kg/day tetracycline). h, hypodermis; u, uterus.
3.1.5 Quantification of hsp60 transcription following Wolbachia depletion
One argument for the increase in nematode mitochondrial HSP60 staining after
doxycycline treatment could be that the anti-Y-HSP60 antibodies are more specific for
the bacterial HSP60 and therefore stain weakly for the filarial HSP60 until the
Wolbachia are depleted. To address this issue, hsp60 gene expression was measured in
onchocercomata extirpated from untreated and doxycycline-treated patients 5 months
after start of the doxycycline regimen to demonstrate that the increase in mitochondrial
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HSP60 is also reflected at the level of transcription. The primers used for the hsp60
gene had no similarity to the hsp60 gene of Wolbachia, as determined by BLAST
analysis. The primers for actin were also tested on human cDNA and did not amplify
the human gene (see Figure 20).
Figure 20. The actin primers used for normalization are nematode specific.
The actin primers were tested in PCR with human cDNA and cDNAs of three different nematode species.
The amplified products were separated on a 2% agarose gel. Lane 1: 100 bp Marker (Fermentas); lane 2:
human cDNA as template; lane 3: L. sigmodontis; lane 4: O. volvulus; lane 5: A. viteae; lane 6: water
control. The actin primers are nematode specific, as no signal was detectable for the human material.
Results
64
It should be noted that 8 out of 16 controls, and 7 out of 23 doxycycline-treated patients
also received a single dose of ivermectin, a medication with microfilaricidal effects.
According to the immunochemichal stainings of ivermectin-exposed nematodes that
sometimes also show an increase of mitochondrial HSP60 (as seen in Figure 17A), we
have split the groups to distinguish between these different treatment groups (Figure
21).
Figure 21. Influence of ivermectin on the hsp60 expression in onchocercomata.
Side-by-side comparison shows that patients that received ivermectin (+Iver) have no difference in hsp60
expression compared to patients that had not received ivermectin. Marginal differences in hsp60 were
only seen if the patients had received doxycycline.
No significant differences were detected between the groups that received ivermectin
and the doxycycline-treated or untreated control group. Henceforth, all controls and
doxycycline-treated patients, no matter if they have been exposed to ivermectin or not,
were combined to a single group each. The resulting data are displayed in Figure 22.
The normalized hsp60/actin index generated by quantitative PCR (qPCR) showed a
significant increase in hsp60 transcript levels after the Wolbachia had been depleted by
doxycycline (Figure 22A). In comparison to the untreated controls, the doxycycline-
treated patients produced a 7.7 fold increase in hsp60 expression. Additionally, the
absence of Wolbachia bacteria in O. volvulus nodules after doxycycline treatment was
confirmed by qPCR, measuring ftsZ, a gene for a bacterial cell cycle protein. As shown
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in Figure 22B, the determined ftsZ levels were drastically reduced (median value = 0)
after doxycycline treatment.
Figure 22. Filarial hsp60 and bacterial ftsZ levels before and after depletion of Wolbachia
endosymbionts from O. volvulus.
Five months after the start of the treatment, nodules were excised from patients taking part in studies on
the effect of doxycycline on O. volvulus in Ghana. (A) Up-regulation of filarial hsp60 by a factor of 7.7
was demonstrated using the ratio of filarial Ov-hsp60 to Ov-actin transcription levels (P = 0.0002). The
transcription levels for each gene (copies/µl) were determined by comparing crossing point data to a
gene-specific standard curve included in every run. Median values are indicated. (B) The ftsZ/Ov-actin
Index was significantly reduced after doxycycline treatment, demonstrating successful depletion of
Wolbachia bacteria from O. volvulus (P = 0.004). Statistical differences were determined by Mann-
Whitney U test using GraphPad Prism 4.02 (Graphpad Software, San Diego, CA, USA).
PCR data for ftsZ were generated by Anna Albers (then a diploma student at IMMIP).
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3.1.6 Spearman Rank Correlation
To test whether the up-regulation of the mitochondrial hsp60 is directly correlated with
depletion of Wolbachia endobacteria, the Spearman Rank test was performed. The
linear regression blot (Ov-hsp60 versus Ov-ftsZ levels) shows a weak but positive
correlation of these two parameters examined, which is indicated by positive R-
(R!=!0.18) and P-values (P!=!0.0448) (Figure 23).
The assumption that the increased expression of hsp60 after the loss of Wolbachia upon
tetracycline antibiotics is due to an interruption of the homeostasis of the endosymbiosis
could hereby be strengthened.
Figure 23. High hsp60 levels correlate with low ftsZ levels.
The linear regression blot of a Spearman Rank test shows a positive correlation (R value = 0.18) between
increasing in Ov-hsp60 transcript levels after doxycycline treatment and decreasing Ov-ftsZ levels upon
doxycycline treatment, due to the depletion of the Wolbachia endobacteria. The correlation was
calculated using Statview 5.0 for Macintosh (P " 0.05).
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3.2 Screening for L. sigmodontis genes affected by tetracycline treatment
3.2.1 Differential display
We used differential display PCR (DD PCR) followed by Reverse Northern blot to
screen for cDNA fragments that truly represent differentially expressed mRNAs after
tetracycline treatment in the rodent filaria L. sigmodontis.
Complex expression patterns were observed by DD PCR with the 14 different primer
sets used. A representative area of a differential display gel identifying several bands
that appeared to be differentially expressed is shown in Figure 24. Many down-
regulated fragments were identified, but cloning and sequencing of a number of these
products showed that they were all of Wolbachia origin, and thus indicate likely
genomic contamination (Figure 24C). Several fragments only displayed a short up-
regulation directly after the beginning of the treatment (Figure 24B), and may represent
responses to the stress induced by tetracycline. Therefore, only transcripts up-regulated
for two or more time points were considered to be responding to Wolbachia depletion
(Figure 24A).
Figure 24. A representative autoradiogram from Differential Display PCR.
The differential display of mRNA from untreated control (con) and tetracycline-treated (tet)
L.!sigmodontis  on days 3, 6 and 15 of treatment using the arbitrary primer set H-AP-8 and anchored
primer HT11G (both from GenHunter) is shown. The indicated bands show: (A) Ls-ppe-1, a gene that is
consistently up-regulated and was therefore considered for further analysis; (B) a gene that is up-
regulated only at day 3, and therefore not further investigated; (C) a gene which is down-regulated.
Cloning and sequencing of these fragments showed they were of Wolbachia origin, indicating genomic
DNA contamination.
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As part of the effort to apply differential display to identify genes that are up-regulated
after tetracycline treatment, PCR products from control and tetracycline-treated animals
over 36 days of treatment time were compared side-by-side, and yielded 12 up-
regulated candidates (in a range of 80 to 700 bp) from four different DD PCR primer
sets (see Table 5). These were cloned for later validation.
Table 5. Fragments differentially expressed upon tetracycline treatment.
Fragment 3’ primer 5’ primer Size [ bp]
DD-1 A 9 180
DD-2 C 9 330
DD-3 C 9 120
DD-4 C 11 450
DD-5 G 11 150
DD-6 G 11 150
DD-7 G 11 150
DD-8 A 13 400
DD-9 G 8 700
DD-10 G 8 80
DD-11 A 8 100
DD-12 A 8 300
Note: 3’primers refer to GenHuter anchored primers H-T11G, H-T11A, or H-T11C.  
5’primers refer to GenHunter arbitrary primers H-AP-1 to -14.
3.2.2 Confirmation assays
Several methods were used to confirm the up-regulation of the 12 fragments cloned
after DD PCR. The standard protocol recommends the use of re-amplified cDNA
directly as a probe for Northern blot verification (Liang, 1993). This was especially
difficult under circumstances where the amount of RNA samples was limited. Thus, we
used the Reverse dot blot technique for which equal portions of the individual plasmids
corresponding to the candidate genes were applied to duplicate nylon membranes. The
blots were then hybridized with labeled cDNA probes (separately for control and
tetracycline treatment) generated from amplified antisense RNA (aRNA).
Results
69
3.2.2.1 Reverse dot blot with fluorescein labeled probes
In order to omit radioactivity, fluorescein-labeled probes made from aRNA (see section
2.4.1) were used for the dot blot hybridization (Figure 25). The results lead to the
suggestion that all candidates applied in lane 3, i.e. DD-9 alias Ls-ppe-1 (indicated in
red), DD-10, DD-11, and DD-12, are clearly up-regulated on day 36, the end of the
tetracycline treatment. The hsp60 gene, that is known to be up-regulated upon antibiotic
therapy (Figure 22A), was here used as an internal positive control, and indeed showed
an increasing expression in the tetracycline-probed blot. As expected, the expression of
the housekeeping gene EE4, which encodes for the 60S ribosomal protein of Brugia
pahangi (Devaney, 1996), was not altered in comparison to the control blot. However,
these results could not be consistently repeated by this method.
Figure 25. Fluorescein labeled cDNA probes are not reliable in reverse dot blots.
6 µg plasmid containing each candidate gene were spotted on nylon membranes and hybridized overnight
with labeled cDNAs from control and tetracycline treated worms from day 36 of the treatment trial. The
12 candidate genes were applied top down as follows: lane 1: DD-1, 2, 3, 4; lane 2: DD-5, 6, 7, 8; lane 3:
DD-9 (Ls-ppe-1, red frame), 10, 11, 12; lane 4: hsp-60 (blue frame), calponin homology domain-1,
calponin homology domain-2, EE4 gene (black frame).
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3.2.2.2 Reverse dot blot with radioactive labeled probes
Since fluorescein labeled cDNA probes could not be used to confirm the up-regulation
of the selected genes, radioactive labeling of cDNA probes was accomplished.
Therefore, we first determined that we could detect a signal over the entire spectrum
from weak to strong gene expression using cDNA probes generated from aRNA and
labeled with either 100 µCi (Figure 26A) or 50 µCi (Figure 26B) of $-32P dCTP per
reaction in comparison to the 500 µCi in the original method (Poirier, Erlander, 1998).
   
Figure 26. Confirmation of signal detection with low amounts radioactivity.
Plasmids containing different gene fragments from DD PCR of control and tetracycline treated samples
(d15) were spotted onto nylon membranes and hybridized with (A) 100 µCi or (B) 50 µCi labeled probes
generated from aRNA. The applied plasmids correspond to genes with weak to strong gene expression.
Additionally, plasmids transferred onto nylon membranes in quantities ranging from
6!µg to 60 ng per spot and hybridized with radioactive labeled cDNA probes derived
from aRNA showed that the probes were always in excess.
Figure 27. Reverse dot blot.
A plasmid was serially diluted (6 µg – 0.06 µg), applied on a nylon membrane, and hybridized with
radioactive labeled probes made from aRNA. Even at the highest plasmid concentration, the probe is still
in excess.
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Whereas reverse dot blots hybridized with the fluorescein labeled cDNA probes (ECL
kit) made from aRNA (day 36) could not deliver reliable results, radioactive $-32P
dCTP-labeled cDNA probes confirmed then the up-regulation of the 12 DD PCR
fragments with a range of 0.5 to 3.2 compared to the controls (Table 6).
For this purpose, cDNA probes made from aRNA of day 15 post treatment were used.
This earlier time point was chosen, since it is conceivable that genes are up-regulated
only for a short period after treatment, and that day 36 might be too late for verification.
We decided to follow up the three fragments with greater than 1.5-fold up-regulation
(arbitrary decision), which were clones DD-1, DD-9, and DD-10.
Table 6. Reverse dot blot analysis on day 15 after tetracycline treatment.
Fragment Factor up-regulation
DD-1 1.73
DD-2 1.28
DD-3 1.30
DD-4 1.11
DD-5 0.48
DD-6 0.81
DD-7 0.91
DD-8 0.62
DD-9 3.21
DD-10 1.56
DD-11 0.59
DD-12 0.66
3.2.2.3 Reverse dot blot with radioactive labeled DD PCR products
In parallel, another method with fewer enzymatic steps than aRNA amplification was
used to independently confirm the up-regulation of the candidate genes. For this,
radioactive-labeled DD PCR products generated from independent reactions were used
as a probe to detect genes by dot blot hybridization (Coetzer, 2003). This technique
confirmed the up-regulation by a factor of >1.5 of only one of the three remaining genes
(data not shown). Fragment DD-9 was the only one out of the 12 candidate genes that
could be confirmed to be up-regulated after tetracycline treatment by a factor >1.5 by all
methods used.
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3.3 Identification of Litomosoides sigmodontis phosphate permease (Ls-ppe-1) as
a tetracycline up-regulated gene
The single DD PCR fragment that had passed the rigorous screening (DD-9) was
sequenced, yielding ~700 bp with an open reading frame of 112 amino acids. This
fragment was significantly similar by BLAST to the C-terminal region of a family of
C.!elegans  phosphate permeases and is hereafter termed L. sigmodontis phosphate
permease 1 (Ls-ppe-1).
3.3.1 Full-length cloning of Ls-ppe-1 and identification of transcript variants
In order to more fully characterize Ls-ppe-1, the missing 5’ and 3’ sequences were
generated by RLM-RACE PCR, subsequently cloned and sequenced. Finally, three
transcript variants were identified: Ls-ppe-1_1 (AY644700), Ls-ppe-1_2 (DQ211815),
and Ls-ppe-1_3 (DQ211816), but all have the same coding sequence. Three different
spliced variants were confirmed by Northern blot analysis (Figure 28B).
Figure 28. Northern blot to identify three transcript variants of Ls-ppe-1.
(A) The RNA gel (1.2%) showed no degradation of the RNA (2 µg/lane). On the left-hand side the RNA
Marker was applied. (B) The Northern blot was hybridized with radioactive-labeled probes for Ls-ppe-1,
using the initial Differential Display clone. Three spliced variants of Ls-ppe-1 could be identified and
show up as discrete bands.
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All three variants are full-length, as each has the spliced leader sequence (SL1:
AAAGGTTTAATTACCCAAGTTTGAG) at its 5’ end and terminates in a polyA
signal (signaling pattern at nucleotide position 1714: TGACTAAAAA) (Figure 29A).
The SL1 sequence is added to the 5’end of more than 70% of the RNAs in filarial
nematodes (Blaxter, Liu, 1996; Liu, 1996). Variants 2 and 3 have an additional 78
nucleotides between the SL1 and the start methionine. The 3 variants differ only in the
3’ untranslated region after the polyA signal. Variant 2 has 85 additional nucleotides
beginning at nucleotide position 1716 of variant 1. Variant 3 has 284 additional
nucleotides from nucleotide position 1716 of variant 1 (Appendix A).
The full-length cDNA of Ls-ppe-1-1 is 1729 base pairs and has an open reading frame
of 523 amino acids (Figure 29).
A
>Ls-ppe-1_1 (1729nt)
AAAGGTTTAATTACCCAAGTTTGAGGTTAACTGAGAAATAAAGGAAGATGTCAACATTGACAGTAACTACGCTAATGCCATCCTCTTC
TACAATGTCAGAAGCATTCATAGCCGCCTTTCGGAATGATGTATTATGGGCATTAATATGTGGTGTAATTTTGGCTTTTGTGCTTGGT
TTTGCGATGGGTGCAAATGACGTTGCAAATGCTTTTGGTACATCGGTTGGTAGCAAAGTGCTGACATTACGGCAAGCTTATATACTTG
CAGTAATTTTTGAAACACTTGGAGCACTGCTTATCGGTTACAACGTAACGGATACGGTACGTAAAGGTGTCATCGATCTGACGTTATA
TGAAGATAAACCAAAAGAGATTTTCATTGGGCAAATCGCCATTCTTGGAGGTTGCTCATTATGGTTATTAATTGCTACACTTGCGCGT
CTACCTGTATCATCAACTCATAGTGTCACTGGAGCTACTGTAGGATTTGGCTTGATGACACGAGGTGTTGCTGGAATACAATGGAAAA
AAATTGCTCATATTGTTGCTTCATGGTTTTTATCACCGATATTGTCTGGCGTCGTGTCAGCCGTTCTGTACATTATTGTTGACCATTC
AGTTCTCAGACGGAAGGATCCATTTCGTTGTGGTTTGAGAGCTTTGCCAATATTTTACTGGTTTTGTATCGCATTTAATATTTTCACC
GCTAGCTATCAAGGATTGAAATTACTTCGCCTGTCAAAGTTGCCGTTGTGGTTGAGCTCATTAGTGAGTATTGGATGTGCAACAGTTG
GCTCCATCGCTATTTACTTTTTGCTCTTGCCGAGGCTGAAAATCTGGATAAACAATTCACTTGGCAGTAATACAGCTAGAGACGATTC
GTTTGAAGTGCAGACTATAAGTAATGCGGTTCAATTGGAGGGAAATGTGATAAATCAAAAATGTCAAGCATCGAAGACAGAAAATGTT
GAGAGTTCAACTGTTATCAAAAGCGATAGCAAAATCATCGAGAGTATGGCGAAAAAGGGTGAAGAAAAGAAACTAACCGATAATACAG
TAATGAAGTTCATTCGTTGGATATTGCCGACTGATAATAGAGCAACGGACAATAGAACAATGAAAATATTTAGTTCGATACAAGCTTT
TACCGCGTGCTTTGCTGGATTTGCGCATGGCGCTAATGACGTCGGGAATGCAATAGCTCCGCTGACAGCATTGATATCGATTTACAGT
AATCTGGATGTTCGACAACGAAGTGAAACACCGATCTATGTGTTACTGTACGGCGTACTTGCAATATGTGTTGGACTTGTGGTACTTG
GACATCACGTAATACAAACTATTGGTACTGATATGTCTACGATCAATGCTGCTAGCGGTTTTACAATCGAATTCGGTGCAGCGGTAAC
TTCACTAACAGCCAGTAAACTTGGCCTACCAATTAGTACAACCCATTCATTGGTGGGAAGCGTGGTATTCGTTGGAATGGTGCGTGCC
AAGAAAGGTGTCCAGTGGTTAATATTCCGAAACATTGCCTTATCGTGGATTTTAACGTTGCCTATTTCAGGTCTTTTGGCAATGGGTT
TGACGTTAATCCTCAAGTTTTCACTTTGAGAGTGTAGTTGGACATTTATTTTTTCTTGTACATTTGTTACTTTGTTGTATATTTTCAT
CAGTTCACCCATTCTCATCTTTGTTTACTTTAATTTTTTTGACTAAAAAAAAAAAAA
B
>Ls_PPE-1 (523aa)
RKMSTLTVTT LMPSSSTMSE AFIAAFRNDV LWALICGVIL AFVLGFAMGA NDVANAFGTS
VGSKVLTLRQ AYILAVIFET LGALLIGYNV TDTVRKGVID LTLYEDKPKE IFIGQIAILG
GCSLWLLIAT LARLPVSSTH SVTGATVGFG LMTRGVAGIQ WKKIAHIVAS WFLSPILSGV
VSAVLYIIVD HSVLRRKDPF RCGLRALPIF YWFCIAFNIF TASYQGLKLL RLSKLPLWLS
SLVSIGCATV GSIAIYFLLL PRLKIWINNS LGSNTARDDS FEVQTISNAV QLEGNVINQK
CQASKTENVE SSTVIKSDSK IIESMAKKGE EKKLTDNTVM KFIRWILPTD NRATDNRTMK
IFSSIQAFTA CFAGFAHGAN DVGNAIAPLT ALISIYSNLD VRQRSETPIY VLLYGVLAIC
VGLVVLGHHV IQTIGTDMST INAASGFTIE FGAAVTSLTA SKLGLPISTT HSLVGSVVFV
GMVRAKKGVQ WLIFRNIALS WILTLPISGL LAMGLTLILK FSL
Figure 29. Sequence information of Ls-ppe-1_1
(A) The nucleotide sequence of Ls-ppe-1_1 (1729 nucleotides) is shown. The SL1 sequence is framed,
the Start codon (ATG) and the Stop codon (TGA) are indicated in bold, and the underlined nucleotides
indicate the polyA signal. (B) The predicted protein sequence of the Ls-PPE-1 has an open reading frame
(ORF) of 523 amino acids.
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The translated protein Ls-PPE-1 was predicted to have an amino-terminal signal peptide
with a predicted cleavage site between amino acid positions 49 and 50. The signal
peptide was predicted by SignalP  and TargetP (Center for Biological Sequence
Analysis) that used neural networks (NN) and hidden Markov models (HMM) trained
on eukaryotes (Bendtsen, 2004b). These two different neural networks were used to
predict the actual signal peptide and the most likely cleavage site (Figure 30).
Figure 30. Signal peptide prediction for Ls-PPE-1 using SignalP.
A signal peptide for Ls-PPE-1 was detected with a potential cleavage site between amino acids 49 and 50.
The program PredictProtein, PHDhtm (Rost, 1996) detected 10 hydrophobic,
transmembrane helices for Ls-PPE-1, which are connected to each other by hydrophilic
loops (Figure 31).
Signal peptides have a common structure: a short, positively charged amino-terminal
region (n-region); a central hydrophobic region (h-region); and a more polar carboxy-
terminal region (c-region) containing the site that is cleaved by the signal peptidase
(Figure 30). The highly variable h-region is helical, whereas the c-region must be in an
extended conformation to be accessible for cleavage (von Heijne, 1998). It is known
from the literature that many signal peptides are misidentified as a transmembrane
segment (Tusnady, Simon, 1998; Zhou, Zhou, 2003). This might also be the case for Ls-
PPE-1 since the potential cleavage site was indicated after the first membrane-spanning
segment. Therefore, it could be possible that Ls-PPE-1 has only 9 membrane spanning
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helices and the first detected helix most likely belongs to the signal peptide. The cellular
compartment the signal peptide will localize Ls-PPE-1 is unknown since consensus
sequences exist for very few systems.
Figure 31. Structural model of Ls-PPE-1.
The program PHDhtm (PredictProtein) detected 10 transmembrane helices for the best model (I-X,
counted from N- to C-terminus). The predicted cleavage site for the signal peptide is indicated (black
arrow). The first helical transmembrane region (I) belongs most likely to the signal peptide.
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3.3.2 Phylogenetic analysis of nematode homologues of Ls-ppe-1
Ls-ppe-1 was identified as a phosphate permease by similarity to homologues from
C.!elegans and other species (analysis by M. Blaxter, Institute of Evolutionary Biology,
University of Edinburgh, UK) (Heider, 2006). While peptides from other taxa were also
identified in these searches, it was most similar to the nematode members of the
phosphate permease family (InterPro domain IPR001204). The extensive nematode
EST datasets available in NemBase (Parkinson et al., 2004) were also searched. Three
matching genes were identified: from Onchocerca volvulus (OVC00569), Globodera
rostochiensis (GRC01656; a potato cyst nematode) and Xiphine index (XIC02915; a
plant ectoparasite). While O. volvulus OVC00569 matches the N-terminal portion of the
permease, the ESTs from the plant parasites matched only the very C-terminus. No
B.!malayi  ESTs were identified, but the emerging genome sequence for this filarial
parasite (Ghedin, 2004) yielded two putative permease matches. One was apparently
complete (TIGR gene model 14967 n01567) while the other, on a small (3000 bp)
contig, only contains some of the 5’ exons of a permease gene (TIGR model 13026
m00037). For both of these B. malayi homologues we reviewed the gene models and re-
predicted their structure based on matches to the Caenorhabditis (Consortium, 1998;
Stein, 2003) and L.!sigmodontis  proteins. An Ls-ppe-1 orthologue was amplified by
reverse transcriptase PCR from cDNA of A.!viteae  using primers designed to quantify
Ls-ppe-1 expression by qPCR. The amplified A. viteae product (DQ211814) matched
the C-terminus of Ls-ppe-1, and was therefore not included in the phylogenetic analysis.
Ls-ppe-1 is most similar to a subset of caenorhabditid homologues, lacking an N-
terminal insertion, and having a relatively extended expansion in the C-terminal half
(Appendix B). The plant parasitic ESTs both match a C-terminal conserved domain, but
do not overlap with O. volvulus OVC00569 or the partial B. malayi gene 13026
m00037. Several of the sequences are slightly 5’ truncated. O. volvulus OVC00569
starts just after the end of the signal peptide, and B. malayi 13026 m00037 ends at a
splice acceptor site in a similar position (no upstream exon was found in the short
genomic contig). No genome sequence likely to correspond to the C-terminal (3’) half
of B. malayi 13026 m00037 was found in the whole genome shotgun data, which is
known to be incomplete (Ghedin, 2004).
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The phylogenetic analysis was carried out using just the N-terminal portion of the
alignment (residues 49 to 180 in the alignment of Appendix B). Both maximum
parsimony and neighbor joining analyses agree on the linking of most of the
caenorhabditid proteins in pairs of orthologues (Figure 32). The one exception is the
triplet Cb_CBP19533/Ce_B0222_2/ Ce_B0222_3, where two C. elegans proteins are
co-orthologues to the C. briggsae protein. As the C. elegans genes are present as a
tandem duplication it is likely that this pattern arose through duplication in the
C.!elegans lineage. The filarial permease homologues are all most closely related to the
Ce_C48A7_2/Cb_CBP01602 orthologue pair. Notably, Ls-PPE-1 and its B. malayi
orthologue have apparently arisen by gene duplication unique to the filarial nematodes.
Figure 32. Phylogenetic analysis of nematode homologues of Ls-ppe-1
An unrooted phylogram showing the inferred relationships of the permease homologues from nematodes
based on maximum parsimony bootstrap analysis of 131 aligned residues. The inferred length, under
maximum parsimony is given next to each branch, with, in brackets, the bootstrap support under
maximum parsimony followed by support under neighbour joining. Bootstrap support values less than
60% are indicated by a ‘-‘. The X. index and G. rostochiensis representatives were not included because
available sequence does not overlap with the OVC00569 or B. malayi 13026 m00037 fragments: they are
most closely related to Ce_B0331_2/Cb_CBP04505, although this relationship is weakly supported in the
case of GRC01656. Analysis by Mark Blaxter (Heider, 2006)
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3.3.3 Quantification of Ls-ppe-1 expression after tetracycline treatment
3.3.3.1 Northern blot analysis
To avoid artifacts resulting from the use of aRNA or differential display PCR products
as probes, a Northern blot analysis was performed to confirm up-regulation of Ls-ppe-1
after tetracycline treatment. By this method, Ls-ppe-1 is up-regulated by factor 2.8 on
day 15 of the tetracycline treatment. The results confirmed those determined by reverse
dot blot (Table 7).
Table 7. Confirmation of Ls-ppe-1 up-regulation by three distinct methods on day 15 after
tetracycline treatment.
Ls-ppe-1 Northern Blot 1 Reverse Northern 2 Real Time PCR 3
control 1.0 1.0 1.0
tetracycline 2.8 3.2 2.0
Note: The data were normalized to 1: Ov-5S rRNA in the Northern blot analysis, 2: to the untreated
controls in the reverse dot blot, and 3: to Ls-act gene expression in the RT-qPCR.
3.3.3.2 Real time-quantitative PCR
RT-qPCR was used to quantify the kinetics of Ls-ppe-1 mRNA expression over the
treatment trial of 36 days. The Ls-ppe-1 expression levels were significantly higher by
day 3 to 6 in tetracycline treated female nematodes (Figure 33A). Significantly
increased expression was maintained from days 3 to 36, though there was a slight but
significant dip in fold expression on day 15. Day 15 expression was nevertheless
significantly up-regulated compared to controls. Ls-ppe-1 was up-regulated by a factor
of 3.3 at the end of treatment on day 36. The same bimodal expression pattern with
peaks on days 6 and 36 through day 70 was obtained from three different treatment
trials of infected mice. In contrast to these results, Ls-ppe-1 expression in tetracycline
treated male nematodes did not have a bimodal expression pattern, being significantly
elevated starting after day 15 and remaining up-regulated through day 70 (Figure 33B).
Here, it should be noted that the Ls-ppe-1 expression index is not increased as a result of
falling actin levels.
Results
79
Figure 33. Ls-ppe-1 is up-regulated in response to loss of Wolbachia in female and male worms.
(A) Ls-ppe-1 has a bimodal expression pattern during Wolbachia depletion by tetracycline treatment of
female L. sigmodontis. Ls-ppe-1 and Ls-act copy numbers were determined for each time point by
quantitative PCR. Ls-ppe-1 copy numbers were then normalized to the transcript levels of actin to
produce the Ls-ppe-1/Ls-act index. PCR reactions were performed in triplicate and reproduced twice.
(B) Ls-ppe-1 expression in male L. sigmodontis shows a steady increase beginning on day 36 and
continuing through day 70. Significance was calculated by the Mann-Whitney U Test (P " 0.05).
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3.3.4 Up-regulation of Ls-ppe-1 is specific to Wolbachia depletion
3.3.4.1 Ls-ppe-1 remains elevated after the end of the tetracycline treatment
In another three independent trials with tetracycline for 36 days, Ls-ppe-1 transcript
levels were measured on days 50 and 70, which represent 14 and 34 days after the end
of treatment, respectively. Ls-ppe-1 expression remained enhanced, and tended to
increase even one month after the treatment had been stopped (Figure 33A). These data
support the hypothesis that the up-regulation of Ls-ppe-1 is not simply a direct side
effect of tetracycline treatment, but rather is related to the loss of Wolbachia.
3.3.4.2 Gentamicin treatment of L. sigmodontis has no effect on Ls-ppe-1
To further test this, gentamicin, an antibiotic that is known to be ineffective against
Wolbachia, was used according to the tetracycline regimen for 36 days. No significant
difference could be observed in Ls-ppe-1 expression between untreated controls and
gentamicin treated L. sigmodontis (Figure 34).
Figure 34. No change in Ls-ppe-1 expression after gentamicin treatment.
Ls-ppe-1 expression in female L. sigmodontis treated for 36 days with gentamicin, an antibiotic
ineffective against Wolbachia, showed no significant alteration over the whole treatment time. The bars
represent the median values with error bars for the range.
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3.3.4.3 Tetracycline treatment of A. viteae has no effect on Ls-ppe-1
An Ls-ppe-1 orthologue was amplified by reverse transcriptase PCR from cDNA of
A.!viteae (DQ211814) using primers designed to quantify the L. sigmodontis sequence.
A.!viteae  is a filarial nematode that is free of Wolbachia. Compared to untreated
controls, no significant differences in expression could be detected in A. viteae after
tetracycline treatment (Figure 35). Thus, the tetracycline treatment itself does not cause
an increase in expression of the nematode phosphate transporter in this related species.
Figure 35. Ls-ppe-1 is not altered in A. viteae after tetracycline treatment.
Ls-ppe-1 expression remains the same in A. viteae (devoid of Wolbachia) by tetracycline treatment for 36
days. A representative experiment with median values and error bars indicating the range is shown.
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3.3.4.4 Ls-ppe-1 is not induced upon oxidative stress and heat shock
In order to exclude the possibility that up-regulation of Ls-ppe-1 was simply a stress
response to tetracycline treatment, naïve L. sigmodontis were exposed to three different
oxidative stress stimuli: paraquat and plumbagin, which generate an internal oxidative
stress by redox cycling within the parasite, and xanthine-xanthine oxidase, which
produces oxygen radicals in the medium surrounding the nematode. In all three
experiments, no significant differences in Ls-ppe-1 expression were detected compared
to unstressed nematodes (Figure 36). In contrast, and as expected, Ls-hsp-60 expression
was increased 3-fold.
In parallel, heat shock (42°C) applied for 2 hours did not increase Ls-ppe-1 expression
compared to controls (Figure 36).
Figure 36. No up-regulation of Ls-ppe-1 in response to oxidative stress and heat shock.
qPCR results for Ls-ppe-1 from Wolbachia-containing L. sigmodontis after exposure to xanthine-xanthine
oxidase (XOD), plumbagin (PG), paraquat (PQ) and heat shock at 42°C (heat) in comparison to Ls-hsp60.
Normalizing the copy numbers to copies of Ls-act generated the respective gene expression index.
Median values with error bars indicating the range of a representative experiment are shown. The PCRs
were performed in triplicate and reproduced once. The black bars indicate the Ls-ppe-1 index after the
different oxidative stress stimuli and heat shock. The gray bars indicate the Ls-hsp60 index. Ls-hsp60 was
significantly increased by all four treatments in comparison to controls. Significance was calculated by
the nonparametric Mann-Whitney U test (P " 0.05).
Ls-ppe-1 Ls-hsp60
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3.4 Quantification of other candidate genes
Reverse dot blot hybridization (Table 6) confirmed the up-regulation of DD-1, DD-9,
and DD-10 on day 15 post treatment, thus primers for real time PCR were designed to
quantify these genes.
The fragment DD-1 identified as U small nuclear RNA, which is an important
component in RNA processing and splicing, was quantified over the treatment duration
of 36 days by RT-qPCR, although it was rejected at a later time point (see 3.2.2.3). The
results show a short-term up-regulation of DD-1 transcripts during the first 15 days of
the tetracycline regime with the peak on day 6, followed by a decreased expression after
30 days, a level comparable to the controls (Figure 37). These data suggest that DD-1
expression reflects either a general stress response to the antibiotic itself or a possible
embryonic-specific expression, as the embryos were always affected first by the anti-
Wolbachia treatment. U RNA is needed for the expression of all genes as part of the
processing of RNA into mRNA, but is not necessarily specific to the Wolbachia
symbiosis.
Figure 37. Short-term up-regulation of DD-1 indicates either a stress response to tetracycline
treatment or an embryonic-specific expression.
The fragment DD-1 shows a significant up-regulation during the first 15 days of the treatment with a peak
on day 6. Afterwards, DD-1 transcript level decline and reach levels comparable to the control group.
DD-1 and Ls-act copy numbers were determined for each time point by RT-qPCR. The DD-1 copy
numbers were normalized to the transcript level of Ls-act to produce the DD-1/Ls-act index. PCR
reactions were performed in triplicate and reproduced in 3 independent experiments. A representative
experiment with median values and error bars indicating the range are shown. Significance was calculated
by the Mann-Whitney U Test. Asterisks denote a significant difference between tetracycline treated
L.!sigmodontis and untreated controls (P " 0.05).
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The fragment DD-10 was an inappropriate candidate for quantitative PCR. Because of
its short sequence length of only 80 base pairs and the sequence composition, it was
impossible to generate adequate primers for real time PCR. For this reason, candidate
gene DD-10 was also excluded from further investigations.
3.5 Establishment of RNAi for Ls-act in adult L. sigmodontis
To establish RNAi in L. sigmodontis the actin gene (Ls-act) was chosen because, as an
important housekeeping gene, a phenotype could be expected from knockdown of its
expression. As a negative control, the Caenorhabditis elegans yolk receptor, Ce-rme-2,
was chosen. Ce-rme-2 is a non-filarial gene that has no homology in the genome of
Brugia malayi (no significant hits of 22 bp by BLAST search in the TIGR B. malayi
database), making it suitable as a negative dsRNA control. To compare gene expression
of the genes measured, the median copies/µl of the dsRNA-free medium control group
was set as 100% in all experiments, and the relative expression of the experimentally
treated groups was calculated. In all cases, the median values were used to limit the
effects of outliers.
3.5.1 RNAi is dependent on the dsRNA concentration
Serial dilutions of Ls-act dsRNA were tested to determine the lowest effective
concentration needed to specifically knockdown gene expression in L. sigmodontis
without generating off-target effects. The nematodes were soaked as described for
B.!malayi for 24 hours in medium containing dsRNA at final concentrations of 35 µM,
17.5 µM, 3.5 µM, 0.35 µM, and 0.035 µM. While all concentrations tested significantly
inhibited Ls-act expression to less than 10% (P " 0.0001) as determined by RT-qPCR
(Figure 38), the 3.5 µM dsRNA concentration was used in subsequent experiments
because it consistently reduced Ls-act expression with the low variation and caused no
significant differences in Ls-hsp60 and Ls-gst2 transcript levels (Figure 39A and B).
After 24 hours incubation with 3.5 µM dsRNA Ls-act transcripts were reduced to 11.8%
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(data not shown), and the inhibition decreased further to 3.1% in dsRNA-free medium
quantified after 48 hours (Figure 38).
Figure 38. Determination of the most effective dsRNA concentration for silencing Ls-act.
Nematodes (five groups of three adult females) were soaked for 24 hours in dsRNA-free medium (con) or
in the presence of different concentrations of Ls-act dsRNA (0.035 – 35 µM). After 24 hours incubation,
the worms were transferred into dsRNA-free medium. Forty-eight hours after the start of the experiment,
Ls-act transcript levels were determined by RT-qPCR and then normalized to Ls-18S rRNA gene
expression to produce the Ls-act/Ls-18S index. The median value of the control group was set to 100%,
and the relative reduction of the experimentally treated groups was calculated accordingly. The
expression of Ls-act was significantly inhibited after incubation of the nematodes with Ls-act dsRNA
(grey bars) in comparison to control worms (white bar). The same results were seen in three different
experiments, one of which is presented here. RT-qPCR was performed in triplicate. The error bars
indicate the inter-quartile range. Asterisks denote a significant difference between RNAi-treated
nematodes and untreated medium controls (Mann-Whitney U Test, P " 0.0001).
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3.5.2 RNAi of Ls-act is gene specific
3.5.2.1 Quantification of non-targeted genes: Ls-hsp60 and Ls-gst2
To demonstrate that the inhibitory effect mediated by the dsRNA was specific for
Ls-act, the Ls-hsp60 and Ls-gst2 genes were also measured by RT-qPCR. All tested
concentrations of dsRNA showed no significant reduction of Ls-hsp60 (Figure 39A) and
Ls-gst2 (Figure 39B) transcript levels. The expression of Ls-hsp60 was significantly
increased at concentrations of 17.5 µM and 35 µM (Figure 39A), suggesting that these
high dsRNA concentrations cause stress in the nematodes. All dsRNA concentrations
lower than 17.5 µM showed no significant differences in Ls-hsp60 expression. No
significant differences were detectable in Ls-gst2 expression (Figure 39B) despite the
higher variation in comparison to Ls-hsp60 expression (Figure 39A).
Figure 39. Soaking in Ls-act dsRNA does not inhibit the expression of Ls-hsp60 or Ls-gst2.
After 48 hours, two non-related genes were quantified by RT-qPCR as a measure for off-target effects of
soaking the nematodes in Ls-act dsRNA (0.035 – 35 µM). (A) Normalized Ls-hsp60 expression was
presented as percent inhibition relative to the control group. The Ls-hsp60 levels were not significantly
reduced compared to the dsRNA-free medium control. The two highest dsRNA concentrations showed a
significant increase in Ls-hsp60 expression, indicating that the worms are stressed with such high
concentrations of dsRNA. (B) Normalized Ls-gst2 levels were presented as percent inhibition relative to
the control group. Ls-gst2 expression was not inhibited by soaking in Ls-act dsRNA. Ls-hsp60 and
Ls-gst2 copy numbers were normalized to Ls-18S rRNA to generate the RNA/Ls-18S index. The median
values of the controls were set to 100%, and the relative reduction of the experimentally treated groups
was calculated accordingly. The same results were seen in three different experiments, one of which is
presented here. RT-qPCR was performed in duplicate. The error bars indicate the inter-quartile range.
Asterisks denote a significant difference between RNAi-treated nematodes and untreated medium
controls (Mann-Whitney U Test, P " 0.05).
Results
87
3.5.2.2 Testing a non-filarial gene from C. elegans as negative control
The specificity of RNAi was further shown using Ce-rme-2 dsRNA as a negative
control. Soaking of L. sigmodontis with Ce-rme-2 did not reduce Ls-act expression at 24
hours (Figure 40A) and 48 hours (Figure 40D). Ls-hsp60 (Figure 40B, E) and Ls-gst2
(Figure 40C, F) expression remained the same after soaking in Ce-rme-2 dsRNA
compared to medium controls, further demonstrating that the reduction in Ls-act was
specific and not due to toxicity of dsRNA or off-target effects.
Figure 40. Soaking L. sigmodontis in dsRNA from a non-filarial gene does not inhibit Ls-act
expression.
Nematodes were soaked for 24 hours in 3.5 µM dsRNA of Ls-act (black bars), 3.5 µM dsRNA of
Ce-rme-2 (gray bars) or dsRNA-free control medium (white bars). Ls-act, Ls-hsp60 and Ls-gst2 levels
were quantified by RT-qPCR 24 hours (A, B, C) and 48 hours (D, E, F) after the start of the experiment
and normalized to Ls-18S. The median values for the expresson index were presented in the graphs as
percent of control (set to 100%). (A+D) Ls-act dsRNA specifically inhibited Ls-act transcripts to ~3% of
control worms. No significant change was seen in the nematodes incubated with Ce-rme-2 dsRNA. (B+E)
Ls-hsp60 and (C+F) Ls-gst2 expression levels were not affected by Ls-act or Ce-rme-2 dsRNA treatment.
The same results were seen in two experiments, one of which is presented her. Significance was
calculated by Mann-Whitney U Test, P " 0.0001.
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3.5.3 Persistence of the RNAi effect in the absence of dsRNA
A key hallmark of RNAi is the persistence of gene knockdown after the removal of the
dsRNA. To test this in L. sigmodontis, the nematodes were removed from the dsRNA
after 24 hours and transferred into a larger volume of dsRNA-free medium. The worms
were then monitored for an additional 48 hours. In the absence of dsRNA, Ls-act gene
expression remained low and was even significantly reduced at 48 hours (7%) and 72
hours (3%) (Figure 41). The percent reduction after 48 hours was equivalent to that
shown in Figure 38. Longer time points were not tested to avoid adverse effects of long-
term culturing of L. sigmodontis causing non-specific stress on the worms.
Figure 41. Inhibition of Ls-act expression persists in the absence of Ls-act dsRNA.
Female L. sigmodontis (five groups of three worms/tube) were soaked for 24 hours in the presence of 3.5 µM
Ls-act dsRNA or in dsRNA-free control medium. The nematodes were then transferred to dsRNA-free
medium and incubated for an additional 48 hours. The Ls-act/Ls-18S index was determined by RT-qPCR, the
median value of the control group was set to 100% and the inhibition of the dsRNA treated groups
calculated. Ls-act expression was reduced to 19% of the controls after the first 24 hours with dsRNA
(+dsRNA). The Ls-act transcript levels were further reduced in the absence of dsRNA (-dsRNA) to 7% after
48 hours, and 3% after 72 hours. RT-qPCR was performed in triplicate. The graph presents one experiment
from multiple experiments (3 or more, depending on the time point). The same results were seen in all
experiments. The error bars represent the inter-quartile range. Asterisks denote a significant difference
between RNAi-treated nematodes and untreated medium controls (Mann-Whitney U Test, P " 0.05).
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3.5.4 Silencing Ls-act produced visible phenotypes in L. sigmodontis
3.5.4.1 Reduced motility after RNAi treatment
Adult L. sigmodontis were soaked in serial dilutions of dsRNA (0.035-35 µM) for 24
hours as described for B. malayi (Aboobaker, Blaxter, 2003). The nematodes of the
three different treatment groups (control, Ls-act, and Ce-rme-2) showed no deleterious
effects after removal from the microvolume dialysis system (after 24 hours) and transfer
into dsRNA-free culture medium, as indicated by their vigorous movement. A visible
phenotype was then clearly seen with Ls-act dsRNA 48 and 72 hours after the start of
the experiment (i.e. 24 and 48 hours after changing the worms to dsRNA-free culture
medium). The nematodes incubated with dsRNA of Ls-act had visibly reduced motility
or were fully elongated rather than being coiled (Movie 1). This phenotype was
consistently observed in all Ls-act treated worms 48 and 72 hours after the start of the
experiment. Nematodes that were soaked in dsRNA-free medium (Movie 2) or in
Ce-rme-2 dsRNA (Movie 3) showed no change in motility.
The enclosed CD contains the original movies.
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Pictures of the recorded worm movements after RNAi treatment were presented here.
Movie 1. Ls-act dsRNA treatment results in paralysis of adult
worms.
L. sigmodontis were soaked for 24 hours in Ls-act dsRNA in a
small volume dialysis system and then transferred to a larger
volume of dsRNA-free medium. After incubating for another 24
hours, the worms were examined for changes in movement by
videotaping for 30-60 s. In comparison to the medium control
(Movie 2) and Ce-rme-2 negative control (Movie 3) the Ls-act
treated nematodes consistently showed signs of paralysis or were
stretched out, indicative of moribund worms. The phenotype
shown in the selected movie was seen in all Ls-act dsRNA treated
worms.
Movie 2. Control nematodes soaked in medium without
dsRNA.
L. sigmodontis were soaked in dsRNA-free medium in a small
volume dialysis system and then transferred to a larger volume of
dsRNA-free medium. After incubating for another 24 hours, the
worms were examined for changes in movement by videotaping
for 30-60 s.  No change in movement was seen when the worms
were observed at 24 hours after transfer into a larger volume of
medium. The selected movie is representative of all
RNAi experiments.
Movie 3. Ce-rme-2 dsRNA does not cause paralysis in
L.!sigmodontis.
L. sigmodontis were soaked for 24 hours in Ce-rme-2 dsRNA in a
small volume dialysis system and then transferred to a larger
volume of dsRNA-free medium. After incubating for another 24
hours, the worms were examined for changes in movement by
videotaping for 30-60 s. No change in movement was seen when
compared to control worms (Movie 2). The selected movie is
representative of all RNAi experiments treated
with dsRNA of Ce-rme-2.
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3.5.4.2 Reduced release of microfilariae after RNAi treatment
Microfilarial release was determined by counting released microfilariae from control
and RNAi-treated nematodes directly after removal of the adult worms from the low
volume dialysis system and after 24 hours in dsRNA-free culture medium. The total
number of released microfilariae was significantly lower in Ls-act treated parasites than
those of control nematodes after 24 (Figure 42A) and 48 hours (Figure 42B). In
contrast, there was no significant decrease in the number of released microfilariae from
Ce-rme-2 treated or control worms. Comparing just the medium controls from each time
point showed no significant difference in the number of released microfilariae (Mann-
Whitney U Test, P " 0.05). The same was true for the Ce-rme-2 treated nematodes.
Thus, the significant reduction in microfilarial release was specific for Ls-act dsRNA
and not the culturing conditions.
Figure 42. Inhibition of Ls-act expression leads to a reduction in microfilarial release from female
L. sigmodontis in culture.
L. sigmodontis (five groups of three worms/tube) were soaked for 24 hours in 3.5 µM dsRNA (Ls-act,
Ce-rme-2) or in medium-alone (con). The worms were then transferred to dsRNA-free medium and
incubated for an additional 24 hours. The microfilariae were collected 24 hours (A) and 48 hours (B) after
the start of treatment. The collected microfilariae were stained with Hinkelmann’s solution and all
microfilariae were counted using a light microscope (10# magnification). Treatment of nematodes with
Ls-act dsRNA lead to a significant reduction in the number of microfilariae released from the worms at
both collection time points. No significant difference was seen from nematodes soaked in Ce-rme-2.
The line in the box represents the median value; the error bars represent the minimum and maximum
values; the top and bottom of the box represents the 75th and 25th quartiles. The median number of
microfilarae released is given in the box. Each graph presents one experiment from multiple experiments
(3 or more, depending on the time point). The same results were seen in all experiments. Asterisks denote
a significant difference between RNAi-treated nematodes and untreated medium controls (Mann-Whitney
U Test, P " 0.05).
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4 Discussion
Filarial infections are a major health problem in more than 80 developing countries. In
endemic areas, mainly in the tropics, an estimated 200 million people are affected, and
over one billion are at risk of infection. The current control regimens aim to interrupt
the transmission by reducing the levels of microfilariae in infected individuals. Since
adult worms can survive up to 15 years (e.g. O. volvulus), chemotherapy to control the
microfilariae requires annual treatments for many years. In regard to this, worm
resistance to the currently administered drugs cannot be excluded. Therefore, a goal for
the World Health Organization is the development of new therapeutics that work in a
shorter treatment time, and that either lead to an efficient long-lasting block of
microfilariae production to control the pathology-inducing worm stages in
onchocerciasis (sterilization) or lead to macrofilaricidal effects (killing). The discovery
that in addition to the many animal filarial species, most of the human pathogenic
filariae also harbor mutualistic Wolbachia endobacteria (Taylor, Hoerauf, 1999) opened
up new strategies for therapy.
In animal studies, administering tetracycline antibiotics (anti-Rickettsiales) depleted the
Wolbachia bacteria from the nematodes and caused embryos to degenerate, resulting in
the reduction of microfilariae released and finally producing sterility of female worms
(Hoerauf, 1999; Hoerauf, 2000c). In the case of bovine onchocerciasis, also macro-
filaricidal effects of tetracycline treatment were reported (Langworthy, 2000).
The results of trials with doxycycline in humans infected with O. volvulus (6 weeks at
100 mg/day) or LF patients infected with W. bancrofti (6-8 weeks at 200 mg/day) also
demonstrated the depletion of Wolbachia, accompanied by a significant reduction of
microfilariae (the main cause of onchocercal disease), followed by amicrofilaremia
which persisted for almost two years. These data suggest that the Wolbachia do not
return, once they are eliminated or depleted below a threshold.
For onchocerciasis patients a significant macrofilaricidal effect was also observed
(Hoerauf, 2008). Doxycycline treatment reduced the adult worms to 70% in contrast to
multiple rounds of IVM treatment that reduced the adult worms to only 30%. Similarly,
a clear macrofilaricidal effect of doxycycline was demonstrated for LF patients (Taylor,
2005b; Supali, 2008).
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The pharmacological efficiency of doxycyline is undisputable but the length of the
treatment and the known contraindications (not to be given to children under 9 years of
age and pregnant or breast-feeding women) make this treatment currently unsuitable for
mass chemotherapy. Doxycycline treatment alone (sterility of adult female worms) or in
combination with ivermectin (elimination of microfilariae) can thus far improve on the
condition of individual patients, and interrupt the transmission of the disease as long as
a new infection can be excluded. Recent studies showed as well that doxycycline, either
alone or in combination with DEC and albendazole, leads to a decrease in
microfilaremia and reduces adverse reactions to antifilarial treatment in B. malayi-
infected individuals (Supali, 2008).
Doxycycline might be used as a reserve drug in case the suspected resistance to IVM
does further develop (Awadzi, 2004a; Awadzi, 2004b). Resistance of Wolbachia to
doxycycline can theoretically not be excluded, but is unlikely, since Wolbachia, being
endosymbionts contained in a vacuole behind several membranes inside the nematodes,
are not accessible to plasmid or transposon exchange as is the case with free-living
bacteria. Also, with other Rickettsiales, there has been no clear resistance development
to doxycycline for more than 50 years (Branger, 2004).
In order to find new possibilities to block the transmission or even kill the adult
nematodes and then to develop suitable treatment approaches, the aim of this thesis was
the screening for nematode genes that might be involved in the symbiosis between
Wolbachia and their filarial hosts and that play an important role when the bacteria were
removed by antibiotic treatment.
4.1 Filarial HSP60 is up-regulated in O. volvulus after Wolbachia depletion but
not directly involved in the symbiosis
The elimination of Wolbachia upon antibiotic treatment was repeatedly monitored by
immunohistochemistry and electron microscopy using antibodies against bacterial
proteins as Y-HSP60 and Bm-WSP (Hoerauf, 2001). In these studies, an up-regulation
of filarial HSP60 was reported in sections from nodules excised 2, 5, 11, 19, and 24
months after the start of doxycycline treatment, being strongest in portions of the
filariae where usually no bacteria are present. A weak staining of filarial HSP60 has
also been seen in worms from untreated patients (Figure 17C) but these latter worms
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have been classified as moribund or dead, as the worms were either old, damaged, or
contained neoplastic cells in the pseudocoeloma (Duke, 2002). These signs of
pleomorphic neoplasms may partly account for the macrofilaricidal effect of the
doxycycline treatment.
One reason for the detected increase in filarial HSP60 could be that the used Y-HSP60
antibodies are more specific to the bacterial HSP60 and stain only weakly for the filarial
HSP60 until the Wolbachia are entirely depleted, as shown by staining consecutive
sections of O. volvulus with Bm-WSP antibodies, specific for bacteria.
To rule this out we decided to quantify the hsp60 expression of onchocercomata
extirpated from untreated and doxycycline treated patients. Specific primers for the
filarial hsp60 gene were designed and tested for specificity by BLAST search as well as
in PCR with cDNA of O. volvulus, L. sigmodontis, A. viteae, and human material. The
BLAST search revealed no hits for bacteria, and the PCR results demonstrated that the
primers were clearly nematode specific, as no signal was detectable in human material.
The same was true for the actin gene, which was used to generate the gene expression
index. The advantage of using RT-qPCR is the exactly quantification of mRNA
transcripts by the use of an external, defined specific standard curve. Any contamination
with genomic DNA would be detectable by this technique running a melting curve after
each PCR run, which was not the case in the reported experiments.
In comparison to semi-quantitative PCR (16S/5S index), which was used in earlier
studies to calculate the decline of Wolbachia (Hoerauf, 2003c; Volkmann, 2003b) at the
DNA level, RT-qPCR is a more sensitive and precise method, and not as time
consuming, as no competitors have to be generated and introduced into the PCR.
Additionally, with the earlier semi-quantitative PCR it was impossible to distinguish
between living or dead organisms since gDNA was measured and would therefore
detect remnant endobacteria present in the samples.
A successful elimination of Wolbachia from patients infected with O. volvulus by
antibiotic treatment could be confirmed by quantification of the bacterial ftsZ mRNA
transcripts. The median value of the doxycycline treated samples was zero. In contrast,
the filarial hsp60 transcripts of the same samples were up regulated by a factor of 7.7
after doxycycline treatment. A direct association between increasing hsp60 transcripts
and Wolbachia reduction was demonstrated when filarial hsp60 index was plotted
against bacterial ftsZ index in the Spearman Rank test (Statview 5.0). The linear
regression plot shows a weak but positive correlation. A way to support this direct
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association between Wolbachia depletion and increased hsp60 expression might be
better shown with greater sample numbers and samples extirpated from several earlier
time points, when Wolbachia levels are not near zero.
For the reasons mentioned above, it is believed that the transcriptional up-regulation of
filarial mitochondrial hsp60 is not just a reaction to the stress of accumulating many
dead Wolbachia bacteria. Rather, the up-regulation may indicate efforts by the filarial
cells to compensate for an interruption in some cell process, which the Wolbachia
provide to the nematode. This interruption may lead to a buildup of proteins which
require HSP60 for proper folding, i.e. the unfolded protein response. Such a response
has been described for mitochondria in mammalian cells and in Caenorhabditis elegans
(Yoneda, 2004). In C. elegans, the accumulation of unfolded proteins leads to the up-
regulation of HSP60 specifically in the mitochondria and is associated with proteins
imported into the mitochondria, which subsequently form multi-protein complexes.
Therefore we conclude that the resulting up-regulation of HSP60 in the mitochondria is
not from other stresses such as reactive oxygen species (Zhao, 2002; Yoneda, 2004).
In summary, the depletion of Wolbachia from filarial worms leads to increased
mitochondrial hsp60 expression at the level of transcription and translation, and this
increase is not a direct effect of the antibiotic treatment since in A. viteae, a filarid that
is devoid of Wolbachia, no increase in hsp60 expression upon tetracycline treatment
was detectable. Since this up-regulation lasts up to 24 months, and hopefully longer, it
demonstrates that doxycycline treatment has a long lasting effect on the metabolism of
O. volvulus.
4.2 Wolbachia, targets for a new chemotherapy against filarial infections
Nematode genes that respond to an anti-wolbachial treatment might be important in the
symbiosis and thus represent targets for new chemotherapeutical approaches. The
development of new drugs is indeed needed since issues of drug resistance, especially
for the currently used mass drugs DEC and IVM, have emerged (Awadzi, 2004a).
Efforts in the Wolbachia community lead to the sequencing and annotation of the
complete Wolbachia genome of B. malayi (wBm), and revealed important insights into
genes that have been kept by the Wolbachia and genes that have been lost during this
symbiosis (Foster, 2005; Pfarr, Hoerauf, 2005). Additionally, the draft genome of
Discussion
96
B.!malayi (Ghedin, 2007) provided evidence for adaptations of B. malayi to niches in its
human and vector hosts and into the molecular basis of a mutualistic interaction with its
Wolbachia endosymbiont. As 9 of 10 enzymes required for the de novo purine
synthesis, 6 of 7 genes required for heme biosynthesis, and all 5 enzymes required for
de novo riboflavin biosynthesis are absent from the B. malayi genome (Ghedin, 2007),
the worm may be forced to meet requirements for these key metabolites by active
uptake of mammalian host-supplied molecules or through reliance on wBm, which has
retained the ability to make all but one amino acid, nucleotides, and purine, heme, and
riboflavin synthesis pathways. All these metabolites may be provided by the
endobacteria to the nematode as part of the symbiosis. Exploitation of this wealth of
information is just beginning.
4.3 Screening for genes involved in the symbiosis between Wolbachia and its
filarial host
The identification of filarial genes that are up-regulated in response to the loss of their
endosymbiotic bacteria due to anti-wolbachial treatment was proposed. In our animal
model, IL-5-deficient Balb/c mice infected with L. sigmodontis were treated with
tetracycline at levels known to deplete endosymbiotic Wolbachia bacteria. Differential
display PCR of mRNA generated from tetracycline treated and untreated nematodes
revealed many fragments that had changed in expression. Many down-regulated
fragments were identified, but after sequencing all were found to be of Wolbachia
origin, indicating genomic DNA contamination. Therefore, we focused on up-regulated
genes only, and found 12 potential candidates (Table 5).
These candidates were rigorously tested to confirm that they were up-regulated, and
further to eliminate false-positives. This was done by Reverse dot blot and Northern
blot. In the first, we used a non-radioactive variant of aRNA generated hybridization
probes that were fluorescein labeled with the ECL kit. Unfortunately, the results were
not reproducible, probably due to the multiple enzymatic steps needed to amplify the
small amounts of RNA extractable from small numbers of worms. These included three
transcription steps (reverse transcription from RNA to cDNA; in vitro transcription to
aRNA; and reverse transcription of aRNA into single stranded cDNA that was
subsequently used for fluorescein labeling). Therefore, we switched to radioactive
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hybridization probes, which allowed a more “direct” labeling of the aRNA since only
two steps were needed between RNA extraction and labeled probe, thus limiting the
introduction of error. In Reverse dot blots with these radioactive hybridization probes
made from aRNA, 3 out of the 12 candidate genes had an up-regulation of factor (1.5 at
day 15 post treatment (Table 6), our arbitrarily chosen cut-off. The candidates that
passed this screening were DD-1, DD-9, and DD-10.
Sequence analysis of the DD-1 gene fragment revealed BLAST hits corresponding to
the small nuclear RNA U6 gene (U snRNA) of Ascaris lumbricoides, another parasitic
nematode (Shambaugh, 1994). In nematodes, nuclear pre-messenger RNAs are
processed by cis- and trans-splicing. Usually, the catalysis of the splicing process
depends on the participation of several snRNAs in the form of ribonucleoprotein
particles (U snRNPs) (Nilsen, 1993). The U6 snRNA is required for both cis- and trans-
splicing. Therefore, the clone DD-1 was further investigated by qPCR, but had just a
short-term up-regulation during the first two weeks of the treatment trial (Figure 37),
suggesting that the raised expression might be due to a general stress response regarding
the tetracycline treatment. On the other hand, the short-term up-regulation might also be
embryonic-specific expression since it is known that the antibiotic treatment affects the
embryos first (Langworthy, 2000). Nevertheless, since this was a gene associated with a
general process, RNA transcription, DD-1 was excluded from further investigations.
Candidate DD-10 (an 80 bp fragment) could not be confirmed by Reverse dot blot
hybridized with radioactive labeled DD PCR products and was also rejected.
Only one gene out of these three candidate genes, DD-9, passed the rigorous screening.
4.4 Identification of a L. sigmodontis phosphate permease
The candidate designated as DD-9, identified by BLAST as a phosphate permease of
L.!sigmodontis (Ls-ppe-1), was verified to have a 2-3 fold up-regulation by Reverse
Northern blot using radioactively labeled aRNA and DD PCR products and was
therefore chosen for additional confirmation and quantification by Northern blot and
quantitative PCR.
Using quantitative PCR, Ls-ppe-1 was shown to be up-regulated in female nematodes in
a bimodal pattern while male nematodes only showed a linear increase in expression.
This 3-fold over-expression remained at its peak level up to one month (day 70) after
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the tetracycline treatment has been stopped, demonstrating a long-term alteration in the
transcriptional state of the gene. These data also suggest that Wolbachia do not return,
once they are eliminated from the nematode.
Experiments in cattle demonstrating killing of adult O. ochengi by tetracycline showed
that the embryos are the first stage to die within 3 months post treatment, followed later
by death of the adult nematodes after 6 months (Langworthy, 2000). The kinetic of
Ls-ppe-1 expression was consistent with a similar pattern in L. sigmodontis. The first
peak in expression of adult female worms between days 3 and 6 after the start of
tetracycline treatment could result from an increased expression of Ls-ppe-1 in embryos
trying to compensate for the lack of Wolbachia, accompanied with decreased delivery
of nucleotides or other metabolites usually provided to the nematode (see also 4.5.4).
The decreased expression on day 15, which is still significantly higher than in control
nematodes, could represent the loss of embryonic expression as embryos are more
sensitive to anti-wolbachial treatment. At this time, a detectable up-regulation in the
adult nematodes is just beginning. In contrast, male nematodes show linearly increasing
Ls-ppe-1 expression beginning on day 6 of treatment with a significant peak on day 36,
the end of the treatment.
Investigation of the dynamics of embryo and adult death, and of the pattern of Ls-ppe-1
expression in pre-fertile females (which would not be expected to show the early peak)
would address this hypothesis.
4.5 Characterization and potential function of Ls-ppe-1
4.5.1 Identification of three Ls-ppe-1 sequence variants
RLM-RACE PCR was used to obtain the full-length sequence of three variants of the
phosphate permease: Ls-ppe-1-1, Ls-ppe-1-2 and Ls-ppe-1-3. These three transcripts
have the same coding sequence and differ only in their 5’ and 3’ untranslated regions.
The predicted Ls-PPE-1 protein was most similar to four phosphate permeases in
C.!elegans (B0222_3, B0222_2, F09G2_3 and C48A7_2). The Ce_C48A7_2 phosphate
permease is expressed in adult nematodes and larvae and shows a severe phenotype in
RNAi experiments (embryonic lethality, sterility of adult nematodes, and other,
undescribed growth and morphological defects) (Maeda, 2001). The two genes on
cosmid B0222 were also tested as part of large-scale RNAi screens by two groups,
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using different methods: feeding (Kamath, Ahringer, 2003) or microinjection
(Sonnichsen, 2005). Both approaches produced no visible phenotype. However, the
same two groups also did not see a phenotype when testing the sequence for
Ce_C48A7_2, whereas Maeda et al. did see a phenotype by soaking the nematodes in
dsRNA. The differences in the techniques may be a source of the different results. It is
also possible that phenotypes may have been missed, since the large scale RNAi
screenings looked only at early development stages and lethality. More subtle
phenotypes could have been missed in these screens. The results from Maeda’s group
are relevant to Ls-ppe-1 since the knock down in C. elegans has a phenotype similar to
that observed in nematodes depleted of Wolbachia upon tetracycline treatment, namely
embryonic death and female sterility.
4.5.2 Phylogenetic studies of nematode homologues of Ls-ppe-1
Phylogenetic analysis (Heider, 2006) using available Caenorhabditis (The C. elegans
Genome Sequencing Consortium, 1998; Stein, 2003), the B. malayi genome sequence
(Ghedin, 2004) and other nematode EST datasets (Parkinson, 2004) shows that the
Ls-ppe-1 gene is not unique to L. sigmodontis but has an orthologue in another filarial
nematode B. malayi. No other orthologues were detected. However, closely related
paralogues were found in O. volvulus, B. malayi and the two Caenorhabditis species
(Appendix B).
O. volvulus OVC00569 and B. malayi 14967 n01567 are significantly more similar to
these caenorhabditid orthologues than are Ls-ppe-1 and B. malayi 13026 m00037,
which have no orthologous caenorhabditid proteins (Figure 32). Indeed, in the portion
of the protein available for comparison, Ls-ppe-1 and B. malayi 13026 m00037 are
more divergent than any of the caenorhabditid orthologue pairs, and are as distant from
each other as O. volvulus OVC00569/B. malayi 14967 n01567 are from their caeno-
rhabditid orthologues. We interpret this pattern to suggest that the Ls-ppe-1 gene arose
from duplication in a lineage predating the L. sigmodontis!B. malayi split, and that it
has undergone accelerated evolution since then in matching the biology and needs of the
Wolbachia symbionts. It will be informative to isolate and complete the sequence of
B.!malayi 13026 m00037 and compare its biology and regulation to Ls-ppe-1.
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4.5.3 Ls-ppe-1 does not respond to stress stimuli
Even though the loss of Wolbachia causes stress in the filarial nematodes, Ls-ppe-1 is
probably not a general stress-response gene. Exposure to oxidative stress and heat shock
did not induce a rise in Ls-ppe-1 transcript levels whereas an increase in Ls-hsp-60
expression could be measured after both stresses. It was not possible to test all possible
sources of stress (e.g. nutrition, cold, etc.), but as all three chemicals used to generate
oxidative stress and an elevated temperature induced Ls-hsp-60 expression but not
Ls-ppe-1, it is likely that other physical stresses would not lead to an up-regulation in
Ls-ppe-1. Secondly, treatment with gentamicin, an antibiotic that does not deplete
Wolbachia from the nematode (Taylor, 2000; Mohanty, 2001), had no effect on
Ls-ppe-1 expression. Finally, and of greater importance, the Wolbachia-free filarid
A.!viteae displayed no increased expression of the orthologue after tetracycline
treatment. The up-regulation of Ls-ppe-1 steady state mRNA levels observed with
tetracycline treatment likely reflects a role for the protein product of this gene in the
physiological interaction between the nematode and Wolbachia.
4.5.4 The hypothetical function of Ls-ppe-1 in the symbiosis
The role of Ls-ppe-1 in the symbiosis between Wolbachia and their filarial hosts may
relate to a possible involvement in nucleotide metabolism. The genome of the
Wolbachia from the filarial nematode B. malayi (wBm) has been completely sequenced
(Foster, 2005). The wBm genome contains a type IV secretion system that in other
intracellular bacteria is used to export molecules to host cells. In contrast to most
endosymbiotic bacteria, wBm is able to make only one amino acid de novo, but has
retained all genes necessary to synthesize nucleotides. wBm may provide nucleotides or
nucleotide precursors to its host for processes such as embryogenesis (Foster, 2005;
Pfarr, Hoerauf, 2005).
Database searches (motif.genome.jp/) for the Ls-PPE-1 protein revealed that apart from
the signal peptide only a PHO4 motif is present (amino acid position: 48-512). PHO4 is
belongs to a phosphate transporter family (NCBI GenomeNet database Pfam; InterPro
domain IPR001204) that includes PHO4 from the filamentous fungus Neurospora
crassa (Versaw, Metzenberg, 1995). Phosphate uptake by PHO4 in N.!crassa was
stimulated 85-fold by the addition of Na+, which supported the idea that PHO4 is a
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Na(+)-phosphate symporter. The sequence difference between Ls-ppe-1 and PHO4 did
not allow a direct comparison and phosphate uptake by Ls-ppe-1 was not examined.
Thus, Ls-ppe-1 is supposed to transport phosphate, and there is no hint for an
antiport/symport mechanism or other function yet.
Phosphate is an essential molecule for nucleotide synthesis. As Wolbachia are contained
within a vesicle in the nematode cells, they do not have direct access to either
extracellular or cytoplasmic phosphate. If Ls-ppe-1 were located in the vesicle
surrounding the Wolbachia it would be well placed to transport phosphate from the
nematode cell to the Wolbachia. This is supported by the presence of a signal sequence
that could potential lead to transport of Ls-ppe-1 to the membrane around the Wolbachia
endobacteria. According to this hypothesis, the loss of Wolbachia after tetracycline
treatment would then lead to a deficiency of nucleotides, or some other metabolite
provided by the endobacteria, in the nematode cell. The cell would then attempt to
compensate for the lack of nucleotides by increasing the expression of Ls-ppe-1, thereby
providing more phosphate to Wolbachia (Figure 43).
Evidence for such a feedback interaction can be inferred from the bimodal regulation of
Ls-ppe-1 expression (see section 4.4). In this scenario, the Wolbachia do not need to
provide the worm cell with nucleotides, but the inability of the endobacteria to
synthesize needed nucleotides would lead to death of the Wolbachia and therefore
deplete the molecules that are provided to the worm by their endosymbionts.
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Figure 43. The hypothetical function of Ls-ppe-1.
(A) The steady state of a nematode cell is shown A nematode-derived vesicle contains Wolbachia
producing metabolites that are delivered to the host cell. (B) Wolbachia depleted by tetracycline (step 1)
leads to a deficiency of the provided metabolites. The cell senses the imbalance and signals the nucleus
(step 2). Then the nematode cells try to compensate for the loss by increasing Ls-ppe-1 (step 3) thereby
pumping more phosphate into the vesicle.
4.5.5 Prospects
RNAi can be suggested as a way to produce a functional knock down of the phosphate
permease in L. sigmodontis and B. malayi to demonstrate that the phosphate transport is
an important feature for embryonic development. To further investigate the function of
ppe-1-like genes, the C. elegans phosphate permease orthologues could be knocked
down and a thorough analysis of the resulting phenotypes could be performed. This
would set the groundwork for recovering phosphate permease activity in C. elegans
using Ls-ppe-1 and orthologues from B. malayi and O. volvulus. Since it is possible that
related C. elegans genes could compensate for one another, a knock down of two genes
through double-target RNAi would need to be performed (Reichhart, 2002). Analysis of
the ultrastructural location of Ls-PPE-1 will test the hypothesis of co-localization with
the vesicle surrounding the Wolbachia.
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4.6 Implementation of RNAi in the model organism L. sigmodontis
The knockdown experiments accomplished in this thesis showed that a housekeeping
gene such as Ls-actin could be efficiently silenced, demonstrating that parts of the
RNAi machinery are also present in the rodent filaria L. sigmodontis.
4.6.1 The characteristics of silencing Ls-act
The efficiency of RNAi depends on the concentration of dsRNA in the medium with the
best effect seen using a ten-fold lower concentration of dsRNA (for Ls-act) than that
reported in the original method of Aboobaker (Aboobaker, Blaxter, 2003) for adult
B.!malayi. A concentration of 3.5 µM dsRNA mediated the specific knockdown of
Ls-act gene expression in L. sigmodontis to less than 10% of controls. Concentrations
lower than 3.5 µM were also effective, but not as consistent between experiments.
This knockdown of Ls-act persisted for at least two days after the removal of the worms
from the dsRNA. This is a key feature of RNAi described also in other systems
(Montgomery, Fire, 1998; Correnti, 2005). To avoid any adverse effects due to long
term culturing of the worms in medium, adult nematodes could be implanted into naïve
Meriones unguiculatus. By this method, the nematodes can then be removed as late as
60 days post implantation and it could be determined how long the RNAi effect persists
as has been shown in Schistosoma mansoni (Correnti, 2005).
The silencing of Ls-act by RNAi resulted in visible phenotypes: it reduced the motility
of adult worms and led to a significant reduction in the number of larvae released into
the medium. Not all worms were affected to the same extent as can be seen by the large
variation in the number of microfilariae released (see the boxes and range bars in Figure
42A and B). Clearly some nematodes make no larvae while others still release a large
number. Such variation is consistent with results reported in other organisms including
Drosophila, C. elegans, Trypanosoma brucei and S. mansoni (Grant, Hirsh, 1999;
Simmer, 2003; Hashmi, 2004; Ullu, 2004; Correnti, 2005).
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4.6.2 Additional control for off-target effects
Another improvement over the original protocol and the methods used for
T.!colubriformis  (Issa, 2005) is the establishment of controls for off-target effects.
Delivery of dsRNA molecules into organisms can have cytotoxic effects, presumably
mediated by acidification of the medium due to high dsRNA concentrations (Huppi,
2005). Off-target-effects such as rapid dying of nematodes and a decrease in expression
of non-targeted genes have been avoided in other systems by lowering the concentration
of dsRNA (Yang, 2000; Persengiev, 2004; Huppi, 2005).
We controlled for off-target effects in two ways:
1) monitoring the expression levels of Ls-hsp60 and Ls-gst2; and
2) including a dsRNA negative control.
The 3.5 µM dsRNA concentration that reduced Ls-act expression was shown not to
reduce the expression of Ls-hsp60 or Ls-gst2. Not unexpectedly, 17.5 µM and 35 µM
dsRNA caused an increase in Ls-hsp60 expression, showing that these high
concentrations of dsRNA were stressful to the worms. The normally low transcript
abundance of Ls-gst2 in the samples (Liebau, 2000) led to a late signal in the RT-qPCR
(between 35 and 40 cycles) and caused high variation in the copy number measured,
even in the control worms. The apparent increase as high as 200% in Ls-gst2 is
therefore not biologically significant. The reduction in Ls-act expression was further
shown to be gene specific and not due to cytotoxicity of dsRNA by incubating worms
with a non-filarial dsRNA from C. elegans. Ce-rme-2, used at the same concentration as
Ls-act, did not significantly inhibit the expression levels of all three genes measured
(Figure 40). Ce-rme-2 dsRNA at 3.5 µM, like Ls-act, did not significantly increase the
expression of Ls-hsp60 and Ls-gst2.
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4.6.3 The differences between different model organisms
Although Aboobaker et al. (2003) demonstrated in adult B. malayi worms that FITC-
labeled dsRNA is localized to the hypodermis and digestive and uterine tracts, the exact
method of uptake in filarial nematodes, whether passive or active, is not known.
Differences in the thickness of the cuticle between individual worms could therefore
contribute to an inefficient uptake of dsRNA from the surrounding medium, especially
if uptake is strictly passive. Additionally, differences between L. sigmodontis and
B.!malayi may account for the differences in the amount of dsRNA needed to produce
an RNAi effect in these two species. In addition to the ease of maintaining the life cycle
of L. sigmodontis, the apparent requirement for lower concentrations of dsRNA by
L.!sigmodontis to produce a phenotype without off-target effects supports the use of this
model organism for further functional studies by RNAi. However, we have tested only
one gene. Further experiments with other genes need to be performed to support this
conclusion.
In contrast to Aboobaker (Aboobaker, Blaxter, 2003) who were unable to deliver FITC-
labeled "-tubulin dsRNA into sheathed and exsheathed first stage larvae, Lustigman
et!al.  (Lustigman, 2004) could demonstrate successful delivery of dsRNA for two
cysteine proteases into O. volvulus third stage larvae by soaking. This group used
~1.5!µM dsRNA to knockdown the gene expression in O. volvulus larvae.
In our present study with adult L. sigmodontis, we found the best effect with 3.5 µM of
dsRNA for the Ls-act gene. We also observed that concentrations as low as 0.035 µM
significantly reduced Ls-act transcript levels, confirming that only a few molecules
dsRNA per cell are required to produce RNAi (Fire, 1998). Thus, Ls-act dsRNA
concentrations lower than 17.5 µM (see Figure 39 and Figure 40) are optimal for RNAi
in L. sigmodontis without causing off-target effects. However, each gene should be
empirically tested to determine the best concentration that reduces gene expression
without off-target effects.
Recently, limited reliability and efficiency of RNAi in parasitic nematodes of plants and
animals has been reported (Issa, 2005; Geldhof, 2006; Visser, 2006). To understand
these variable outcomes, the available preliminary parasite genomes of H. contortus
(95% coverage) and B. malayi (98% coverage), and expressed sequence tag (EST)
datasets were searched for genes that are known to be involved in the RNAi pathway in
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C. elegans (Zawadzki, 2006; Knox, 2007). Both groups were unable to identify the
following genes (Table 8) that were thought to be essential for a functional and systemic
RNAi pathway:
Table 8. Unidentified genes essential for a functional RNAi pathway
C. elegans gene name Protein function
Rde-4 RNA binding in dicer complex
Rde-2 siRNA accumulation
Sid-2 Systemic RNAi
Rsd-2 Systemic RNAi
These observations were crucial since C. elegans, with mutations in the rde-4 gene are
deficient in RNAi induced by dsRNA but not by siRNA, which shows the essential role
of RDE-4 in siRNA generation. It is possible that an rde-4 homologue has yet to be
sequenced from parasitic nematodes or that rde-4 is considerably divergent from
C.!elegans rde-4 and the Drosophila melanogaster homologue r2d2 (Liu, 2003). It is
not known whether the function of RDE-4 is undertaken by a different protein or rde-4
has been lost during evolution. If this were the case, how would one explain the
increasing number of reports describing successful RNAi in parasitic nematodes? One
possibility is that standard dsRNA preparations, which are used at relatively high
concentrations, contain contaminating partially degraded dsRNA, aRNA or siRNAs at a
concentration sufficient to induce RNAi downstream of the interaction of RDE-4 and
Dicer (Knox, 2007). The other possibility would be an alternative pathway.
If the sid-2 and rsd-2 genes were indeed absent, this would infer that the RNAi effect
would not systemically spread throughout the worm. In this case, the effects would only
be observed in areas of the worms that were directly accessible to the dsRNA such as
the outer surface, the gut and the reproductive tract (Geldhof, 2007).
Nevertheless, it has been clearly demonstrated that RNAi is possible in helminths under
certain conditions (delivery mode of dsRNA, developmental stage targeted).
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4.6.4 Prospects
The reduction in the dsRNA concentration used for the soaking method makes RNAi
possible in filarial nematodes without incurring extremely high material costs. Lower
dsRNA concentrations could also be tried with electroporation so that an alternative
method to introduce dsRNA might be developed for those cases where soaking fails.
This is a valid concern as has been demonstrated in the sheep parasite T. colubriformis
(Issa, 2005). In this system, electroporation lead to a better reduction in T. colubriformis
ubiquitin (Tc ubq-1) expression compared to feeding or soaking with dsRNA. Also to
be tested is whether siRNA could be used for filarial nematodes. Again, Issa et al. (Issa,
2005) showed successful reduction in Tc ubq-1 expression using a 22 bp synthetic
dsRNA (siRNA). The authors showed that Tc ubq-1 siRNA works better by soaking
than the corresponding full length dsRNA, and that the Tc ubq-1 knockdown with
siRNA is even more efficient by electroporation. Our own experiments demonstrated
that a short dsRNA (99 bp) lead to efficient RNAi in adult L. sigmodontis. Our results
with dsRNA of 99 bp and those of Issa et al. (Issa, 2005) with siRNA suggest that
shorter dsRNAs may be better for RNAi in parasitic nematodes and should be examined
formally in more parasitic nematodes, especially filarial nematodes, with more genes.
The similarity of many genes in filarial nematodes (Blaxter, 2002) allows for functional
testing of unique genes identified from the B. malayi genome in the rodent filaria
L.!sigmodontis. Using L. sigmodontis for RNAi studies is advantageous because it may
require, as shown here with Ls-act, lower concentrations of dsRNA, and any long-term
RNAi effect can be monitored by implantation of the nematodes into a natural host.
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5 Summary
Filariasis is a vector-borne disease that affects 200 million individuals in the tropics, a
large number of them seriously, where the disease leads to blindness (onchocerciasis) or
elephantiasis (lymphatic filariasis). The prevalence of infections with lymphatic
filariasis is declining but for onchocerciasis newer data revealed an additionally 20
million cases (Basanez, 2006). Despite intensive efforts, it may be impossible to
eradicate filariasis by conventional therapies (Stolk, 2006). The Wolbachia, which are
mutualistic endobacteria of most filarial nematodes, are essential for embryogenesis and
larval development into adults and were thus identified as new target for anti-filarial
drug development. Tetracycline antibiotics deplete Wolbachia in the animal model
filariae Litomosoides sigmodontis and Brugia pahangi, as well as in the human parasites
Brugia malayi, Onchocerca volvulus and Wuchereria bancrofti. Still, very little is
known about the molecular details of the symbiosis between Wolbachia and its filarial
host but nematode genes that respond to an anti-Wolbachia treatment may play
important roles in the symbiosis. Therefore, the aim of this thesis was first to screen for
such genes that might be involved in the symbiosis, and second to establish RNAi in the
rodent filaria L. sigmodontis to study the function of filarial genes.
Differential display PCR was used to detect several candidate genes that are up-
regulated upon antibiotic treatment. One of these genes, Ls-ppe-1, was similar to a
family of phosphate permeases, and had putative orthologues in O. volvulus and
B.!malayi . Ls-ppe-1 mRNA levels were elevated by day 3 to 36 of treatment and
remained elevated through to 70 days post infection, one month after the treatment had
been stopped, demonstrating a long-term alteration in the transcriptional state of the
gene (Heider, 2006). In Caenorhabditis elegans, the knockdown of a homologous
phosphate permease results in embryonic lethality, with the production of degenerating
embryos, a phenotype that is also seen in filarial nematodes after the depletion of
Wolbachia with tetracycline. The role of Ls-ppe-1 in the symbiosis may relate to a
possible direct or indirect involvement in nucleotide metabolism. In contrast to other
endosymbionts that have undergone gene reduction, Wolbachia has retained the ability
to synthesize nucleotides (in addition to other metabolites). Potentially the phosphate
permease provides the Wolbachia with phosphate as part of the mutualistic symbiosis.
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The mitochondrial HSP60 was found to be up-regulated in immunohistochemical
stained sections of O. volvulus after the depletion of Wolbachia by doxycycline
treatment. The anti-HSP60 serum binds specifically to this protein in both Wolbachia
and mitochondria but the distinct localization of Wolbachia bacteria and mitochondria
allows for the differentiation of the two. Immunohistochemistry data showed an up-
regulation of filarial HSP60 after Wolbachia depletion. This could have been the result
of the antiserum that binds preferentially to Wolbachia when they are present. To
address this question, the mRNA levels of filarial hsp60 in O. volvulus were measured.
After depletion of Wolbachia, the hsp60 transcripts were significantly increased
compared to untreated control worms (Pfarr, 2008). The results lead to the hypothesis
that the increased expression of HSP60 is due to a disruption of the homeostasis of
metabolic pathways for which Wolbachia may be needed.
RNAi in adult worms of the rodent filaria L. sigmodontis was established and
optimized. The actin gene of L. sigmodontis was successfully knocked-down, whereas
the transcript levels of Ls-hsp60 and Ls-gst2, used as controls to measure off-target
effects, were not reduced (Pfarr, 2006). Soaking of nematodes with dsRNA coding for
the C. elegans yolk receptor (Ce-rme-2), which has no orthologues in filaria, did not
affect Ls-act transcription, demonstrating that the reduction of Ls-act is specific and not
due to toxicity of dsRNA or off-target effects. The inhibition of Ls-act persisted for 72
hours, the length of the observation time. Two additional phenotypes were seen: first,
the adult nematodes observed 48 and 72 hours after the beginning of the experiment
showed paralysis by being stretched out and having slower movements, second, the
release of microfilariae was significantly inhibited after soaking with dsRNA.
The use of lower concentrations of dsRNA than those previously reported for RNAi in
B. malayi as well as the establishment of proper controls for off-target effects could
make RNAi a possibility to study the function of filarial genes. However, there are
issues with RNAi in filarial nematodes and other parasitic nematodes, namely that their
genomes appear to lack the genes to allow spreading of the dsRNA signal from cell to
cell, indicating that the process is still hit-or-miss, depending on the gene to be silenced
and/or the method of delivery.
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Appendix A
CLUSTAL W (1.74) multiple sequence alignment for the 3 Ls-ppe-1 variants
Ls_phos_perm1      AAAGGTTTAATTACCCAAGTTTGAG-----------------------------------
Ls_phos_perm2      AAAGGTTTAATTACCCAAGTTTGAGAGTGTATAATTTCGGATGGTTCTTTTTTCAAACGG
Ls_phos_perm3      AAAGGTTTAATTACCCAAGTTTGAGAGTGTATAATTTCGGATGGTTCTTTTTTCAAACGG
                   *************************
Ls_phos_perm1      -------------------------------------------GTTAACTGAGAAATAAA
Ls_phos_perm2      TTATGTGCGCATCACGTCCATCCTGTTATTTCATCACTATATTGTTAACTGAGAAATAAA
Ls_phos_perm3      TTATGTGCGCATCACGTCCATCCTGTTATTTCATCACTATATTGTTAACTGAGAAATAAA
                                                              *****************
Ls_phos_perm1      GGAAGATGTCAACATTGACAGTAACTACGCTAATGCCATCCTCTTCTACAATGTCAGAAG
Ls_phos_perm2      GGAAGATGTCAACATTGACAGTAACTACGCTAATGCCATCCTCTTCTACAATGTCAGAAG
Ls_phos_perm3      GGAAGATGTCAACATTGACAGTAACTACGCTAATGCCATCCTCTTCTACAATGTCAGAAG
                   ************************************************************
Ls_phos_perm1      CATTCATAGCCGCCTTTCGGAATGATGTATTATGGGCATTAATATGTGGTGTAATTTTGG
Ls_phos_perm2      CATTCATAGCCGCCTTTCGGAATGATGTATTATGGGCATTAATATGTGGTGTAATTTTGG
Ls_phos_perm3      CATTCATAGCCGCCTTTCGGAATGATGTATTATGGGCATTAATATGTGGTGTAATTTTGG
                   ************************************************************
Ls_phos_perm1      CTTTTGTGCTTGGTTTTGCGATGGGTGCAAATGACGTTGCAAATGCTTTTGGTACATCGG
Ls_phos_perm2      CTTTTGTGCTTGGTTTTGCGATGGGTGCAAATGACGTTGCAAATGCTTTTGGTACATCGG
Ls_phos_perm3      CTTTTGTGCTTGGTTTTGCGATGGGTGCAAATGACGTTGCAAATGCTTTTGGTACATCGG
                   ************************************************************
Ls_phos_perm1      TTGGTAGCAAAGTGCTGACATTACGGCAAGCTTATATACTTGCAGTAATTTTTGAAACAC
Ls_phos_perm2      TTGGTAGCAAAGTGCTGACATTACGGCAAGCTTATATACTTGCAGTAATTTTTGAAGCAC
Ls_phos_perm3      TTGGTAGCAAAGTGCTGACATTACGGCAAGCTTATATACTTGCAGTAATTTTTGAAGCAC
                   ************************************************************
Ls_phos_perm1      TTGGAGCACTGCTTATCGGTTACAACGTAACGGATACGGTACGTAAAGGTGTCATCGATC
Ls_phos_perm2      TTGGAGCACTGCTTATCGGTTACAACGTAACGGATACGGTACGTAAAGGTGTCATCGATC
Ls_phos_perm3      TTGGAGCACTGCTTATCGGTTACAACGTAACGGATACGGTACGTAAAGGTGTCATCGATC
                   ************************************************************
Ls_phos_perm1      TGACGTTATATGAAGATAAACCAAAAGAGATTTTCATTGGGCAAATCGCCATTCTTGGAG
Ls_phos_perm2      TGACGTTATATGAAGATAAACCAAAAGAGATTTTCATTGGGCAAATCGCCATTCTTGGAG
Ls_phos_perm3      TGACGTTATATGAAGATAAACCAAAAGAGATTTTCATTGGGCAAATCGCCATTCTTGGAG
                   ************************************************************
Ls_phos_perm1      GTTGCTCATTATGGTTATTAATTGCTACACTTGCGCGTCTACCTGTATCATCAACTCATA
Ls_phos_perm2      GTTGCTCATTATGGTTATTAATTGCTACACTTGCGCGTCTACCTGTATCATCAACTCATA
Ls_phos_perm3      GTTGCTCATTATGGTTATTAATTGCTACACTTGCGCGTCTACCTGTATCATCAACTCATA
                   ************************************************************
Ls_phos_perm1      GTGTCACTGGAGCTACTGTAGGATTTGGCTTGATGACACGAGGTGTTGCTGGAATACAAT
Ls_phos_perm2      GTGTCACTGGAGCTACTGTAGGATTTGGCTTGATGACACGAGGTGTTGCTGGAATACAAT
Ls_phos_perm3      GTGTCACTGGAGCTACTGTAGGATTTGGCTTGATGACACGAGGTGTTGCTGGAATACAAT
                   ************************************************************
Ls_phos_perm1      GGAAAAAAATTGCTCATATTGTTGCTTCATGGTTTTTATCACCGATATTGTCTGGCGTCG
Ls_phos_perm2      GGAAAAAAATTGCTCATATTGTTGCTTCATGGTTTTTATCACCGATATTGTCTGGCGTCG
Ls_phos_perm3      GGAAAAAAATTGCTCATATTGTTGCTTCATGGTTTTTATCACCGATATTGTCTGGCGTCG
                   ************************************************************
Ls_phos_perm1      TGTCAGCCGTTCTGTACATTATTGTTGACCATTCAGTTCTCAGACGGAAGGATCCATTTC
Ls_phos_perm2      TGTCAGCCGTTCTGTACATTATTGTTGACCATTCAGTTCTCAGACGGAAGGATCCATTTC
Ls_phos_perm3      TGTCAGCCGTTCTGTACATTATTGTTGACCATTCAGTTCTCAGACGGAAGGATCCATTTC
                   ************************************************************
Ls_phos_perm1      GTTGTGGTTTGAGAGCTTTGCCAATATTTTACTGGTTTTGTATCGCATTTAATATTTTCA
Ls_phos_perm2      GTTGTGGTTTGAGAGCTTTGCCAATATTTTACTGGTTTTGTATCGCATTTAATATTTTCA
Ls_phos_perm3      GTTGTGGTTTGAGAGCTTTGCCAATATTTTACTGGTTTTGTATCGCATTTAATATTTTCA
                   ************************************************************
Ls_phos_perm1      CCGCTAGCTATCAAGGATTGAAATTACTTCGCCTGTCAAAGTTGCCGTTGTGGTTGAGCT
Ls_phos_perm2      CCGCTAGCTATCAAGGATTGAAATTACTTCGCCTGTCAAAGTTGCCGTTGTGGTTGAGCT
Ls_phos_perm3      CCGCTAGCTATCAAGGATTGAAATTACTTCGCCTGTCAAAGTTGCCGTTGTGGTTGAGCT
                   ************************************************************
spliced leader 1
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Ls_phos_perm1      CATTAGTGAGTATTGGATGTGCAACAGTTGGCTCCATCGCTATTTACTTTTTGCTCTTGC
Ls_phos_perm2      CATTAGTGAGTATTGGATGTGCAACAGTTGGCTCCATCGCTATTTACTTTTTGCTCTTGC
Ls_phos_perm3      CATTAGTGAGTATTGGATGTGCAACAGTTGGCTCCATCGCTATTTACTTTTTGCTCTTGC
                   ************************************************************
Ls_phos_perm1      CGAGGCTGAAAATCTGGATAAACAATTCACTTGGCAGTAATACAGCTAGAGACGATTCGT
Ls_phos_perm2      CGAGGCTGAAAATCTGGATAAACAATTCACTTGGCAGTAATACAGCTAGAGACGATTCGT
Ls_phos_perm3      CGAGGCTGAAAATCTGGATAAACAATTCACTTGGCAGTAATACAGCTAGAGACGATTCGT
                   ************************************************************
Ls_phos_perm1      TTGAAGTGCAGACTATAAGTAATGCGGTTCAATTGGAGGGAAATGTGATAAATCAAAAAT
Ls_phos_perm2      TTGAAGTGCAGACTATAAGTAATGCGGTTCAATTGGAGGGAAATGTGATAAATCAAAAAT
Ls_phos_perm3      TTGAAGTGCAGACTATAAGTAATGCGGTTCAATTGGAGGGAAATGTGATAAATCAAAAAT
                   ************************************************************
Ls_phos_perm1      GTCAAGCATCGAAGACAGAAAATGTTGAGAGTTCAACTGTTATCAAAAGCGATAGCAAAA
Ls_phos_perm2      GTCAAGCATCGAAGACAGAAAATGTTGAGAGTTCAACTGTTATCAAAAGCGATAGCAAAA
Ls_phos_perm3      GTCAAGCATCGAAGACAGAAAATGTTGAGAGTTCAACTGTTATCAAAAGCGATAGCAAAA
                   ************************************************************
Ls_phos_perm1      TCATCGAGAGTATGGCGAAAAAGGGTGAAGAAAAGAAACTAACCGATAATACAGTAATGA
Ls_phos_perm2      TCATCGAGAGTATGGCGAAAAAGGGTGAAGAAAAGAAACTAACCGATAATACAGTAATGA
Ls_phos_perm3      TCATCGAGAGTATGGCGAAAAAGGGTGAAGAAAAGAAACTAACCGATAATACAGTAATGA
                   ************************************************************
Ls_phos_perm1      AGTTCATTCGTTGGATATTGCCGACTGATAATAGAGCAACGGACAATAGAACAATGAAAA
Ls_phos_perm2      AGTTCATTCGTTGGATATTGCCGACTGATAATAGAGCAACGGACAATAGAACAATGAAAA
Ls_phos_perm3      AGTTCATTCGTTGGATATTGCCGACTGATAATAGAGCAACGGACAATAGAACAATGAAAA
                   ************************************************************
Ls_phos_perm1      TATTTAGTTCGATACAAGCTTTTACCGCGTGCTTTGCTGGATTTGCGCATGGCGCTAATG
Ls_phos_perm2      TATTTAGTTCGATACAAGCTTTTACCGCGTGCTTTGCTGGATTTGCGCATGGCGCTAATG
Ls_phos_perm3      TATTTAGTTCGATACAAGCTTTTACCGCGTGCTTTGCTGGATTTGCGCATGGCGCTAATG
                   ************************************************************
Ls_phos_perm1      ACGTCGGGAATGCAATAGCTCCGCTGACAGCATTGATATCGATTTACAGTAATCTGGATG
Ls_phos_perm2      ACGTCGGGAATGCAATAGCTCCGCTGACAGCATTGATATCGATTTACAGTAATCTGGATG
Ls_phos_perm3      ACGTCGGGAATGCAATAGCTCCGCTGACAGCATTGATATCGATTTACAGTAATCTGGATG
                   ************************************************************
Ls_phos_perm1      TTCGACAACGAAGTGAAACACCGATCTATGTGTTACTGTACGGCGTACTTGCAATATGTG
Ls_phos_perm2      TTCGACAACGAAGTGAAACACCGATCTATGTGTTACTGTACGGCGTACTTGCAATATGTG
Ls_phos_perm3      TTCGACAACGAAGTGAAACACCGATCTATGTGTTACTGTACGGCGTACTTGCAATATGTG
                   ************************************************************
Ls_phos_perm1      TTGGACTTGTGGTACTTGGACATCACGTAATACAAACTATTGGTACTGATATGTCTACGA
Ls_phos_perm2      TTGGACTTGTGGTACTTGGACATCACGTAATACAAACTATTGGTACTGATATGTCTACGA
Ls_phos_perm3      TTGGACTTGTGGTACTTGGACATCACGTAATACAAACTATTGGTACTGATATGTCTACGA
                   ************************************************************
Ls_phos_perm1      TCAATGCTGCTAGCGGTTTTACAATCGAATTCGGTGCAGCGGTAACTTCACTAACAGCCA
Ls_phos_perm2      TCAATGCTGCTAGCGGTTTTACAATCGAATTCGGTGCAGCGGTAACTTCACTAACAGCCA
Ls_phos_perm3      TCAATGCTGCTAGCGGTTTTACAATCGAATTCGGTGCAGCGGTAACTTCACTAACAGCCA
                   ************************************************************
Ls_phos_perm1      GTAAACTTGGCCTACCAATTAGTACAACCCATTCATTGGTGGGAAGCGTGGTATTCGTTG
Ls_phos_perm2      GTAAACTTGGCCTACCAATTAGTACAACCCATTCATTGGTGGGAAGCGTGGTATTCGTTG
Ls_phos_perm3      GTAAACTTGGCCTACCAATTAGTACAACCCATTCATTGGTGGGAAGCGTGGTATTCGTTG
                   ************************************************************
Ls_phos_perm1      GAATGGTGCGTGCCAAGAAAGGTGTCCAGTGGTTAATATTCCGAAACATTGCCTTATCGT
Ls_phos_perm2      GAATGGTGCGTGCCAAGAAAGGTGTCCAGTGGTTAATATTCCGAAACATTGCCTTATCGT
Ls_phos_perm3      GAATGGTGCGTGCCAAGAAAGGTGTCCAGTGGTTAATATTCCGAAACATTGCCTTATCGT
                   ************************************************************
Ls_phos_perm1      GGATTTTAACGTTGCCTATTTCAGGTCTTTTGGCAATGGGTTTGACGTTAATCCTCAAGT
Ls_phos_perm2      GGATTTTAACGTTGCCTATTTCAGGTCTTTTGGCAATGGGTTTGACGTTAATCCTCAAGT
Ls_phos_perm3      GGATTTTAACGTTGCCTATTTCAGGTCTTTTGGCAATGGGTTTGACGTTAATCCTCAAGT
                   ************************************************************
Ls_phos_perm1      TTTCACTTTGAGAGTGTAGTTGGACATTTATTTTTTCTTGTACATTTGTTACTTTGTTGT
Ls_phos_perm2      TTTCACTTTGAGAGTGTAGTTGGACATTTATTTTTTCTTGTACACTTGTTACTTTGTTGT
Ls_phos_perm3      TTTCACTTTGAGAGTGTAGTTGGACATTTATTTTTTCTTGTACACTTGTTACTTTGTTGT
                   ******************************************** ***************
Ls_phos_perm1      ATATTTTCATCAGTTCACCCATTCTCATCTTTGTTTACTTTAATTTTTTT-GACTAAAAA
Ls_phos_perm2      ATATTTTCATCAGTTCACTCATTCTCATCTTTGTTTACTTTAATTTTTTTTGACTAAAAA
Ls_phos_perm3      ATATTTTCATCAGTTCACTCATTCTCATCTTTGTTTACTTTAATTTTTTTTGACTAAAAA
                   ****************** ******************************* *********
polyA signal
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Ls_phos_perm1      AAAAAAAA
Ls_phos_perm2      AAAGAATTTCACTATCATCAATTTTTCGTTAATTTTTATTTGTGTCCTTGAAAAAGCAAC
Ls_phos_perm3      AAAGAATTTCACTATCATCAATTTTTCATTAATTTTTATTTGTGTCCTTGAAAAAGCAAC
                   *** **
Ls_phos_perm1
Ls_phos_perm2      TACTTCCTTAAAAAAAAAGAAAAAAAAAAGAAAAAAAAAAA
Ls_phos_perm3      TACTTCCTTATATTGCAGCTCCACGATATAAATTGAAAGATCTTTGCTCAAATTAATTTC
Ls_phos_perm1
Ls_phos_perm2
Ls_phos_perm3      CATATTAGTTGATAGAAGGTAGGGTAATATTCTTCTGATTTCAATAATTCATCAATTACT
Ls_phos_perm1
Ls_phos_perm2
Ls_phos_perm3      TATTTAACTGCAATCAATGGCAAATCGTATTTGATGAGGGAAATGTTAGATTAAATTAAT
Ls_phos_perm1
Ls_phos_perm2
Ls_phos_perm3      CAATGTTTGAGAAAGAAGATTGACTTAATTTTATTAAAATTTTAATTGAAAAAAAAAAAA
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Appendix B
Alignment of the available nematode homologues of Ls-ppe-1.
The C. elegans (Ce) and C. briggsae (Cb) genes are designated by their WormPep (Ce) (The C. elegans Genome
Sequencing Consortium, 1998) and BriggPep (Cb) (Stein, 2003) names respectively. The sequences derived
from ESTs are named using the NemBase cluster identifiers (Parkinson, 2004). The sequences derived from the
B. malayi whole genome sequence assembly (Ghedin, 2004) are designated by their TIGR gene model names,
suffixed with “MB” to indicate that these differ slightly from the current TIGR database versions because of re-
prediction during this work. N- and C-terminal missing data is indicated by blank cells, while ‘-‘ indicates an
introduced gap residue. One amino acid in OVC00569 was not predictable because of ambiguity in EST
sequence (residue X). Residues with >80% conservation in aligned residues are shaded. Analysis by Mark
Blaxter (Heider, 2006).
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